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Abstract
Salmonella enterica is an intracellular bacterial pathogen that replicates within membrane-
bound vacuoles by delivering virulence (effector) proteins across the vacuolar membrane by
the SPI-2 type III secretion system (T3SS). In this thesis I show that through the action
of this T3SS, Salmonella selectively interferes with a subset of endosome-to-trans-Golgi
network (TGN) traffic that is involved in mannose-6-phosphate receptor (MPR) recycling.
Two pathways of endosome-to-TGN traffic have been described: one involves the Q-SNARE
syntaxin 6; the other is defined by the Q-SNARE syntaxin 10 and involves retrograde trans-
port of the MPRs. Salmonella specifically disrupted syntaxin 10-dependent endosome-to-
TGN traffic and this was accompanied by redistribution of MPR from the TGN, misrouting
of newly synthesized lysosomal enzymes and attenuation of lysosome function. The SPI-2
T3SS effector SifA is an important virulence determinant that is known to interact with
the endolysosomal system. SifA was shown to be required and sufficient to mediate the
effects on lysosome biogenesis during infection or following transfection of host cells. By
contrast, a variant of SifA with a single amino acid substitution that prevents interaction
with its host protein target, SKIP, failed to redistribute MPR or to reduce lysosomal func-
tion. SKIP was found to contribute to lysosomal biogenesis in uninfected cells. Inhibition
of lysosomal enzyme function with a lysosomal protease inhibitor or by depleting cells of
syntaxin 10 enhanced intracellular bacterial replication. I conclude that SifA attenuates
lysosomal activity through its interaction with SKIP and that this facilitates intracellular
bacterial replication.
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Chapter 1
Introduction
1.1 Salmonella - General information
1.1.1 Taxonomy
Salmonella are rod-shaped, Gram-negative, motile bacteria that belong to the family En-
tereobacteriaceae. The genus Salmonella is divided into two species, Salmonella bongori
and Salmonella enterica, which itself is sub-divided on the basis of sequence variation and
biochemical properties, into a further 6 sub-species: S. enterica (I), S. salamae (II), S.
arizonae (IIIa), S. diarizonea (IIIb), S. houtenae (IV), and S. indica (VI) (Boyd et al.,
1996; McQuiston et al., 2008). Further classification of these sub-species based on spe-
cific surface antigens, the O antigen from lipopolysaccharide structures and the H antigen
associated with variations in flagellin (a component of the flagellum), has resulted in ap-
proximately 2500 serovars being identified (Brenner et al., 2000; Lan et al., 2009). The
huge variety of subspecies and serovars of S. enterica is indicative of the broad range of
host and environmental niches occupied by this organism.
The vast majority of serotypes associated with disease in humans and warm-blooded
animals belong to sub-species I, S. enterica sub-species enterica, hereafter referred to as
either, S. enterica or Salmonella (Brenner et al., 2000). Serotypes of S. enterica show
significant differences with respect to host adaptation, clinical presentation and biological
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diversity (Kingsley & Bäumler, 2000). For example some serotypes are restricted in their
host range, such as S. Typhi and S. Paratyphi for humans, or S. Pullorum for fowl, and are
unable to cause disease in other hosts. Other serovars show a preference for certain hosts
but are not restricted and are said to be host-adapted, as is the case with porcine-adapted
S. Dublin and S. Choleraesuis, which can occasionally be isolated from the blood of humans
(Kingsley & Bäumler, 2000). In contrast to the more restricted serovars there are those,
such as S. Typhimurium, that cause a broad range of diseases in a variety of hosts including
rodents, sheep, humans, cattle, horses, poultry and pigs (Kingsley & Bäumler, 2000; Ohl
& Miller, 2001; Lan et al., 2009).
1.1.2 Diseases in humans
Salmonella enterica is the causative agent of several diseases in humans which can be
broadly divided into three categories based on their clinical manifestations and causative
serovars: typhoid fever, a systemic infection, caused by S. Typhi or S. Paratyphi; gastroen-
teritis, predominantly caused by S. Typhimurium and S. Enteritidis; and non-typhoidal
Salmonella (NTS) bacteremia caused by S. enterica serotypes other than S. Typhi or S.
Paratyphi, predominantly S. Typhimurium and S. Enteritidis.
1.1.2.1 Disease incidence in humans
Salmonella infection is a major economic and public health burden. A survey on the
frequency and morbidity of typhoid fever estimated the annual incidence in excess of 21.5
million cases with over 200,000 associated deaths (Crump et al., 2004). Similarly, there is
a significant impact of NTS disease globally, with over 94 million cases recorded annually,
and approximately 155,000 deaths (Majowicz et al., 2010). Furthermore, NTS serovars
which cause invasive disease are increasingly linked with a high morbidity rate, especially
when complicating factors such as co-infection with HIV or malnutrition are considered
(Gordon & Graham, 2008; Gordon, 2008).
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1.1.2.2 Gastroenteritis
Gastroenteritis in humans is most frequently caused by S. Typhimurium and S. Enteritidis,
although some other NTS serovars can also cause a similar disease. The predominant mode
of transmission is through the oral-fecal route with contamination of food or water being
the usual source of infection. Symptoms of the disease first appear after an incubation
period of between 10 and 72 h after exposure. These include vomiting, abdominal cramps,
nausea, fever, chills and inflammatory diarrhoea. Initially bacteria invade and colonise
the ileum, Peyer’s patches and mesenteric lymph nodes. There is a resultant localised
immune response which involves massive infiltration of neutrophils (Hapfelmeier & Hardt,
2005). Diarrhoeal symptoms are believed to be caused by the neutrophil-rich exudate.
The resultant risk of dehydration is one of the greatest factors contributing to morbidity
in otherwise healthy patients. In the vast majority of cases gastroenteritis is an acute but
self-limited disease that does not require pharmacological intervention, resolving in 7 to 10
days. Management primarily involves adequate rehydration with water and electrolytes to
negate the risk of dehydration (Zhang et al., 2003; Raffatellu et al., 2008).
1.1.2.3 Typhoid fever
If left untreated, typhoid fever can lead to death in approximately 10% of cases (Raffatellu
et al., 2008). As with gastroenteritis, transmission is through the oral-fecal route with
contaminated food and water being the predominant sources of infection. The pathology of
the illness differs greatly from gastroenteritis. S. Typhi and S. Paratyphi both infect Peyer’s
patches of the intestinal ileum. However they induce only a mild intestinal inflammatory
response, localised to the Peyer’s patches (Parry et al., 2002). Once translocated across the
intestinal epithelium the bacteria begin to replicate in the lamina propria and mesenteric
lymph nodes. Here the bacteria gain access to the bloodstream which they use as a conduit
to colonise the spleen, liver and bone-marrow. After phagocytosis by monocytic cells at
these sites Salmonella undergoes a second period of extensive intracellular replication and
spread within these regions. The bacteria can also colonise the gall bladder from which
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they can re-seed the gut. Secondary exposure of the intestinal tissue to the bacteria
frequently causes hemorrhagic necrosis of the gut epithelium. This can result in perforation
of the intestinal wall leading to infected peritonitis. Much of the morbidity associated with
typhoid fever is a consequence of infected peritonitis (Everest et al., 2001).
Symptoms at the earlier stages of infection include prolonged fever and mild inflamma-
tion of the small intestinal lymphoid tissue. Later, following reseeding of the gut from the
gall bladder, the disease is characterised by a high fever, headaches, and strong abdomi-
nal pain. Secondary symptoms include malaise, constipation, anorexia and in some cases
diarrhoea (Raffatellu et al., 2008).
Approximately 1–5% of patients resolve acute typhoid fever but go on to develop a
chronic asymptomatic infection. In these individuals S. Typhi is continually shed in urine
or stools (Bhan et al., 2005). Chronicity in the population is also thought to be brought
about by subclinical infections (Mohan & Mohan, 2006). Together this population of
chronically infected individuals is thought to be an important reservoir of transmission
in the community. Furthermore, there is evidence to suggest that long term carriage of
S. Typhi gives rise to an increased risk of developing gall bladder carcinomas placing
chronically infected individuals in a high risk category (Nath et al., 2008).
1.1.2.4 Invasive bacteremia
Less than 5% of patients with NTS-associated gastroenteritis go on to develop non-typhoidal
bacteremia, largely caused by S. Typhimurium and S. Enteritidis (Hohmann, 2001). This
is most prevalent in young and immunocompromised individuals especially when secondary
factors of malnutrition, malaria or anemia are present (Gordon et al., 2002; Gordon & Gra-
ham, 2008; Gordon, 2008). In sub-saharan Africa, where the incidence of HIV infection
is high, invasive bacteremia, associated with NTS, is much more prevalent and is a major
cause of death (Gordon, 2008). The pathology of this disease differs to typhoidal Salmonella
infection, in that it is largely a disease of the blood. In immunocompromised individuals
with invasive NTS a factor contributing to susceptibility is a dysregulation of the adaptive
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immune response. In immunocompetent individuals infection would normally be cleared
from the blood through complement and antibody mediated killing (MacLennan et al.,
2008; Gondwe et al., 2010; MacLennan et al., 2010). In contrast in immunocompromised
individuals the blood contains large numbers of antibodies against LPS which obstruct or
otherwise prevent the bactericidal activity of antibodies that recruit complement to the
bacterial surface (Moir & Fauci, 2010).
1.1.3 Experimental models of infection
To study the different virulence mechanisms of Salmonella, as well as host responses, several
model systems have been developed.
1.1.3.1 Animal models of human gastroenteritis
S. Typhimurium and S. Dublin are natural pathogens of calves and have both been used
to model human gastroenteritis in this host. Infection of calves with S. Typhimurium is
generally believed to provide a more representative system with which to study the disease,
as it produces a diarrhoeal disease which more closely resembles the human illness (Zhang
et al., 2003). After inoculation, S. Typhimurium invades the intestinal epithelium at the
Peyer’s patches, leading to a large inflammatory response predominantly associated with
neutrophil infiltration (Tsolis et al., 1999). Clinical symptoms of the disease include diar-
rhoea, fever, dehydration and prostration and the intestinal pathologies are similar to those
found in human enteritis caused by S. Typhimurium (Zhang et al., 2003). Streptomycin-
treated mice have also been utilised to study gastroenteritis as a more cost effective animal
model (Barthel et al., 2003). Infection using this system produces an illness that resembles
many aspects of the human infection, including epithelial ulceration, edema, and large
infiltration of neutrophils. In addition to the advantage of cost, the use of mice also allows
for greater investigation into host pathogen interactions due to the availability of an ever
increasing panel of genetic knock-out mice.
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1.1.3.2 Animal models of typhoid fever
The host restriction of S. Typhi has made it difficult to study virulence mechanisms.
Although higher primates and rhesus monkeys can be infected with S. Typhi to cause
an illness similar to typhoid fever, the restricted availability and cost associated with
using these animals has severely limited their use (Gaines et al., 1968a,b; Rout et al.,
1974). The more widely adopted model for the study of systemic Salmonella infection is
susceptible mice infected with S. Typhimurium. This combination produces a systemic
illness with many of the features of human typhoid fever and has provided a great deal of
information concerning both virulence and host defence mechanisms. However, differences
in the pathologies and host tropism between S. Typhi and S. Typhimurium indicate distinct
virulence mechanisms, some of which are not replicated in the mouse model. A clear
example of differences in the pathology of S. Typhi in humans and S. Typhimurium in
mice is the ability of S. Typhi to re-infect the intestine from the gall bladder (Everest et al.,
2001). Although S. Typhimurium can be detected in the mouse gall bladder, significant
re-seeding of the gut does not occur via this route (Menendez et al., 2009). Furthermore,
there are important differences in the virulence determinants of these strains. For example,
the virulence plasmid (spv) operon of S. Typhimurium is absent from S. Typhi and the
Vi capsule antigen of S. Typhi is absent from S. Typhimurium. The spv operon has been
shown to be important for virulence in mice whereas the Vi capsule antigen has anti-
inflammatory activity and a role in resistance to complement-mediated killing during the
development of typhoid fever in humans (Bäumler, 1997; Raffatellu et al., 2006).
S. Typhimurium can gain access to the spleen and liver when susceptible mice are
inoculated orally, intraperitonealy or intravenously. Oral inoculation represents the most
physiological route of infection, with bacteria traversing the low pH of the stomach to
colonise the small intestine (Carter & Collins, 1974). Here they traverse the epithelium
through direct invasion of M-cells in the Peyer’s patches, and/or enterocytes or through
phagocytosis by CD18+cells, likely to be dendritic cells (Vazquez-Torres et al., 1999). After
traversing the intestinal barrier the bacteria migrate via the reticuloendothelial system
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to colonise the liver and the spleen (Carter & Collins, 1974; Fields et al., 1986). The
proliferative phase of infection largely takes place in these organs in which the bacteria are
predominately located within macrophages and Kupffer cells (Richter-Dahlfors et al., 1997;
Salcedo et al., 2001). Unrestricted bacterial proliferation at these sites of infection leads to
bacteremia and eventual death due to lipopolysacharide (LPS)-induced septic shock (Khan
et al., 1998; Santos et al., 2001).
1.1.3.3 In vitro models
An essential component of Salmonella virulence is its ability to survive and replicate within
host cells. Much of our understanding of how it achieves this at the cellular level is derived
through the use of cultured epithelial and macrophage cells. Infection using cells has yielded
much greater insight into the molecular basis of invasion (Patel & Galán, 2006), Salmonella-
containing-vacuole (SCV) maturation (Méresse et al., 1999a) and other host-vesicular traf-
ficking interactions (Garcia-del Portillo et al., 1993; Garcia-del Portillo & Finlay, 1995;
Knodler & Steele-Mortimer, 2003). The importance of replication in macrophages is ev-
ident by the finding that many mutants that are defective for growth in macrophages
are avirulent in mice (Fields et al., 1986). A variety of cell lines are commonly used, in-
cluding those from both human and mouse origin, such as mouse RAW 264.7 and J774
macrophage-like cell lines, and human HeLa epithelial cells. Primary bone marrow derived
mouse macrophages and elicited peritoneal macrophages are also useful cell types with
which interactions with Salmonella can be studied in a more physiological and restrictive
environment.
1.2 Molecular determinants of pathogenesis
S. enterica employs a broad range of molecular factors that help it to subvert host function
in a manner that allows for successful colonisation and infection. Some factors are present
in all serovars whereas others are unique to specific serovars which determines the types of
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disease caused.
1.2.1 Salmonella pathogenicity islands
Many virulence genes of S. enterica have been acquired via horizontal gene transfer and are
located in genetic elements such as pathogenicity islands (PAI), prophages and plasmids
(Groisman & Ochman, 1997). Genetic screens have shown that pathogenicity islands (SPI)
are present in the genome and encode many virulence factors that contribute to pathogen-
esis (Galan & Curtiss, 1989; Shea et al., 1996). Some PAIs are present throughout the
entire genus whereas others are only present in certain serovars and are believed to confer
to host specificity (Marcus et al., 2000; Hansen-Wester & Hensel, 2001; Hensel, 2004). S.
Typhimurium, which is extensively used in mice as a model system for the study of typhoid
fever, shares 11 pathogenicity islands with S. Typhi, though their genetic makeup differs
(Sabbagh et al., 2010). Distinct aspects of Salmonella pathogenesis have been linked to
specific PAIs. These include its ability to invade and replicate within host cells. These
actions have been attributed to the activity of two type three secretion systems (T3SS) en-
coded by SPI-1 and SPI-2. The T3SS (discussed in more detail below) translocate a range
of bacterial proteins into the host cell that interfere with host cell processes to promote
infection.
1.2.2 Fimbriae
Salmonella attaches to the mucosal surfaces of the small intestine and subsequently invades
epithelial cells. Fimbriae are hair-like surface appendages of approximately 8 nm that
enable Salmonella to adhere to the intestinal epithelium (Bäumler et al., 1996; Humphries
et al., 2001). Furthermore, fimbrial adhesins are believed to confer a tropism towards
Peyer’s patches of the small intestine, which is a predominate site of intestinal colonisation
by Salmonella (Bäumler et al., 1997). It has also been suggested that fimbrial adhesins can
target Salmonella for direct uptake by dendritic cells (DC)(Guo et al., 2007). DCs have
been visualised taking up Salmonella directly from the gut lumen through the intestinal
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epithelium (Niess et al., 2005; Chieppa et al., 2006). Thus DCs represent an alternative
route through which the intestinal barrier can be traversed.
1.2.3 Flagella
Flagella are surface-localised long helical filaments with a diameter of approximately 20
nm. The rotational movement of the flagella provides motility to Salmonella and this in
turn contributes to virulence by increasing invasiveness (Schmitt et al., 2001). Additionally,
flagellin subunits of the flagella have been shown to be translocated by the SPI-1 T3SS
into the cytosol of infected macrophages. This is believed to induce caspase-1-mediated
cell death through activation of the inflammasome (Ren et al., 2006; Miao et al., 2007; Sun
et al., 2007b). Once inside the cell flagella are believed to be coordinately down-regulated
together with the SPI-1 T3SS (Eriksson et al., 2003).
1.2.4 Two component regulatory systems
An essential aspect of Salmonella virulence is its ability to respond to environmental
molecules and coordinately regulate expression of specific genes required for pathogene-
sis. The two-component regulatory system PhoP/PhoQ is a major regulator in this re-
gard, co-ordinating the expression of over 40 genes (Groisman et al., 1989; Miller, 1991).
The PhoP/PhoQ system responds to environmental signals of low pH, Mg2+concentration
and antimicrobial peptides (AMP)s (Alpuche Aranda et al., 1992; García Véscovi et al.,
1996; Bader et al., 2005). PhoQ is an inner membrane-bound kinase that senses low pH,
Mg2+concentration and/or antimicrobial peptides and phosphorylates its cognate response
regulator, PhoP, which can then function as a transcriptional regulator of many genes
(Groisman, 2001). Genes positively regulated by PhoP/PhoQ (pags) include those en-
coding a family of proteins involved in Mg2+ uptake and transport and others involved
in LPS modification (Ernst et al., 2001). The PhoP/PhoQ system has also been shown
to be important to repress expression of certain genes (prgs). These include regulators
of the SPI-1 T3SS (Bijlsma & Groisman, 2005). It has been suggested that PhoP/PhoQ
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might also regulate SPI-2 T3SS expression as mutations in the phoP gene led to reduced
expression of the SPI-2 T3SS in vitro (Deiwick, 1999; Lee et al., 2000; Worley et al., 2000).
This conclusion has been disputed though as the SPI-2 T3SS expression in cultured in-
fected macrophages is largely independent of PhoP-PhoQ (Valdivia & Falkow, 1997). In
addition, during competitive infection experiments in mice these two systems were found
to contribute independently to virulence (Beuzón et al., 2001).
A second two component regulatory system important for the pathogenesis of Salmonella
is OmpR/EnvZ which responds to changes in osmolarity and pH (Bang et al., 2000, 2002).
Expression of the SPI-2 T3SS is indirectly regulated by this system through its effect on the
SsrA-SsrB two component system encoded by SPI-2. This directly controls the expression
of the SPI-2 T3SS (Cirillo et al., 1998; Garmendia et al., 2003).
1.2.5 Type III secretion systems
T3SSs are likened to ‘molecular syringes’ that deliver bacterial virulence proteins, called
effectors, directly from the bacterial cytoplasm into the host cell (Mota & Cornelis, 2005;
Galán & Wolf-Watz, 2006). These effectors manipulate cellular processes, frequently by
acting as mimics of host proteins. In Salmonella, the SPI-1 and SPI-2 T3SSs are regulated
at different stages of infection. The SPI-1 T3SS is essential for bacterial invasion (Galan &
Curtiss, 1989), whereas the SPI-2 T3SS, expressed intracellularly post-invasion, is required
for replication within host cells (Ochman et al., 1996; Hensel et al., 1998).
1.2.5.1 SPI-1 T3SS, invasion and SCV biogenesis
Salmonella translocates approximately 15 effectors via the SPI-1 T3SS into the host cell
(McGhie et al., 2009). SopE/SopE2, SopB, SptP and SipA, are SPI-1 T3SS effectors which
cooperate to induce actin rearrangements which allow invasion of non-phagocytic host cells
(Zhou & Galán, 2001; Patel & Galán, 2005). This occurs via extensive membrane ruﬄing
caused by protrusion of actin fibers at the cell surface. The ruﬄes trap bacteria, leading to
their internalisation. SopE/SopE2 function as guanine nucleotide exchange factors (GEF)s
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for Cdc42 and Rac1 and stimulate F-actin assembly by the Arp2/3 complex (Friebel et al.,
2001; Unsworth et al., 2004). Once inside the cell Salmonella resides in a membrane bound
compartment known as a SCV. SptP is a GTPase activating protein (GAP) and functions
to down regulate ruﬄe formation post-invasion (pi) (Fu & Galan, 1999). In addition, it
dephosphorylates AAA+ ATPase VCP modifying recruitment of cellular proteins to the
SCV (Humphreys et al., 2009) and together with some other SPI-1 effectors has been
implicated in early SCV biogenesis. SipA enhances actin polymerisation which contributes
to membrane ruﬄing facilitating bacterial internalisation. SipA functions to mechanically
stabilise the filament by linking actin subunits in opposing strands (Lilic et al., 2003).
SipA is also believed to co-operate with the SPI-2 effector SifA by influencing juxtanuclear
positioning and morphology of SCVs (Brawn et al., 2007). SopB is a inositol phosphatase
which modifies the phosphoinositide content of the SCV membrane (Patel & Galán, 2006).
The phosphatase activity has a range of effects and is responsible for activating SGEF which
acts on RhoG to promote actin rearrangement facilitating invasion. It is also implicated
in efficient sealing of the nascent SCV membrane. Furthermore, SopB modifies the charge
composition of the SCV membrane, which has been reported to influence SCV maturation
by reducing fusion with lysosomes (Terebiznik et al., 2002; Knodler et al., 2005; Patel &
Galán, 2006; Bakowski et al., 2010). Other phenotypes associated with the role of the
SPI-1 T3SS include macrophage cytotoxicity and inflammatory responses in the intestinal
mucosa (Hersh et al., 1999; Hapfelmeier et al., 2004; Bruno et al., 2009).
1.2.5.2 SPI-2 T3SS and associated effectors
The SPI-2 T3SS is required for virulence in mice (Hensel et al., 1995; Shea et al., 1996) and
replication within macrophages (Ochman et al., 1996; Hensel et al., 1998). Approximately
30 effectors are translocated in a tightly regulated process via this secretion system and are
responsible for a several intracellular phenotypes including SCV positioning in the infected
cell, SCV membrane dynamics, host cell migration and immune modulation. The secretion
apparatus is expressed in response to low pH, nutrient deprivation, Mg2+ concentration
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and AMPs encountered in the lumen of the SCV (Yoon et al., 2009). It is then assembled
in a hierarchical manner, initially with the formation of a secretion machinery spanning
the inner and outer membrane of the bacterial cell envelope. This is used to secrete three
classes of proteins in an ordered fashion. First, protein subunits are secreted to form a
hollow needle-like structure which protrudes from the cell surface. Then translocon proteins
are delivered through the needle and insert into the SCV membrane to form a pore. Finally,
the neutral pH of the host cell cytosol is sensed. This signal precipitates the disassembly
in the bacterial cell of a secretion system-associated regulatory complex composed of SpiC,
SsaM and SsaL. This then allows for the secretion and translocation of the effector proteins
(Yu et al., 2010).
After invasion of epithelial cells, SCVs migrate along microtubules to a perinuclear re-
gion that coincides with the microtubule-organising centre (MTOC) and the Golgi network
(Salcedo & Holden, 2003; Harrison et al., 2004; Ramsden et al., 2007). Here, Salmonella
undergoes replication, forming intracellular microcolonies comprising bacteria contained
within discrete vacuoles that are maintained in proximity to the Golgi network and MTOC.
SseF and SseG are two functionally interdependent effectors that interact to maintain the
SCV at the MTOC (Kuhle & Hensel, 2002; Salcedo & Holden, 2003; Deiwick et al., 2006;
Ramsden et al., 2007). It is currently unclear how this is achieved mechanistically.
The Golgi network is a point of convergence for secretory and endosomal traffic in the
cell. The ability of Salmonella to establish and maintain a microcolony juxtaposed to the
MTOC/Golgi network could increase SCV-endosomal or SCV-Golgi interactions to enable
nutrient and membrane acquisition (Salcedo & Holden, 2003; Ramsden et al., 2007; Mota
et al., 2009). This hypothesis is supported by the observation that Salmonella can alter
post Golgi traffic and in some cases redirects traffic to the SCV in a SPI-2 dependent
fashion (Kuhle et al., 2006; Mota et al., 2009).
A characteristic of intracellular Salmonella is its ability to induce the formation of
dramatic tubular membranous structures known as Salmonella-induced filaments (Sifs)
(Garcia-del Portillo et al., 1993). The SPI-2 T3SS effector, SifA, is essential for Sif for-
25
Chapter 1: Introduction
mation as mutant strains lacking SifA do not produce Sifs (Stein et al., 1996). SifA is
also critical in the maintaining the integrity of the SCV membrane, as sifA mutant strains
are released from their vacuole into the host cell cytosol several hours after internalisation
(Beuzón et al., 2000). Intriguingly, SPI-2 T3SS null mutants, that fail to translocate any
SPI-2 effectors maintain an intact vacuolar membrane, implicating other SPI-2 effectors
in the destabilisation of the SCV observed in a sifA mutant (Beuzón et al., 2000). The
SPI-2 effectors SseJ, PipB2 and SopD2 have been shown to contribute to the membrane
instability of the vacuolar membrane around the sifA mutant strain (Ruiz-Albert et al.,
2002; Schroeder et al., 2010).
SifA mediates its function through binding SKIP (SifA and kinesin-interacting protein)
also known as PLEKHM2 (pleckstrin homology domain containing, family M (with RUN
domain) member 2) (Boucrot et al., 2005). SifA functions through SKIP to maintain
SCV integrity as in cells depleted of SKIP wild-type bacterial cells are released into the
cytosol, phenocopying a sifA mutant strain (Boucrot et al., 2005). SKIP contains a RUN
domain within its N-terminal region that interacts with the (TPR) domain of kinesin light
chain to promote anterograde transport on microtubules (Diacovich et al., 2009). The C-
terminal region of SKIP contains a pleckstrin homology (PH) domain to which SifA binds
(Jackson et al., 2008a; Ohlson et al., 2008; Diacovich et al., 2009). Upon translocation,
SifA is prenylated by a host cell geranylgeranyl transferase allowing it to insert into the
SCV membrane (Reinicke et al., 2005). Here SifA interacts with SKIP, cross-linking the
SCV with kinesin-microtubule network to promote anterograde movement of membrane,
generating Sif formation (Dumont et al., 2010; Schroeder et al., 2011).
SifA also affects cellular GTPases and has been reported to bind to Rab7 and to act as
an exchange factor for the RhoA (Harrison et al., 2004; Boucrot et al., 2005; Ohlson et al.,
2008). As well as SifA, SKIP also binds the Rab9 (Jackson et al., 2008a). Rab9 is involved
with late endosome (LE)/lysosome function (Riederer et al., 1994a; Ganley et al., 2004)
and is reported to be antagonised by the interaction of SifA with SKIP (Jackson et al.,
2008a).
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As mentioned above, PipB2, SseJ and SopD2 are three SPI-2 T3SS effectors that are
functionally linked with SifA through the impact they have on Sif formation and vacuo-
lar stability. A pipB2 mutant strain displays impaired Sif formation (Knodler & Steele-
Mortimer, 2005). A sifA mutant strain has increased kinesin labelling associated with
the SCV prior to rupture (Boucrot et al., 2005). In a sifA pipB2 double mutant strain
kinesin recruitment is no longer enhanced, suggesting that PipB2 recruits kinesin to the
SCV (Henry et al., 2006). Furthermore, the same study showed direct binding between
PipB2 and kinesin-1.
SseJ, a glycerophospholipid-cholesterol acyltransferase (GCAT) that modifies the SCV
membrane, is activated by RhoA which is recruited and activated by SifA (Lossi et al.,
2008; Ohlson et al., 2008). Together, the combination of SifA, SseJ, RhoA and SKIP
increases membrane tubulation.
Though the function of SopD2 remains unclear, cells infected with a sopD2 mutant
strain of Salmonella have fewer Sifs than those infected with wild-type bacteria suggest-
ing a function in Sif formation (Schroeder et al., 2010). Furthermore, in sifA sseJ and
sifA sopD2 double mutant strains, defects in vacuolar stability associated with the sin-
gle sifA mutant strain are partially rescued. This provides further evidence of functional
interactions between these proteins (Ruiz-Albert et al., 2002; Schroeder et al., 2010).
Recently an hypothesis of how these proteins could be functionally interlinked has been
suggested. It is proposed that inactive kinesin-1 is recruited to the SCV by PipB2. Kinesin-
1 is then activated indirectly by SifA through SKIP. Together with RhoA, SseJ and SopD2,
anterograde transport along microtubules is extended from the SCV to drive Sif formation
(Schroeder et al., 2011). The molecular mechanisms of how these proteins are related
remains unknown and future work is required to enable a more coherent understanding of
the function and interaction between these bacterial and host proteins.
The host cell ubiquitin system is also a target for modulation by effectors of the SPI-2
T3SS. There are four effectors that interact with the ubiquitin pathway (Rytkönen et al.,
2007; Bernal-Bayard & Ramos-Morales, 2009; Quezada et al., 2009). SspH1 and SspH2 are
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E3 ligases with unknown physiological activity (Quezada et al., 2009). SlrP is also an E3
ligase that has been reported to increase host cell death by ubiquitinating thioredoxin to
reduce its activity (Bernal-Bayard & Ramos-Morales, 2009). SseL is an effector that has
deubiquitinase activity. It lacks a known cellular target but has been reported to induce
host cell cytotoxicity and to have a preference for lysine 63-linked chains in vitro (Rytkönen
et al., 2007).
The actin cytoskeleton is rearranged extensively during Salmonella invasion of non-
phagocytic cells. This is dependent on several SPI-1 T3SS effectors (see above). These
effects are transient and shortly after invasion the cortical cytoskeleton resumes its normal
morphology. However, beginning approximately four hours post-uptake a dense F-actin
meshwork accumulates in proximity to the SCVs (Méresse et al., 2001; Unsworth et al.,
2004). This is dependent on the SPI-2 T3SS effector SteC, which is a kinase (Poh et al.,
2008). In addition, unpublished data from our laboratory has identified MEK1 as a target
of phosphorylation by SteC. This leads to the activation of myosin-II, an actin motor
protein, which facilitates F-actin bundling and a formation of a meshwork around the
microcolony (Odendall and Holden, unpublished). This appears to regulate the replication
rate of intracellular bacteria, as mutants lacking SteC display increased intracellular growth
when compared to wild-type bacteria (Odendall and Holden, unpublished).
The SPI-2 T3SS effector protein SseI is thought to influence host cell motility, although
there is disagreement as to the effects. One study reported that it interacts with filamin
and thyroid receptor protein 6 (TRIP6) to enhance motility (Worley et al., 2006), whereas
another investigation identified a different cellular target of SseI; IQ-motif GTPase acti-
vating protein (IQGAP1). Here the effects reported are of an inhibition of cell migration
(McLaughlin et al., 2009). Clearly further work is required to resolve these contradictory
results.
Other SPI-2 T3SS effectors are thought to have a function in immune modulation.
Salmonella infection leads to polyubiquitination of MHC class II molecules in infected
antigen-presenting cells. This results in the removal of mature, peptide loaded molecules
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from the cell surface and is likely to be a immune evasion mechanism. Furthermore, this was
shown to be dependent on the activity of the SPI-2 T3SS though the effector(s) mediating
this effect remains unknown (Lapaque et al., 2009). SpvC is a SPI-2 T3SS effector that
is encoded by the spv operon (discussed further below). It is a member of a family of
effectors having phosphothreonine lyase activity on MAPKs involved in immune signaling
(Li et al., 2007; Mazurkiewicz et al., 2008). Phosphothreonine lyases remove the phosphate
group and adjacent oxygen atom from phosphothreonine in an irreversible process known
as eliminylation (Li et al., 2007; Brennan & Barford, 2009). In macrophages infected with
bacteria over-expressing SpvC there were reduced levels of secreted TNFα and IL-8 which
correlated with effects on the cellular MAP kinases ERK and JNK (Mazurkiewicz et al.,
2008).
There have been several other SPI-2 effectors identified. These include SifB, PipB,
GogB, SteA, SteB, SseK1, SseK2, SseK3, GtgE, GtgA, SpvD, SteD, SteE and CigR (Nie-
mann et al., 2011). The host targets, mechanisms and physiological effects of these proteins
are not known.
1.2.6 spv operon
Some Salmonella serovars carry virulence plasmids (Boyd & Hartl, 1998) whose phenotypes
are largely attributed to the action of the spv operon (Gulig et al., 1993; Chu & Chiu, 2006).
In mouse models of infection the spv genes of S. Typhimurium are required for systemic
growth in the spleen and liver (Gulig & Doyle, 1993). The expression of spvR, A, B, C and
D, is up-regulated in vivo and in tissue culture models of infection as well as in vitro where
conditions mimic those of the SCV (Wilson et al., 1997; Wilson & Gulig, 1998; Ygberg
et al., 2006). SpvR is a transcriptional regulator controlling the expression of spvA, B, C
and D. The functions of spvA and spvD remain unknown (Roudier et al., 1992; Matsui
et al., 2001b). spvB and spvC encode proteins translocated by the SPI-2 T3SS into the
host cell cytosol (Libby et al., 2000; Matsui et al., 2001a; Mazurkiewicz et al., 2008). spvB
encodes an actin-ribosyltransferase that prevents F-actin filaments forming, resulting in
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delayed cytotoxicity of infected cells (Libby et al., 2000; Otto et al., 2000; Lesnick et al.,
2001; Tezcan-Merdol et al., 2005). SpvC is a phosphothreonine lyase which is proposed to
have a role in the modulation of the immune response (see above) (Mazurkiewicz et al.,
2008) similar to a homolog found in Shigella flexneri known as OspF (Li et al., 2007).
1.3 Host cell vesicular traffic
The spatial and temporal organisation of membrane compartments inside the eukaryotic
cell is essential for life. Many vital physiological processes take place enclosed in, on or
across membranes. These include the synthesis of ATP, biogenesis of organelles of spe-
cialised function, protein secretion/uptake and cellular signaling. Intracellular membrane
systems create compositionally and morphologically distinct compartments that allow the
cell to regulate different activities through spatial separation. An example of one such
compartment is the separation of hydrolytic enzymes into lysosomes where through their
hydrolytic activity they breakdown macromolecules such as proteins, lipids and carbohy-
drates. Membrane enclosed transport vesicles and tubules (referred to as tubular-vesicular
transport) are utilised as a means by which the cell transfers material between membranous
organelles (Mellman & Warren, 2000). For the purposes of this thesis I will deal primarily
with the vesicular transport of proteinaceous cargo.
1.3.1 Cytoskeleton
The eukaryotic cell is provided with structure and shape by an internal filamentous cy-
toskeleton (Frixione, 2000). It comprises three primary protein networks of filaments: actin
filaments, intermediate filaments and microtubules. In addition to structural functions the
cytoskeleton plays an essential role in vesicular traffic, where it acts as a support network for
the movement of transport vesicles between compartments (Doherty & McMahon, 2008).
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1.3.1.1 Actin filaments
Actin is 42-kDa globular protein found in eukaryotic cells which is known as globular actin
(G-actin) in its monomeric form. It can polymerise to form linear actin filaments known as
F-actin. Two parallel F-actin filaments can intertwine to create double helix structures of
approximately 7 nm in diameter with a helix repeat every 37 nm. This creates the double
helix microfilament structure of the cytoskeleton. Actin filaments are polar in nature and
contain dynamic barbed polymerising (plus) ends and less active pointed (minus) ends.
Actin is involved in a range of cellular processes including muscle contraction, cell division,
cell signaling and cell motility. It is also important for the formation and maintenance
of cell junctions and cell shape (Doherty & McMahon, 2008). Furthermore, the actin cy-
toskeleton functions as a support network on which myosin motor proteins mediate short
range movement of vesicle carriers (Kjeken et al., 2004). Filament turnover involving nu-
cleation, elongation, and depolymerisation is controlled by actin-binding proteins including
ARP2/3, WASP, WAVE, WHAMM, WASH and JMY (Campellone & Welch, 2010).
1.3.1.2 Intermediate filaments
Intermediate filaments are made up from a large family of related proteins that share
common structural and sequence characteristics (Herrmann et al., 2007). There are ap-
proximately 70 different intermediate filament proteins including lamins, which are nuclear
structural components; vimentin, which support cellular membranes and maintain the spa-
tial distribution of some organelles within the cytoplasm; keratins, which function in acidic
and basic pairs to form filaments for a variety of structures like hair, nails and in epithelial
cell structural components (Herrmann et al., 2007). The majority are polymers of around
10 nm in diameter. The subunit proteins consist of globular domain at the N and C-termini
linked by an alpha-helical rod domain. The proteins form dimers consisting of a coiled coil
between the alpha-helical rod domains (Qin et al., 2009). Dimer protein complexes come
together to form multimeric filamentous structures. They help maintain the cell shape by
bearing tension and act as mechanical stress absorbers (Herrmann et al., 2007). In addition
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the internal distribution of some organelles are maintained by anchoring to intermediate
filaments (Herrmann et al., 2007). Unlike actin or microtubule filaments they are non-polar
with respect to their polymerisation (Herrmann et al., 2007).
1.3.1.3 Microtubules
Microtubules are composed of α- and β-tubulin subunit dimers that form in a head to tail
arrangement to form protofilaments. The protofilaments arrange themselves in a helical
formation of 13 filaments to create a hollow cylinders about 23 nm in diameter. The dimer
subunits exhibit a bent conformation when bound to GDP and a straight conformation
when bound to GTP. Tubulin polymerises end to end with the α subunit of one tubulin
dimer contacting the β subunit of the next. Accordingly, the protofilament has an exposed
α subunit at one end and β subunit at the other, which confers polarity. Protofilaments
bundle parallel to one another to form microtubules so polarity is extended to the micro-
tubule. The end that has exposed α subunits is designated the plus end and the β exposed
end being designated minus end. There is a cap at the minus end, which is normally
anchored at the microtubule organising centre and was recently identified to be composed
of a protein called Patronin (Howard & Hyman, 2007; O’Rourke & Sharp, 2011). Mi-
crotubules have a very dynamic behavior. Elongation occurs in the plus direction which,
like the minus end, is also capped to prevent depolymerisation. The subunit dimers bind
GTP straightening them to facilitate incorporation into the elongating plus end. After
incorporation the GTP is hydrolysed to GDP but the dimer subunits are kept in their
straightened conformation by the tubulin lattice and are prevented from reverting to their
bent shape. The resultant ’bending energy’ is stored within the microtubule and released
upon plus end cap dissociation. It is the driving force for microtubule depolymerisation
(Nogales & Wang, 2006; Howard & Hyman, 2007). Microtubules are biologically important
for many cell processes including cell motility, meiosis and mitosis. They also contribute to
cell structure by resisting compressive force. In addition, they play key roles in intracellu-
lar vesicular transport with the network acting as a substrate along which motor proteins
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move tubular-vesicular traffic. There are two major classes of motor proteins, kinesins and
dyneins, which generally move along the microtubule towards the plus end and the minus
end respectively (Vale, 2003).
1.3.1.4 Anterograde traffic
Anterograde vesicular traffic is generally associated with kinesin dependent vesicular move-
ment along microtubules towards their plus ends (Vale, 2003). Within eukaryotes it is car-
ried out among highly organised, directional, and compartmentalised routes. Post-synthesis
in the endoplasmic reticulum (ER), cargo is packaged in vesicular carriers and ferried from
the ER exit sites to Golgi network. After arriving at the Golgi, cargo is sorted into specific
post-Golgi carriers that move through the cytoplasm to target organelles in the endoso-
mal network or directly to the cell membrane. The directional anterograde movement of
membrane away from the ER and Golgi network is balanced by retrograde endocytic and
retrieval pathways.
1.3.1.5 Retrograde traffic
Retrograde traffic occurs in a dynein-mediated process along microtubules towards their
minus ends. Cargo proteins can be targeted to terminal degradative endocytic compart-
ments or to the Golgi network and subsequently to the ER (Pfeffer, 2007; Johannes &
Popoff, 2008). Often, retrograde pathways are exploited by pathogens to facilitate toxin
transport to the cell cytoplasm (Duclos & Desjardins, 2000; Watson & Spooner, 2006).
1.3.2 Major trafficking machinery
1.3.2.1 SNARES
In eukaryote cells soluble N-ethylmaleimide-sensitive factor attachment protein receptors
(SNAREs) are involved in almost all membrane fusion events (Behnia & Munro, 2005;
Hong, 2005; Jahn & Scheller, 2006; Leabu, 2006). They function in distinct groups of
polypeptides (from 3 or 4 proteins) to form an active SNARE complex. Vesicles, containing
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a specific R type SNARE subunit, fuse with vesicles or membranes containing 2 or 3 partner
specific Q-SNAREs. The Q-SNAREs can be subdivided into three categories, Qa, Qb, and
Qc. Each category, (R, Qa, Qb and Qc) contribute 1 sub-domain, categorised according
to their conserved motifs, to form the active SNARE complex. Once the R SNARE binds
to the QaQbQc SNARE sub domains on the target membrane an extended four helical
bundle is formed. The trans-complex functions to pull the two membranes closer together
to overcome the fusion energy barrier and the two membranes fuse. Specific complexes of
SNARE family proteins govern vesicular trafficking pathways, as well as their intermediary
steps.
1.3.2.2 Rabs
Rab GTPases are molecular switches that control much of the trafficking machinery within
the cell to regulate the spatio-temporal activity of vesicular traffic. They are synthesised
as cytosolic proteins and post-translationally modified by prenylation which allows them
to associate with and insert into target membranes. Localisation to specific organelles is
believed to be initially undertaken by Rab escort proteins (REP)s (Ali & Seabra, 2005).
They alternate between two conformational states of a GTP-bound active form and
a GDP-bound inactive form. A GEF converts the inactive GDP to GTP-bound forms,
whereas GAP induce a GTP active form conversion to a GDP inactive form (Stenmark,
2009). In their active form Rabs undergo a conformational change that allows them to
bind proteins known as Rab effectors. It is through these effectors and the functions they
mediate that Rab proteins exert influence on cellular traffic. In this way Rab GTPases
specify membrane identity through the proteins they recruit (Ali & Seabra, 2005; Stenmark,
2009). An example of the cascading regulation of Rab proteins is illustrated in their binding
of tethering factors, which themselves interact with SNAREs enabling their assembly (Epp
et al., 2011).
Rab proteins can be extracted from membranes by Rab GDP dissociation inhibitor
(GDI) when they are no longer needed. They remain in a GDI bound state in cytosol until
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required. GDI proteins can be displaced by Rab GDI-displacement factors (GDF)s which
allows retargeting to the membrane and reactivation of the Rab proteins (Ali & Seabra,
2005).
Specific Rab proteins function on cell organelles that have unique characteristics. This
spatial regulation is thought to be due in a large part to the lipid composition of the
membrane, most especially the phosphoinositide composition. Targeting of Rabs and ef-
fectors to restricted membranes can be accomplished in two ways. Firstly, certain Rab
effector proteins have domains that can recognise unique phosphoinositide content which
is believed to enhance their recruitment to membranes with this phosphoinositide composi-
tion, thereby increasing the frequency of interaction with their cognate Rab. Furthermore,
Rab protein association with the membrane can be stabilised in the presence of a bound
effector, as can be seen with Rab9 and tail interacting protein of 47kD (Tip47) (Ganley
et al., 2004; Aivazian et al., 2006). A second method is associated with an interesting
aspect of Rab GTPases effector activity. Some Rab effectors can function to modify the
phosphoinositide composition facilitating the recruitment of downstream effectors. Rab5
functions in this regard by recruiting a class III PI3K complex to produce phosphatidylinos-
itol 3-phosphate (PI(3)P) on endosome membranes. Interestingly, the Rab5 effectors early
endosomal antigen 1 (EEA1), rabenosyn 5 and rabankyrin 5 contain PI(3)P recognition
domains suggesting they may be recruited after PI3K (Stenmark, 2009).
1.3.2.3 Retromer
A component of cellular machinery that is of particular importance during retrograde
recycling is the retromer complex (Bonifacino & Rojas, 2006; Bujny et al., 2007). It
functions to sort and package cargo into tubular vesicular carriers derived from early endo-
some/endocytic recycling compartments (EE/ERC) that are destined for the trans-Golgi
network (TGN) or late-endosome/multi-vesicular body (LE/MVB) compartments (Bonifa-
cino & Hurley, 2008; Pfeffer, 2009). The complex is composed of two sub-complexes which
include a multimeric cargo recognition complex of Vps26-Vps35-Vps29 and tubulating com-
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plex of sorting nexins (SNX) proteins (Seaman, 2005; Rojas et al., 2007). The retromer
has been shown to be a critical component in endosome-to-TGN pathways affecting the
traffic of a broad variety of cargo including mannose-6-phosphate receptors (MPR)s (Arighi
et al., 2004; Seaman, 2004; Bonifacino & Hurley, 2008), wntless, Shiga toxin, and polymeric
immunoglobulin receptors (Vergés et al., 2004; Bujny et al., 2007; Belenkaya et al., 2008).
1.3.2.4 ESCRT complex
Endosomal sorting complex required for transport (ESCRT) refers to the cellular machinery
that sorts ubiquitin-modified cargo proteins targeted for degradation in the lysosome into
multivesicular bodies (MVBs). The complex is composed of 4 sub-complexes (ESCRT-0,
ESCRT-I, ESCRT-II, and ESCRT-III) that act sequentially by recognising a mono ubiq-
uitin modification on the cytosolic side of a membrane associated target protein. In this
way cells modify ubiquitinated protein to target them for degradation in the lysosome.
Through acting in concert the complexes invaginate and pinch off the membrane inter-
nalising the ubiquitinated protein on the luminal side of a vesicle contained in a MVB.
These vesicles and the cargo they contain are then degraded after subsequent fusion with
lysosomes (Hurley & Emr, 2006; Hurley, 2008).
1.3.2.5 Coat proteins and adapter proteins
The self-assembling molecular cytosolic coat scaffolds play an important role in vesicular
trafficking between sub-cellular organelles. They are directly recruited from the cytosol to
the membrane by small GTPases of the Arf1/Sar1 family where they help to deform flat
membranes into round buds (Springer et al., 1999). There are three known coat protein
complexes described to date in mammalian cells. These are clathrin, coat protein complex
I (COPI) and coat protein complex II (COPII) (Stagg et al., 2007). These coats all contain
an inner layer of adaptor protein (AP) complexes that link different types of cargo and aid
in the selective incorporation of cargo into specific vesicle carriers for specific trafficking
pathways (Cai et al., 2007).
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Clathrin forms a triskelion shape composed of three clathrin heavy chains and three
light chains. Triskelions interact to form a polyhedral lattice to enclose a vesicle (Stagg
et al., 2007). Clathrin-coated vesicles (CCV) selectively function in several membrane
trafficking pathways in post-Golgi traffic throughout the endosomal network and at the
cell membrane. APs such as the Epsin family of proteins (Hirst et al., 2004; Miller et al.,
2007) and AP180 (Ford et al., 2001) are important for self-assembly and recruitment of
the lattice as well as the correct selection of cargo.
COPI is a protein complex consisting of 7 subunits in a heptameric complex. COPI
vesicles traffic cargo from the cis-Golgi to the ER and between Golgi stacks (Beck et al.,
2009; Hsu & Yang, 2009; Pinot et al., 2010). COPI vesicle formation initiates with coat self-
assembly followed by membrane deformation and fission of the coated vesicle and finally
coat disassembly for recycling. Cargo containing the sorting motif KKXX interact with
COPI to form carriers which are transported from the cis-Golgi to the rough ER (Beck
et al., 2009; Pinot et al., 2010).
COPII is the coat protein involved in traffic from the ER to the Golgi. The COPII
protein complex comprises two protein heterodimers Sec23/Sec24 and Sec13/Sec31 which
are recruited to the site of budding on the ER membrane by Sar1 (Lee & Miller, 2007).
GTP bound Sar1 initially recruits Sec23/Sec24. Sec23 activates the GTPase activity of
Sar1 and Sec24 facilitates the selection cargo for incorporation into the nascent vesicle by
recognising IxM, LxxLE and DxE class motifs on target proteins (Mancias & Goldberg,
2008). Sec13/Sec31 are then recruited to the membrane to complete the outer layer of the
COPII coat which buds off and is transported to the Golgi (Lee & Miller, 2007).
1.3.2.6 Tethers
Molecular tethers are a class of large proteins that function in the initial interaction between
a vesicle and its target membrane. The tether guides the vesicle into position to allow the
pairing of transmembrane SNAREs on apposing membranes to facilitate fusion. Tethers
have been shown to interact at long range with the coat proteins of incoming vesicles (Ford
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et al., 2001). Together with Rabs, SNAREs and coat proteins they play an important role
in the specificity of vesicle targeting (Cai et al., 2007).
1.3.3 Organelles of the vesicular trafficking network
Cellular organelles are composed of proteins and lipids with distinct biochemical properties
and processes. They maintain these characteristics in spite of a large flux of transiting
cargoes.
1.3.3.1 The endoplasmic reticulum
The ER is a large cellular organelle that forms an interconnected network of tubules,
vesicles, and cisternae. There are two types of ER in the cell. Rough ER are intimately
associated with ribosomes and are the sites of protein synthesis within the cell whereas
smooth ER are the sites within the cell where synthesis of lipids, steroids and the regulation
calcium concentration occurs (McMaster, 2001; Hegde & Ploegh, 2010).
Proteins that are destined for secretion or transport to cellular organelles carry a signal
sequence of between 5-15 hydrophobic amino acids preceded by a positively charged amino
acid. When they are being synthesised by the ribosome the signal is recognised by the
signal recognition protein on the ER membrane. This enables the ribosome to associate
with the ER membrane and to translocate the emerging polypeptide into the lumen of
the ER. In the ER lumen chaperone proteins function to ensure that newly synthesised
proteins are correctly folded. This is also where proteins are modified through N-linked
glycosylation (Matlack et al., 1998; Baumann & Walz, 2001; Lee et al., 2004; Hegde &
Ploegh, 2010).
Vesicular carriers traffic continuously between the ER and the cis-Golgi ferrying pro-
teins and lipids between these compartments. Proteins within the ER containing IxM,
LxxLE and DxE class motifs are incorporated in COPII coated vesicles that leave the ER
exit sites and traffic to the cis-Golgi. Then COPI coated vesicular carries traffic from the
cis-Golgi back to the ER retrieving ER resident proteins and vesicle machinery (Lee &
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Miller, 2007; Hsu & Yang, 2009). Soluble ER resident proteins that exit the ER and traf-
fic to the cis-Golgi in vesicular carriers contain a specific KDEL motif that is recognised
by KDEL receptor. At the cis-Golgi the KDEL receptor, which itself contains a KKXX
COPI recognition sequence, binds the KDEL motif. The receptor and bound ligand are
then transported from the cis-Golgi back to the ER in a retrograde manner in COPI coated
vesicles (Pfeffer, 2007; Beck et al., 2009).
1.3.3.2 The Golgi network
Synthesis of macromolecules in a cell is a continuous process which is essential for the
viability of the cell. The Golgi network functions as a staging post within the cell for
newly synthesised material and is integral in modifying, sorting and packaging them into
carrier vesicles for anterograde traffic as well as receiving incoming retrograde traffic.
The Golgi network is composed of a series of cisternal membrane structures that are
arranged in closely associated stacks. The stacks are arranged end to end in animal cells
forming a ribbon-like structure (De Matteis & Luini, 2008). The stack is polarised and
contains three substructure networks known as the cis-Golgi network,medial -Golgi network
and the TGN. The cis-Golgi network exchanges proteins and lipids with the ER, whereas
the TGN exchanges proteins and lipids with the plasma membrane and compartments
of the endosomal network (Shorter & Warren, 2002; Wei & Seemann, 2010). Secretory
material from the ER traverses through the Golgi network in a cis to trans direction.
During this process proteins are post-translationally modified (e.g. O-glyosylation and
N-glycosylation modification) in a hierarchical fashion (Wei & Seemann, 2010).
1.3.3.3 The trans-Golgi network
The TGN is a tubular network that sorts newly synthesised proteins that arrive from
earlier Golgi network compartments into carrier vesicles for onward traffic as well as re-
ceiving incoming vesicular traffic from the endosomal network (De Matteis & Luini, 2008).
TGN associated sorting motifs and signals are present in many of the proteins to allow
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for the correct incorporation into carrier specific carrier vesicles. Examples include NPXY
or YXXØ and di-leucine [DE]XXXL[LI] or DXXLL consensus motifs which are recognised
as signals for endosomal-directed proteins. Post-translational modifications of cargo in-
cluding O-glycosylation and N-glycosylation and ubiquitylation can also affect its sorting
(De Matteis & Luini, 2008). Ubiquitylation can signal endosomal targeting in coopera-
tion with ARF-binding proteins and Golgi-localised-ear-containing (GGA) proteins (Scott
et al., 2004).
Cytosolic adapter-protein (AP) complexes that recognise cargo sorting motifs are re-
cruited to the TGN face in an ARF1 dependent fashion and mediate the packaging of cargo
into emerging coated vesicles. AP proteins can also bind clathrin and function as adaptors
between cargo proteins and the clathrin coat of the budding CCVs. Different AP proteins
function in different trafficking pathways such as AP1A and AP3 complexes which mediate
endosomal sorting (Robinson, 2004).
Despite being highly dynamic, the Golgi network maintains its structural organisation
through a mixture of Golgi-resident matrix proteins and a balance between incoming and
outgoing traffic (Short et al., 2005).
1.3.3.4 The endosomal network
Endosomes are membrane-bound compartments within the cell which are components of
the endocytic membrane transport pathway from the plasma membrane to the lysosome.
There are three main classes of cellular endosomes, early endosomes (EE), late endosomes
(LE), and recycling endosomes (RE). They differ in their biochemical and molecular prop-
erties and the cargo they are associated with (Mukherjee et al., 1997; Mellman & Warren,
2000). These compartments and the endocytic trafficking pathway are discussed in more
detail below.
Lysosomes are membrane bound compartments filled with acid hydrolase enzymes that
digest materials, including microorganisms and cellular debris. The lumen of the lysosome
is approximately pH 4.8. It is maintained by the pumping of H+ ions by vacuolar-type H+-
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ATPase (v-ATPase) proton pump from the cytosol across the membrane into the lumen.
Enzymes within the lysosome are pH sensitive and have an optimum activity around pH
4.5. This helps to restrict their activity to the lysosomal and late endosomal compartments
as they are not active at the neutral pH in other cellular compartments. Lysosomes function
by fusing with other membrane bound vacuoles, digesting their contents by exposing them
to the degradative enzymes within their lumen (Luzio et al., 2007). Lysosomal biogenesis
and maintenance is discussed in greater detail below.
1.3.4 Major vesicular trafficking pathways
Major vesicular trafficking pathways of the cell are illustrated in Fig. 1.1.
1.3.4.1 The secretory pathway
The secretory membrane system allows cells to regulate delivery of newly synthesised pro-
teins, carbohydrates, and lipids to the cell surface. Secretory cargo is synthesised in the ER
and, once correctly folded, is transported from the ER to the Golgi network in a COPII
mediated vesicular trafficking process (Palmer & Stephens, 2004). The cargo then tra-
verses through the cisternae of the Golgi network, where it can be enzymatically modified
by processes such as glycosylation. Eventually it arrives at the TGN where it is sorted and
packaged into appropriate carrier vesicles for onward traffic. Apical and basolateral sec-
retary proteins are sorted into their relevant vesicular trafficking routes based on specific
signal sequences or glycosylation motifs (De Matteis & Luini, 2008). Secretory protein
traffic can travel directly or via trans-endosomal routes to reach the plasma membrane
(De Matteis & Luini, 2008).
1.3.4.2 Endocytic pathway
Endocytosis of extracellular molecules taken up at the plasma membrane can be clathrin
dependent or independent (Maxfield & McGraw, 2004; Jones et al., 2006). Following inter-
nalisation and formation of vesicles, material traverses the endocytic network of organelles
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to be delivered to its final destination. The endocytic network consists of individual or-
ganelles with specific characteristics denoted by their protein and lipid content, their pH
and morphology, all of which enable the correct sorting of cargo traveling in a retrograde
manner (Johannes & Popoff, 2008).
Following internalisation, the newly formed vesicle moves through the endocytic net-
work in a progressive manner. Initially, endocytic vesicles fuse with EE, denoted by the
presence of PI(3)P, mild pH, Rab5 and Rab5 effector proteins such as EEA1 and PI3K.
From here cargo can be targeted for degradation in the lysosome, recycled to the plasma
membrane or targeted to the Golgi network. In the case of cargo destined for degradation
in lysosomal compartments their carrier EE continues to mature, transitioning from an
EE Rab5 positive compartment to late endosome/multi-vesicular body (LE/MVB) Rab7
positive compartment. These events are marked by a remodeling of the EE by the ESCRT
machinery, resulting in the creation of intralumenal vesicles, a marked drop in luminal pH
and Rab5 and its associated effectors being replaced by Rab7 and its effectors (Rink et al.,
2005; Poteryaev et al., 2010; Wollert & Hurley, 2010). Finally the intralumenal vesicles of
the LE/MVB are delivered to the lysosome, in a Rab7 dependent manner, for hydrolysis
(Saftig & Klumperman, 2009; Cabrera & Ungermann, 2010).
1.3.4.3 Endocytic recycling to the plasma membrane
Endocytosis is a continuous process that removes membrane and protein from the plasma
membrane. This is replenished by a process of endocytic recycling pathways, efficiently
returning proteins and lipids to the plasma membrane. Plasma membrane composition is
specified and maintained by balancing uptake and recycling. As such, endocytic recycling
pathways are important factors in cellular activities, such as nutrient uptake, cell migra-
tion, cell adhesion and junction formation, cell cycle, signal transduction, and cell polarity
(Maxfield & McGraw, 2004).
After internalisation vesicles quickly adopt the characteristics of EEs, recruiting Rab5
and EEA1 (Poteryaev et al., 2010). At this stage a proportion of the endocytosed cargo
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Figure 1.1 : Major vesicular trafficking routes. Retrograde trafficking routes are denoted by
red arrows and anterograde trafficking routes are denoted by black arrows. Recycling
trafficking processes are denoted by green arrows and involve both anterograde and
retrograde transport. EE, early endosome; RE, recycling endosome; MVB, multi-
vesicular body; ER, endoplasmic reticulum.
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can be rapidly recycled back to the cell surface in a Rab4 and Rab35 dependent fash-
ion. A slower recycling pathway to the plasma membrane involves the migration of cargo
from EEs to the tubular early endosome recycling compartment (ERC) in a manner that
requires SNX4 , Rab22A, Rab10, Rab11, dynein and Rab11 family-interacting protein
(Rab11FIP)2/3/5 (Grant & Donaldson, 2009). From the ERC cargo can be packaged into
tubular vesicular carriers and recycled to the plasma membrane, dependent on the function
of Rab10, Rab11, Rab22A, Rab35, CDC42, ADP-ribosylation factor (Arf) 6 and cortical
actin (Maxfield & McGraw, 2004; Grant & Donaldson, 2009).
An example of a cellular protein that undergoes recycling to the plasma membrane
through the endocytic recycling pathway is the transferrin receptor (TrfR). It is a carrier
protein for transferrin which is required to import of iron into the cell. It is regulated
in response to intracellular iron concentration, internalising the transferrin-iron complex
through endocytosis at the plasma membrane. It is transported to the ERC where the
mild acidic environment causes iron cations to be released from transferrin and pass into
the cytoplasm. The receptor, still bound to empty transferrin, is then transported back to
the cell surface through the endocytic recycling pathways (Grant & Donaldson, 2009).
1.3.4.4 Endosome-to-TGN pathways
Anterograde traffic leaving the Golgi network is balanced by retrograde and retrograde
recycling pathways. Cargo molecules that have been targeted to endosomes from the
Golgi network or through the endocytic pathway can be transported to the TGN, other
Golgi membranes and/or on to the ER via retrograde and retrograde recycling pathways
(Bonifacino & Rojas, 2006; Johannes & Popoff, 2008).
Certain cellular proteins need to be recycled after they have carried out their function
in the cell. Continuous cycling between endosomes and the TGN is a means by which the
cell can maintain homeostasis between compartments. One of the most widely studied ret-
rograde recycling pathways is that of the MPRs that function in the delivery of hydrolytic
enzymes to lysosomes. Aspects of this trafficking pathway are discussed in section 1.3.4.6.
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Additional cargoes trafficked in a retrograde manner include a protein of unknown
function named TGN46/TGN38 and Shiga, Cholera and Ricin toxins that are transported
to the Golgi network and then on to the ER before being translocated into the cytosol
(Watson & Spooner, 2006; Ganley et al., 2008; Johannes & Popoff, 2008; Stechmann et al.,
2010).
Much of the cellular machinery utilised in endosome-to-TGN pathways is common to
all retrograde vesicular traffic to the Golgi and includes, among others, the multi-protein
retromer complex and a clathrin adaptor protein known as EpsinR (Saint-Pol et al., 2004;
Bujny et al., 2007; Bonifacino & Hurley, 2008). Two distinct retrograde trafficking routes
that differ in the cargo trafficked and in the Q SNAREs that govern their specificity have
recently been described by Ganley et al. (2008). MPRs are recycled to the TGN in a
Syntaxin (Syn)10-dependent fashion whereas TGN46 and Cholera toxin B subunit require
Syn6 (Ganley et al., 2008). It is also likely that certain Rab GTPases and their effector
proteins are restricted in the retrograde trafficking pathways that they function in. For
example Rab9 and Tip47 are believed to function in retrograde recycling of MPRs from
the LE/MVB compartment to the TGN but have little effect on Shiga toxin traffic from
EE/ERC to the TGN (Johannes & Popoff, 2008; Pfeffer, 2009).
1.3.4.5 Endolysosomal homeostasis
Lysosomal organelles are maintained in the cell by a tightly regulated biogenesis pathway
that requires constant delivery of synthesised lysosomal proteins to ensure homeostasis of
the compartment. This is primarily undertaken by two MPRs, the cation-independent
MPR (CI-MPR) and the cation dependent MPR (CD-MPR), that cycle between the TGN
and the endocytic compartment (Ghosh et al., 2003).
Most lysosomal hydrolases acquire a mannose-6-phosphate glycosylation tag during
transport through the Golgi network, which is recognised by MPRs in the TGN (Ghosh
et al., 2003). The trafficking of the two MPR receptors has been studied extensively
(Ghosh et al., 2003; Johannes & Popoff, 2008). Although there is some debate as to the
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finer details of the receptor trafficking, it is widely accepted that they bind their cargo
of immature lysosomal enzymes in the Golgi network and traffic within nascent clathrin-
coated-vesicles (CCV)s from the TGN to early endosomes. In the predominant pathway
of MPR trafficking, the receptors remain with the maturing EE until they develop into
LE/MVB compartments, an event characterised by increasing acidity of the luminal envi-
ronment. In this acidic environment, the lysosomal enzymes dissociate from the receptors
and mature, via peptide cleavage, into active lysosomal enzymes. After cargo dissocia-
tion, the receptors are sequestered to specific regions of the LE/MVB membrane and then
recycled back to Golgi network to engage in another round of lysosomal enzyme binding
and ferrying. In the case of the CI-MPR, a small proportion traffics from the TGN to the
plasma membrane from where it is internalised into the endocytic pathway to traffic to be
cycled back to the TGN (Ghosh et al., 2003). Retrograde trafficking of MPRs has been
shown to be dependent on a range of proteins and protein complexes including EpsinR,
the retromer complex and SNX1 and 2, Rab9 and its effector Tip47 as well as the SNARE
protein Syn10 (Riederer et al., 1994a; Hanna et al., 2002; Arighi et al., 2004; Burguete
et al., 2004; Saint-Pol et al., 2004; Ganley et al., 2008; Mari et al., 2008). Interference with
any of these proteins by siRNA or dominant-negative proteins results in reduced Golgi-
localisation of MPRs in HeLa cells. In the case of Rab9, Tip47 and Syn10, this caused
increased secretion of lysosomal enzymes via the default secretory pathway (Riederer et al.,
1994a; Díaz & Pfeffer, 1998; Ganley et al., 2008). Furthermore, it has been shown through
investigations of CLN3, a Golgi network resident protein necessary for exit of MPR from
the TGN, that a blockade in MPR traffic can directly affect lysosomal function (Metcalf
et al., 2008).
There is also evidence to suggest that there is a degree of MPR independent targeting of
lysosomal enzymes. This conclusion is primarily based on observations of fibroblasts from
patients with I-cell disease which are unable to add the mannose-6-phosphate modification
to newly synthesised lysosomal enzymes. The predicted phenotype of enhanced secretion
of lysosomal enzymes was observed for most but not all enzymes suggesting that some
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were retained and trafficked independently of the MPRs (Neufeld, 1991). In agreement,
LIMP-2 is a protein that has been reported to target beta-glucocerebrosidase to lysosomes
in a mannose-6-phosphate-independent manner (Reczek et al., 2007).
1.4 Interactions between bacterial pathogens and vesic-
ular pathways
1.4.1 Phagosomal maturation
Phagocytosis is a form of endocytosis that allows cells to take up large particles, including
bacteria, and is an essential innate immune function. Once the particles are internalised
they are enclosed in a membrane bound compartment known as a phagosome. The phago-
some matures in a process similar to endocytosis through sequential interactions with the
endosomal network culminating in fusion with lysosomes (Vieira et al., 2002).
The early phagosome recruits Rab5 and EEA1, fuses with EE/ERC and but not lyso-
somes. It has a neutral pH and very little hydrolytic activity (Mukherjee et al., 1997;
Flannagan et al., 2009). The Rab5 effector PI3K is also recruited which generates PI3P
on the membrane similar to EE membranes (Vieira et al., 2001). As the early phagosome
matures, EEA1 is lost from the intermediate phagosome but Rab5 is retained (Flannagan
et al., 2009). This maturation process continues with Rab5 being supplanted by Rab7
and its effectors on the late phagosomal membrane in a process probably dependent on
the VpsC–homotypic protein sorting (HOPS) complex (Rink et al., 2005). Additionally,
Lamp1/2/3,CD63 and the v-ATPase, which reduces the luminal pH to 5.5 are recruited to
the late phagosomal membrane (Desjardins et al., 1994; Flannagan et al., 2009). Finally
the late phagosome fuses with lysosomes in a process dependent on Rab7 and Rab inter-
acting lysosomal protein (RILP), and the late endocytic SNAREs Vamp8 and Vti1b to
form a highly acidic, hydrolytic and microbicidal compartment known as a phagolysosome
(Vieira et al., 2002; Haas, 2007; Smith et al., 2007; Furuta et al., 2010).
47
Chapter 1: Introduction
Although not considered phagocytic cells, epithelial cells have fully functional endolyso-
somal systems. Bacteria that invade these cells and either do not escape or modify the
vacuole, undergo a process of phagolysosomal fusion very similar to that observed in phago-
cytic cells.
1.4.2 Interference with phagolysosomal maturation
1.4.2.1 Bacterial pathogens other than Salmonella
When bacteria enter phagocytic host cells they are contained a membrane-bound vacuo-
lar compartment called the phagosome. Following invasion of non-phagocytic cells, this
is referred to as a vacuole. Under normal circumstances this compartment is trafficked
sequentially through the endocytic network until fusion with degradative lysosomal com-
partments occurs (Vieira et al., 2002; Haas, 2007). Many intracellular pathogens target
the maturation process at a variety of stages, interfering with fusion steps between EE
and LE and lysosomes or they modify the environment within the phagolysosome to allow
intracellular survival and/or replication (Méresse et al., 1999b; Duclos & Desjardins, 2000;
Haas, 2007). Another class of invasive intracellular pathogen lyses the vacuolar membrane
to escape into the host cytosol after entry into cells (Ray et al., 2009).
The intracellular vacuole is lysed by pathogens such as Shigella flexneri and Listeria
monocytogenes, after which they are propelled throughout the cytosol by the formation of
an actin tail at one pole of the bacterial cell (Ray et al., 2009). The vacuole integrity is com-
promised by bacterial proteins that are known virulence factors. In the case of Shigella, two
T3SS effectors, IpaB and IpaC, that can insert into the membrane, are required for vacuolar
rupture though the precise mode of action remains unclear (Blocker et al., 1999; Mounier
et al., 2009). Vacuole lysis by Listeria monocytogenes is a result of several bacterial pro-
teins including a pore-forming toxin listeriolysin-O (LLO), a phosphatidylinositol-specific
phospholipase C (PI-PLC) and a broad-range phosphatidylcholine-specific phospholipase
C (PC-PLC) (Smith et al., 1995; Beauregard et al., 1997; Ray et al., 2009). Perforation
of the vacuolar membrane by LLO also results in an alteration of pH and calcium ion
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concentration which is believed to delay fusion with lysosomal compartments prior to full
vacuolar escape (Shaughnessy et al., 2006).
An example of an intracellular pathogen that deviates the phagosome from the endo-
cytic route to create a specific intracellular niche is Chlamydia. The specialised membrane-
bound compartment that Chlamydia resides in is known as an inclusion. After uptake the
inclusion traffics to a region in close proximity to the Golgi network which then becomes
fragmented, forming mini-stacks around the inclusion that are important for bacterial repli-
cation (Hackstadt et al., 1996; Heuer et al., 2009). The inclusion preferentially fuses with
sphingomyelin containing exocytic vesicles that facilitate its growth (Hackstadt et al., 1996;
van Ooij et al., 2000). The inclusion lacks markers of LE and lysosomes such as lysosomal
membrane glycoproteins (lgps). In this manner Chlamydia creates a unique compartment
that selectively interacts with a subset of host cell vesicular traffic enabling growth and sur-
vival (Capmany & Damiani, 2010). Small Rab GTPase proteins and SNAREs are thought
to be candidates for subversion by Chlamydia effectors translocated across the inclusion
membrane by a T3SS to enable specific interaction with cellular traffic (Betts et al., 2009).
An interesting effector protein of Chlamydia known as IncA contains domains that are sim-
ilar to mammalian SNAREs and are believed to function as SNARE mimics, facilitating
fusion at the inclusion surface with vesicular traffic (Delevoye et al., 2008).
The Mycobacterium tuberculosis phagosome is believed to be retarded in its maturation
as it retains Rab5, is of a neutral pH and excludes the late phagosomal GTPase Rab7, lgps
and V-ATPase (Sturgill-Koszycki et al., 1996; Deretic & Fratti, 1999; Li & Xie, 2011).
EEA1, a Rab5 effector protein from the early phagosome is also absent potentially indi-
cating a maturation block at the intermediate phagosome (Flannagan et al., 2009). In
this way Mycobacterium tuberculosis is believed to negate the harmful effects of lysosomal
fusion (Deretic & Fratti, 1999; Li & Xie, 2011). There are several bacterial factors and
unique features of the Mycobacterium tuberculosis phagosome that are thought to have a
role in preventing its maturation. Coronin-1 (also referred to as TACO) is a host protein
that has been observed on the Mycobacterium tuberculosis phagosome which is absent from
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phagosomes containing killed bacteria or phagosomes of activated macrophages. In cells
depleted of Coronin-1, Mycobacteria bovis is delivered to lysosomes implicating it in having
a role in inhibiting maturation (Jayachandran et al., 2008). The mycobacterial lipoamide
dehydrogenase C (LpdC) has been shown to bind Coronin-1 and is believed to have a role
in its retention on the Mycobacterium phagosome (Deghmane et al., 2007). Mycobacterium
is also believed to disrupt the interaction between Rab7 and its effector RILP, thereby pre-
venting phagolysosomal formation (Sun et al., 2007a). In addition, SapM is a phosphatase
of Mycobacterium tuberculosis which hydrolyses PI(3)P, depleting it from the phagosomal
membrane (Vergne et al., 2005). This is thought to prevent the transition to form the
phagolysosome.
Both Legionella pneumophila and Brucella abortus are retained within vacuoles that
segregate from the endocytic pathway and interact extensively with the ER. They also
acquire LC3, a protein integral to the autophagic response pathway, suggesting that these
compartments also interact with the autophagic membranes (Haas, 2007; Lerena et al.,
2010).
Coxiella burnetii is the only intracellular pathogen which appears to survive and repli-
cate in an acidified lysosomal-like compartment (Méresse et al., 1999b). Early on after
uptake into macrophage cells, C. burnetii recruits the autophagic protein LC3 which is
thought to delay fusion with lysosomes (Romano et al., 2007). The delay allows time for
the bacteria to enter into its replicative large-cell variant phase of its life cycle (Flannagan
et al., 2009). Later on, C. burnetii resides in a compartment called the replicative Cox-
iella vacuole that is acidic (pH 4.8) and contains several lysosomal proteins, including the
V-ATPase (Maurin et al., 1992). The mechanisms of how Coxiella burnetii survives and
replicates is such a compartment are not yet known (Flannagan et al., 2009).
1.4.2.2 Interaction between Salmonella and endosomal pathways - early events
After uptake into host cells by phagocytosis or invasion, Salmonella resides in a membrane
bound compartment or SCV. Immediately after entry, the SCV begins to migrate to a
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perinuclear location, that in epithelial cells coincides with the Golgi network, to establish
an intracellular replicative niche (Salcedo & Holden, 2003; Knodler & Steele-Mortimer,
2003; Abrahams & Hensel, 2006). During this process of migration, the SCV undergoes
a variety of changes which resemble that of the normal pathway of endocytic/phagosomal
maturation (Méresse et al., 1999b). Within 5-10 minutes following uptake markers such as
EEA-1 and the Rab5 GTPase are present on the SCV membrane, indicating association
with EE (Steele-Mortimer et al., 1999). As the trafficking of the SCV progresses towards
the centre of the cell these early markers are lost and LE/lysosome markers such as Rab7
and the lgps, Lamp1 and Lamp 2 are detectable on the SCV surface (Méresse et al., 1999a;
Garcia-del Portillo & Finlay, 1995). However, LE/lysosomes markers such as cathepsin
D and the MPRs are reduced on the SCV indicating that Salmonella selectively avoids
fusion with mature lysosomes within the first two hours of infection (Garcia-del Portillo
& Finlay, 1995; Knodler & Steele-Mortimer, 2003; Brumell & Grinstein, 2004; Bakowski
et al., 2010).
1.4.2.3 Interaction between Salmonella and endosomal pathways - late events
In epithelial cells bacterial replication occurs after SCV migration to the perinuclear region
(Ramsden et al., 2007). The onset of bacterial replication coincides with the translocation
of SPI-2 T3SS effectors and the appearance of Sifs (Garcia-del Portillo et al., 1993; Stein
et al., 1996). In addition, Salmonella replication in epithelial cells is characterised by the
formation of tight bacterial clusters (microcolonies) in the vicinity of the Golgi network
(Salcedo & Holden, 2003). Efficient intracellular bacterial growth, Sif formation, SCV
integrity and microcolony location have been shown to be dependent on the SPI-2 T3SS.
At later time points the SCV and Sifs are enriched in the lgps Lamp1 and Lamp2 and
the Golgi network associated protein SCAMP3 but not with other proteins such as MPRs
and cathepsins (Garcia-del Portillo & Finlay, 1995; Smith et al., 2005; Mota et al., 2009).
This implies the SCV requires the fusion of certain membranous compartments and the
segregation of others. This was believed to be the basis through which Salmonella avoided
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the detrimental effects associated with lysosomal fusion. Recently this view has been
challenged after live cell imaging experiments suggested that at late stages of infection
some fusion between the SCV and lysosomal compartments occurs (Drecktrah et al., 2007).
This is a view that is corroborated by an older study that shows complete phagolysosomal
formation in Salmonella infected macrophages (Oh et al., 1996). The mechanisms by which
Salmonella is able to integrate certain components of the host endomembrane system whilst
excluding others is not understood.
1.5 Aims
Little is known about the specific vesicular trafficking pathways that Salmonella inter-
acts with, although fusion and fission of vesicles with SCVs can be readily observed by
live imaging microscopy (Dumont et al., 2010). It seems likely that through interaction
with vesicular traffic in the perinuclear region Salmonella acquires the materials necessary
for its replication (Drecktrah et al., 2008; Jackson et al., 2008a). The possibility that
Salmonella manipulates specific host cell machinery to modulate vesicular traffic is highly
likely given the observation that the SCV acquires some LE/Lysosome proteins but ex-
cludes others (Garcia-del Portillo & Finlay, 1995). However, the roles that specific cellular
components may have in the recruitment of membrane for replication and Sif formation
during Salmonella infection remain unclear. Key cellular candidates that could be involved
in the interaction between Salmonella and late endocytic compartments are SNARE pro-
teins, especially the LE R-SNAREs, VAMP7 and VAMP8, and Q-SNARES, Syntaxin7
(Syn7), Syntaxin8 (Syn8) and Vti1b as well as late endocytic GTPases that govern LE
homeostasis.
During this study I aimed to understand more about the interactions between Salmonella
and vesicular traffic that intersects with LE compartments. This was to be achieved by:
• undertaking an immunofluorescence microscopy screen in infected HeLa cells infected
with Salmonella to assess any morphological changes in the distribution of proteins
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involved in trafficking pathways of LE compartments.
• analysing, in a quantitative manner, the changes in distribution of any proteins found
to have altered labelling in infected cells.
• assessing what role SPI-2 T3SS effector proteins might have in altering the distribu-
tion of any candidate proteins.
• understanding what the physiological impact that any altered protein localisation
might have on the cellular environment and how this could influence Salmonella
virulence.
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Materials and Methods
2.1 Bacterial strains and plasmids
The S. Typhimurium strains used in this study were wild-type 12023s and its mutant deriva-
tives: ssaV::aphT (Deiwick et al., 1998), aroCpurD (Ruiz-Albert et al., 2002), sifAsseJ
(Ruiz-Albert et al., 2002), sifAsopD2 (Schroeder et al., 2010) and sseJ (Ruiz-Albert et al.,
2002). All S. Typhimurium strains carried the pFPV25.1 plasmid carrying gfpmut3A un-
der the control of the rpsM constitutive promoter (Valdivia & Falkow, 1997) with the
exception of those used during experiments to quantify levels of CD-MPR at the TGN,
where detection of pSifAwt-2HA, pSifA(L130D)-2HA or pSseJ-2HA was required. The plas-
mids pSifAwt-2HA and pSifA(L130D)-2HA (Diacovich et al., 2009) and transfection vectors
encoding EGFP::SifA and EGFP::SifAL130D were gifts from Dr. Stéphane Méresse (Cen-
tre d’Immunologie de Marseille-Luminy; Marseille, France). Plasmid pSseJ-2HA, which
is a derivative of pACYC184 carrying the sseJ-2HA gene fusion under the control of a
constitutive promoter (Chang & Cohen, 1978), was introduced into the aroCpurD mutant
to detect effector translocation from this strain.
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2.2 Antibodies
The primary antibodies used in this work are listed in Table 2.1. Working dilutions for each
individual applications are also displayed in Table 2.1. Alexa 488- (Invitrogen), Alexa 555-
(Invitrogen), Alexa 633- (Invitrogen) conjugated donkey anti-goat, anti-rabbit, anti-mouse,
anti-sheep or anti-rat antibodies were used for immunofluorescence at a dilution of 1:200.
Goat anti-rabbit (Santa Cruz) and sheep anti-mouse (Amersham Pharmacia Biosciences)
were used at a dilution of 1:10,000 for immunoblot analysis.
2.3 siRNA oligos
siRNA oligo duplexes targeted against non-overlapping regions of Vti1b, CD-MPR, Syn-
taxin 10 or Syntaxin 6 mRNA, were either used singly or in pools of 4 (SMARTpool,
Dharmacon Inc., UK). The siRNA oligo duplex targeted against SKIP was custom synthe-
sised using a previously described targeting sequence (Boucrot et al., 2005). The scramble
pool of 4 control oligos (Dharmacon Inc., UK) were designed not to target any human
mRNA transcript.
2.4 Cell growth
Bacteria were grown in Luria Bertani (LB) medium at 37 °C with shaking and supple-
mented with ampicillin (50 μg/ml), kanamycin (50 μg/ml), tetracycline (25 μg/ml) or
chloramphenicol (34 μg/ml) as appropriate.
HeLa (human epithelial cell line 93021013) cells used in this study were maintained
in Dulbecco’s modified Eagle’s medium (DMEM) (GIBCO BRL) supplemented with 10%
foetal calf serum (FCS) (PAA Laboratories) at 37 °C in 5% CO2. RAW264.7 macrophages
were obtained from the European Collection of Cell Cultures (Sigma, U.K.) were main-
tained in DMEM supplemented with 10% FCS at 37 °C in 5% CO2.
Primary bone-marrow macrophages (BMM) were obtained from C57BL/6 WT (Charles
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River) mice. Cells were grown in RPMI (GIBCO BRL) supplemented with 10% FCS, 2 mM
glutamine, 10 mM Hepes, 50 μM β-mercaptoethanol, 100 U/mL penicillin/streptomycin,
and L929 cell-conditioned medium 20% (vol/vol; National Institute for Medical Research)(complete
medium). After 3 days of culture, further fresh complete medium containing L929 cell–conditioned
medium was added to the growing macrophages. On day 7, cells were washed and seeded
in complete medium without antibiotic and incubated for 24 h before bacterial challenge.
2.5 Bacterial infection of macrophages
For infection, RAW264.7 macrophages and BMM were grown overnight then infected
with S. Typhimurium strains as described previously (Beuzón et al., 2000). In brief, all
bacteria were grown in LB broth, supplemented with the appropriate antibiotic, overnight
at 37 ºC with shaking. For RAW264.7 macrophage infections bacteria were opsonised with
DMEM containing 10% of FCS and 10% of normal mouse serum for 20 min. Bacteria
were added to the cell monolayers at a multiplicity of infection (MOI) of approximately
5, centrifuged at 110 x g for 5 min at room-temperature (RT) and incubated at 37 ºC,
5% CO2 for 25 min. The cells were washed 3 times with DMEM containing 10% FCS
and 100 μg/ml gentamicin and incubated in the same medium for 1 h. After 1 h cells
were washed once with fresh medium and the concentration of gentamicin was decreased
to 20 μg/ml for the remainder of the experiment. The infection protocol for BMM was as
described for RAW264.7 macrophages with the exceptions that complete medium (without
penicillin/streptomycin and LCM) was used in place of DMEM for opsonisation of bacteria
prior to infection and subsequent media exchanges.
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Antibody, Species Application, Source
Antigen Origin Dilution
TGN46 Sheep IF 1/200 ABD Serotec
C19 Rab6 Rabbit IF 1/500 Santa Cruz
GM130 Mouse IF 1/1000 Transduction Laboratories
EpsinR Rabbit IF 1/100 Gift from Professor Margaret Robinson,
(Cambridge Institute for Medical Research)
Vamp3 Rabbit IF 1/400 Gift from Doctor Andrew Peden,
(Cambridge Institute for Medical Research)
Vamp 4 Rabbit IF 1/500 Gift from Doctor Andrew Peden
Vamp 7 Rabbit IF 1/400 Gift from Doctor Andrew Peden
Vamp 8 Rabbit IF 1/400 Gift from Doctor Andrew Peden
Vti1b Mouse IF 1/33 BD Biosciences
IB 1/250
FACS 1/100
Syntaxin 6 Mouse IF 1/100 BD Biosciences
Syntaxin 7 Rabbit IF 1/500 Gift from Doctor Andrew Peden
Syntaxin 10 Rabbit IF 1/50 Gift from Doctor Andrew Peden
IB 1/250
Table 2.1 : Antibodies used in this work. IF - Immunofluorescence; IB - Immunoblot; FACS
- flow cytometry.
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Antibody, Species Application, Source
Antigen Origin Dilution
Syntaxin 8 Rabbit IF 1/500 Gift from Doctor Andrew Peden
Syntaxin 16 Mouse IF 1/1000 Gift from Doctor Andrew Peden
H68.4 TrfR Mouse IF 1/50 Invitrogen
SNX1 Mouse IF 1/100 BD Biosciences
SNX2 Mouse IF 1/100 BD Biosciences
VPS29 Rabbit IF 1/200 Gift from Doctor Matthew Seaman,
(Cambridge Institute for Medical Research)
VPS35 Rabbit IF 1/200 Gift from Doctor Matthew Seaman
H4A3 Lamp1 Mouse IF 1/500 Santa Cruz
SKIP Mouse IB 1/1000 Gift from Doctor Stéphane Méresse
University of Iowa
E7 Tubulin Mouse IB 1/1000 Human Hybridoma Bank
Actin Rabbit IB 1/5000 Sigma
HA Mouse IF 1/200 Roche
22D4 CD-MPR Mouse IF 1/100 Human Hybridoma Bank
IB 1/1000
FACS 1/300
2G11 CI-MPR Mouse IF 1/5000 Abcam
FACS 1/5000
Table 2.2 : Antibodies used in this work. IF - Immunofluorescence; IB - Immunoblot; FACS
- flow cytometry.
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2.6 Bacterial infection of HeLa cells
For infection, HeLa cells were grown overnight and then infected with S. Typhimurium
strains as described previously (Beuzón et al., 2000). In brief, all bacteria were grown in LB
broth, supplemented with the appropriate antibiotic, overnight at 37 ºC with shaking. The
bacterial cultures were diluted 1:33 in 3 ml of fresh medium, supplemented with appropriate
antibiotic, and were grown under the same conditions until the culture reached OD600 of 1.5
– 2.0. Bacteria were diluted in pre-warmed Earl’s buffered salt solution (EBSS, Invitrogen)
and added to the cells at a MOI of approximately 100 (5 μl of bacterial culture to 5 x 104
HeLa cells). Invasion was allowed to proceed for 15 min at 37 ºC, 5% CO2. After 15 min
cells were washed once with DMEM containing 10% FCS and 100 μg/ml gentamicin and
incubated in the same medium for 1 h. After 1 h cells were washed once with fresh medium
and the concentration of gentamicin was decreased to 20 μg/ml for the remainder of the
experiment.
2.7 Preparation and transformation of electrocompetent
cells
Bacteria were grown in LB overnight at 37 ºC with shaking. The culture was diluted 1:100
in 5 ml of fresh medium and bacteria were grown under the same conditions until the culture
reached OD600 of 0.5–0.6. Bacteria were incubated on ice for 15-30 min, centrifuged at
1000 x g at 4 ºC for 10 min and then the supernatant was discarded. The bacterial pellet
was washed three times in 25 ml ice-cold sterile MilliQ water with centrifugation and
supernatent removal after each wash. The final centrifugation and supernatent removal
was followed by resuspending the bacterial pellet in 0.25 ml ice-cold sterile 10% glycerol.
Aliquots of 75 μl were used immediately or stored at -80 ºC.
Bacteria were transformed by electroporation by incubating 75 μl of electrocompetent
bacterial cells with approximately 25 ng plasmid DNA in a 2 mm electroporation cuvette
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(Molecular Bioproducts) on ice for 5 min. Electroporation was performed at 2.5 kV, 200 Ω,
25 mF for 4-5 milliseconds using a GenePulser II (BioRad). Bacteria were then incubated
in 1 ml SOC medium and incubated at 37 ºC with shaking for 1 h. Transformants were
selected by plating on LB agar containing the appropriate antibiotic.
2.8 siRNA transfection
HeLa cells were seeded in 12 well plates and grown until they were 70% confluent. siRNA
transfection using RNAiMAX (Invitrogen, UK) was carried out according to the manufac-
turer’s protocol with a final concentration of pooled or single siRNA oligos of 10 nM. A
scrambled pool of 4 oligo sequences was included in all experiments as a negative control.
Cells were collected 24 h after transfection and re-seeded in 12 well plates at a concentra-
tion of 1 x 105 cells/well. Cells were then transfected a second time as above and 24 h
after that were seeded again at appropriate concentrations for analysis.
2.9 DNA transfection
HeLa cells were seeded in 24 well, 12 well or 35 mm glass bottomed dishes (Matek) and
grown until they were 70% confluent. DNA transfection procedures were carried out ac-
cording to the manufacturer’s protocol (Lipofectamine™ 2000, Invitrogen, UK) with 400 ng
of DNA. Samples were prepared for analysis 24 h after transfection. Only cells with sim-
ilar levels of expression, as determined from their GFP fluorescence using FACS analysis
or fluorescence microscopy, were included for analysis.
2.10 Fixation, fluorescence labelling and microscopy
Cell monolayers were fixed, permeabilised and labelled as described previously (Beuzón
et al., 2002). Briefly, samples were fixed using 4% paraformaldehyde (PFA) in phosphate
buffered saline (PBS) for 15 min at RT. Remaining free aldehyde was quenched by incu-
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bation with 10 mM NH4Cl for at least 1 h. Samples were permeabilised for 5 min in 0.1%
saponin in PBS (saponin-PBS). The antibodies were diluted to the appropriate concentra-
tion in 10% horse serum in saponin-PBS. Coverslips were washed twice in saponin-PBS
and incubated with primary antibodies for 1 h at RT. Following incubation coverslips were
washed twice with saponin-PBS and incubated with secondary antibodies for 30 min. Af-
ter incubation with secondary antibodies cells were washed twice in saponin-PBS, once in
PBS, once in MilliQ H2O and mounted in Mowiol mounting medium. Fluorescently la-
belled samples were analyzed using either an epi-fluorescence microscope (BX50; Olympus,
Melville, NY) or a confocal laser-scanning microscope (LSM510; Zeiss, Thornwood, NY).
2.11 Qualitative scoring of Vti1b localised to the TGN
HeLa cells were infected with wild-type or ssaV mutant S. Typhimurium for 14 h. Quan-
tification of the number of cells showing a TGN localisation of Vti1b in Salmonella infected
and non-infected cells was performed by epi-fluorescent microscopy. Quantification was ini-
tially conducted in the fluorescent channels associated with Vti1b and TGN46 labelling.
The cells were assessed as to whether there was TGN-associated labelling of Vti1b or not.
Next, the fluorescent channel was switched to reveal Salmonella and the same cells were
assessed according to whether they were infected or not. At least 50 cells were analyzed
for each condition. Triplicate experiments were conducted for each condition analyzed.
Statistical differences were determined using a two-tailed student t-Test. A probability
value of less than 0.05 was used to indicate a statistically significant difference.
2.12 Quantification of proteins localised to the TGN
Confocal three-dimensional projections were acquired for each sample using a slice incre-
ment of 0.4 μm and 40 x optical magnification. Individual TGNs from cells were selected
automatically using a protocol established in Volocity image analysis software (Perkin
Elmer, UK). TGNs were identified as objects within a volume range of 50 to 500 μm3
61
Chapter 2: Materials and Methods
according to an arbitrary threshold of fluorescence intensity associated with anti-TGN46
or anti-Rab6 antibody labelling. Once individual objects were identified, the mean fluores-
cent signal from pixel-to-pixel co-labelled protein was quantified using Volocity software.
These values were further partitioned, where appropriate, into those arising from infected
and non-infected or transfected and non-transfected cells, determined by GFP or HA la-
belling. At least 50 TGNs from each condition were quantified for each sample. Unless
stated otherwise, all experiments were repeated at least three times. Statistical differences
were determined using a two-tailed student t-Test. A probability value of less than 0.05
was used to show a statistically significant difference.
2.13 Plasma membrane-to-TGN transport assays
CI-MPR transport or CTxB transport assays were undertaken as described previously
(Ganley et al., 2008; Robinson et al., 2010) with the following modifications. HeLa cells
were transfected with Syn6 siRNA as described above or were infected with wild-type or
ssaV mutant S. Typhimurium for 13 h. Then, cells were incubated with culture medium
containing either anti-CI-MPR antibody (2G11) or Alexa Fluor 555-CTxB (Invitrogen,
U.K.) for 30 min followed by a chase of 30 min with medium only.
Quantification of the number of cells showing CI-MPR or CTxB localisation at the TGN
was done by epi-fluorescence microscopy. Quantification was initially conducted in the
fluorescent channels associated with CI-MPR or CTxB and TGN46 or Rab6 labelling. The
cells were assessed as to whether there was TGN-associated labelling of CI-MPR or CTxB
or not. Next, where appropriate, the fluorescent channel was switched to reveal Salmonella
and the same cells were assessed according to whether they were infected or not. At least
50 cells were analyzed for each condition. Triplicate experiments were conducted for each
condition analyzed. Statistical differences were determined using a two-tailed student t-
Test. A probability value of less than 0.05 was used to show a statistically significant
difference.
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2.14 Lysosomal enzyme secretion assays
The activities of secreted β-hexosaminadase and cathepsin D were analyzed as described
(Riederer et al., 1994b; Yasuda et al., 1999) with the following modifications: HeLa cells
were grown in 6 well plates, seeded at a concentration of 2 x 105 cells/well, for 24 h. Cells
were infected with wild-type or ssaV mutant S. Typhimurium. At 1 h after inoculation and
for every subsequent media exchange DMSO or amiodarone (Sigma, U.K.) were added to
negative and positive control cells, respectively. Amiodarone was used at a concentration of
8 μM. At 8 h after inoculation cells were washed 4 times with pre-warmed collection media
(OPTI-MEM, GIBCO BRL) supplemented with 10 mM mannose-6-phosphate (Sigma,
U.K.) and 20 μg/ml gentamicin. Collection medium (1.5 ml) was then added to each well
and the cells were incubated once more at 37 °C. At 14 h after inoculation extracellular
β-hexosaminidase activity was assayed in 480 μl of the collection medium by addition of 120
μl of β-hexosaminidase substrate buffer (0.5 M NaOAc pH 4.4, 0.5% Triton X-100, 5 mM
4-methylumbelliferyl-2-acetamido-2-deoxy-β-d-glucopyranoside (Sigma, UK)). After 1 h 30
min at 37 °C, reactions were stopped by addition of 600 μl of 0.5 M glycine, 0.5 M Na2CO3,
pH 10.0. Release of fluorescent substrate was measured by a Cary Eclipse fluorescence
spectrophotometer using an excitation wavelength of 360 nm and emission wavelength of
447 nm. Intracellular β-hexosaminidase activity was determined by scraping the cells of
one well in 500 μl of cell collection buffer (10 mM phosphate buffer, pH 6.0, 0.15 M NaCl,
0.5% Triton X-100) followed by centrifugation at 60,000 g for 30 min. The supernatant was
transferred into a fresh tube and 120 μl of sample and 120 μl of hexosaminidase substrate
buffer were diluted with 360 μl of OPTI-MEM. After 1 h 30 min at 37 °C, reactions were
stopped by addition of 600 μl of 0.5 M glycine, 0.5 M Na2CO3, pH 10.0 and samples were
assayed as described for extracellular β-hexosaminidase activity.
At 14 h after inoculation, extracellular cathepsin D activity was assayed in 80 μl
of the collection medium by addition of 20 μl of cathepsin D substrate buffer (0.25 M
NaOAc, pH 4.2, 0.25% Triton X-100, 100 μM MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-
Leu-Lys(Dnp)-d-Arg-NH2 (Peptide Institute, Japan)). After 1 h at 37 °C, reactions were
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stopped by addition of 600 μl of 5% TCA. Release of fluorescent substrate was measured
by a Cary Eclipse fluorescence spectrophotometer using an excitation wavelength of 328
nm and emission wavelength of 398 nm. Intracellular cathepsin D activity was determined
by scraping the cells from one well in 500 μl of cell collection buffer (10 mM phosphate
buffer, pH 6.0, 0.15 M NaCl, 0.5% Triton X-100) followed by centrifugation at 60,000 g
for 30 min. The supernatant was transferred into a fresh tube and 20 μl of sample and 20
μl of cathepsin D substrate buffer were diluted with 60 μl of OPTI-MEM. After 1 h at 37
°C, reactions were stopped by addition of 600 μl of 5% TCA and samples were assayed as
described for extracellular cathepsin D activity. β-hexosaminidase and cathepsin D activity
from intracellular and extracellular samples were expressed as a % ratio of total enzyme
activity, which equals the sum of intracellular and extracellular activities. Statistical dif-
ferences were determined using a two-tailed student t-Test. A probability value of less than
0.05 was used to show a statistically significant difference.
To analyze protein levels of intracellular and secreted cathepsin D, HeLa cells were
grown in 10 cm circular plastic dishes and seeded at a concentration of 2.5 x 106 cells/dish.
Cells were infected with wild-type or ssaV mutant S. Typhimurium. At 1 h after inocu-
lation and for every subsequent media exchange DMSO, amiodarone (8 μM) or chloram-
phenicol (34 μg/ml) were added as appropriate. At 8 h after inoculation the cells were
washed 4 times with pre-warmed collection media (OPTI-MEM, GIBCO BRL). Collection
medium (4 ml) was then added to each dish and the cells were incubated once again at 37
°C. At 14 h after inoculation the collection medium was harvested (extracellular fraction)
and concentrated using Amicon Ultra-15 Centrifugal Filter Units according to the manu-
facturer’s protocol (Millipore, U.K.). Cells were collected using a trypsin-EDTA solution
(GIBCO BRL), then resuspended in equal volume of lysis buffer (20 mM Tris-Cl pH 8.0,
0.5% NP40, 150 mM NaCl) in the presence of protease inhibitors (Complete EDTA-Free,
Roche). Intracellular samples were normalised by dilution to give the same overall protein
concentration. The same dilution factor was applied to each of the corresponding extracel-
lular fractions, so that samples reflected an equivalent number of cells. Intracellular and
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extracellular proteins were then separated by SDS-PAGE and analyzed by immunoblot
using antibodies against cathepsin D and actin (loading control).
2.15 FRAP analysis
HeLa cells, RAW264.7 macrophages or BMM were grown on 35 mm glass bottomed dishes
(Matek) seeded at a concentration of 1.0-5.0 x 105 cells/dish in appropriate media. Cells
were then either transfected or infected with S. Typhimurium strains. At 1 h 30 min prior
to imaging, growth medium was replaced with imaging medium (OPTI-MEM, GIBCO
BRL) and incubated at 37 °C. For imaging, Magic Red cathepsin B peptide (MAGIC
RED™ Cathepsin B, ABD Serotec, U.K.) was added to the medium at one tenth the
manufacturer’s recommended concentration and maintained for the duration of imaging.
Live cell imaging and FRAP analysis were done using a LSM510 Zeiss confocal microscope.
FRAP bleaching was done on entire cells using 458, 488, 543, and 633 nm lasers with a 40
x objective. Approximately 5 to 8 cells per field of view were bleached for a duration of 100
bleaching cycles according to the bleaching module within the LSM510 software (LSM510
version 3.2). Post-bleaching images were acquired every three seconds for 150, 200 or 300
seconds. Quantification of fluorescence was carried out using Volocity software, with each
data set having approximately 25 cells in each condition analyzed. Fluorescence values were
converted to relative values by expressing the first post-bleach value as zero. Inter-sample
normalisation was done using the fluorescence values of non-infected or non-transfected
samples, as appropriate. All experiments were repeated at least three times.
2.16 FACS analysis
For assays to determine intracellular bacterial replication, HeLa cells were seeded at a
concentration of 2 x 105 cells/well in 6 well plates and treated with mock, scramble, Syn6
or Syn10 siRNA oligos or exposed to a lysosomal protease inhibitor (Cathepsin Inhibitor
III, Merck, U.K.) at a concentration of 0.4 μM, 4 h prior to infection. The inhibitor
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was maintained through all subsequent media exchanges. Cells were then infected with
wild-type S. Typhimurium as described above. Cells were collected at 2 h and 8 h after
inoculation following exposure to trypsin-EDTA solution and cells from each well were
resuspended in 10 ml of 10% FCS DMEM. Cells were then washed twice in PBS, centrifuged
and resuspended in 1 ml of PBS. Cells were fixed in 4% paraformaldehyde-PBS for 20 min,
washed twice in PBS and then re-suspended in 1 ml PBS for analysis. A total of over
10,000 events were analyzed on a FACS CaliburTM flow cytometer (Becton Dickinson)
for fluorescence intensities in channel FL-1. Uninfected cells were used to calibrate the
instrument settings. Data were analyzed with FlowJoTM 8.6.3 (Tree Star Inc., U.S.A.)
software. Results were expressed as GFP fluorescence per HeLa cell and represent the
median of the ratio between 2 h and 8 h after inoculation normalised to mock or DMSO
treated cells.
For FACS assays to determine cathepsin B activity, HeLa cells were transfected as
described above. At 2 h prior to analysis, cell growth medium was replaced with imaging
medium and cells were incubated at 37 °C for 1 h 30 min. Cells were collected and washed
twice in PBS, then resuspended in 1 ml of imaging medium. Magic Red cathepsin B peptide
was added as described above and maintained for the duration of the analysis. A total of
over 10,000 events were analyzed on a LSR FortessaTM flow cytometer (Becton Dickinson)
for fluorescence intensities using a 530 nm emission filter and a 640-670 nm band pass
emission filter. Untransfected cells were used to calibrate instrument the settings. Data
were analyzed with FlowJoTM 8.6.3 software.
For assays FACS assays to quantify the intracellular levels of Vti1b and CD-MPR,
HeLa cells were seeded as appropriate and treated with mock, scramble, Vti1b or CD-
MPR siRNA oligos as described above. Mock treated cells were then infected with wild-
type or ssaV mutant S. Typhimurium as described above. Cells were collected at 14 h
after inoculation following exposure to trypsin-EDTA solution and cells from each well were
resuspended in 10 ml of 10% FCS DMEM. Cells were then washed twice in PBS, centrifuged
and resuspended in 4% PFA-PBS and fixation was allowed to proceed for for 20 min. Cells
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were then washed twice in PBS and re-suspended in 300 μl of FACS permeablisation PBS
solution (0.1% saponin, 1% azide, 10% horse serum). Primary antibodies were added to the
cells at concentrations stated in Table 2.1 and Table 2.2. Labelling was allowed to proceed
for 1 h at room temperature. Cells were then washed in 4 ml of FACS permeablisation
buffer, centrifuged, resuspended in 300 μl of FACS permeablisation buffer and secondary
antibodies were added at concentrations iterated above. Labelling was allowed to proceed
for 30 min in the absence of light at room temperature. Cells were then washed twice in
PBS solution and then resuspended in 1 ml PBS solution for analysis. A total of over 10,000
events were analyzed on a FACS CaliburTM flow cytometer for fluorescence intensities in
channel FL-1 (Salmonella) and FL-4 (Vti1b or CD-MPR). Unlabelled and uninfected cells
were used to calibrate the instrument settings. Data were analyzed with FlowJoTM 8.6.3
(Tree Star Inc., U.S.A.) software.
FACS assays to determine the surface labelling of CI-MPR were conducted as described
for the intracellular labelling of Vti1b and CD-MPR with the exception that FACS per-
meablisation buffer was replaced with FACS non-permeablisation buffer (1% azide, 10%
horse serum).
2.17 BFA treatment
Samples were treated with BFA (Sigma) at a working concentration of 5 μg/ml or with
DMSO control and left for 2 hrs under the previously specified growth conditions of HeLa
cell culture. Cells were then fixed, labelled and analysed by confocal microscopy for effects
on Golgi morphology.
2.18 Immunoblot analysis
For immunoblot analysis of the levels of Syntaxin 6, Syntaxin 10, Vti1b, CD-MPR and
SKIP cells were seeded in 6 well plates at a concentration of 2x105/well collected using 400
μl trypsin-EDTA solution per well (GIBCO BRL), centifuged at 2000 x g then resuspended
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in equal volume of lysis buffer (20 mM Tris-Cl pH 8.0, 0.5% NP40, 150 mM NaCl) in the
presence of protease inhibitors (Complete EDTA-Free, Roche). Lysates were centrifuged
at 14,000 x g at 4 ºC for 5 min to pellet cell debris. The protein concentration of sam-
ple supernatents was determined against a standard curve of BSA concentration using a
colourmetric Bradford’s-reagent protein concentration assay, according to the manufactur-
ers protocol (BioRad, UK). Supernatants were resuspended in equal volume of 2 x sample
buffer and boiled at 100 ºC for 5 min. Samples were used immediately or stored at -20ºC.
Proteins in lysates, corresponding to 20 μg of sample, were separated using 12% poly-
acrylamide gels by SDS-PAGE. Proteins were transferred into polyvinyldene fluoride (PVDF)
membranes using a semi-dry transfer cell (BioRad) at 3 mA/cm2 and 24 V for 1 h. Mem-
branes were blocked with TBS (20 mM Tris-Cl, pH 7.5 150 mM NaCl) containing 5% milk
powder, 0.05% Tween 20 for at least 2 h. Membranes were incubated with primary anti-
bodies (Table 2.1; Table 2.2) in TBS 5% milk 0.1% tween 20 overnight at 4 ºC. Following
incubation with primary antibodies membranes were washed three times for 15 min in TBS
containing 0.2% tween. Membranes were incubated with secondary antibodies diluted in
TBS containing 5% milk powder, 0.1% tween for 1 h at room temperature. Following
three further washes of 15 min with TBS 0.2% tween, proteins were detected using en-
hanced chemiluminescence ECL (GE Heallthcare). Tubulin or actin were used as loading
controls.
2.19 Statistical Analysis
All results are reported as mean ± standard error of the mean (SEM) unless otherwise
stated. Statistical analyses were performed using two-tailed, un-paired Student’s t-test on
data arising from experimental assays repeated more that two times. P values < 0.05 were
considered as statistically significant.
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The interaction of Salmonella with host
trafficking proteins
3.1 Introduction
As detailed in chapter 1, it is thought that one of the key mechanisms through which
Salmonella is able survive and replicate in cells is through its interaction with the host
vesicular trafficking pathways. By fusing its vacuole with specific endocytic compartments
and avoiding fusion with others Salmonella could satisfy requirements for nutrients and
vacuolar membrane (Ramsden et al., 2007). As discussed earlier, as the SCV matures it
recruits cellular proteins such as the lgps (Lamp1, Lamp2, CD63) and v-ATPase and fails to
recruit others that are usually present on and within maturing phagosomes and lysosomes,
such as MPRs and cathepsins. This suggests that the SCV interacts with LE but has
limited interactions with lysosomes (Garcia-del Portillo & Finlay, 1995; Rathman et al.,
1997; Steele-Mortimer et al., 1999). To further investigate the selectivity of interactions
between the SCV and the late endosomal system I undertook an immunofluorescence screen
of infected HeLa cells. A range of proteins were analysed that are involved in trafficking
with LE and lysosomes. Initially I analysed the immunofluorescence labelling of proteins
according to their recruitment to the SCV and Sifs as well as any obvious changes in
distribution compared to non-infected cells. Proteins selected for analysis included cargo
proteins transported through endocytic compartments, SNAREs involved in trafficking of
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LE compartments and retrograde transport to the TGN, GTPases involved in LE trafficking
and/or recycling and other cellular machinery involved in trafficking from endosomes to
the TGN.
3.2 Distribution of proteins that traffic in well-defined
pathways in infected cells
Within the endomembrane system there are certain proteins that are transported with a
well-defined itinerary. Interference with their trafficking often results in changes to their
cellular distribution. Therefore, altered distribution can be exploited as indicators of dis-
ruption of specific pathways (Ganley et al., 2008; Metcalf et al., 2008; Stechmann et al.,
2010). I selected four proteins (TGN46, CD-MPR, CI-MPR and TrfR) that are known to
traffic in well-defined pathways. I examined their distributions in HeLa cells infected for
14 h with wild-type GFP-expressing Salmonella and compared them to uninfected cells
using immunofluorescence analysis.
TGN46 is a glycoprotein of unknown function is commonly used to selectively label the
TGN in cells (Prescott et al., 1997; Salcedo & Holden, 2003). The protein is also known
to be transported in a retrograde manner from the plasma membrane through endocytic
compartment to the TGN (Ganley et al., 2008).
Both CD-and CI-MPRs are known to be recycled back to the TGN after they carry
out the function of ferrying newly synthesised lysosomal enzymes to endosomes. Their
retrograde transport to the TGN is dependent on Syn10 and occurs via a pathway distinct
from that used by TGN46 (Ganley et al., 2008).
TrfR is a carrier protein for transferrin, which is required for import of iron into the cell.
It is regulated in response to intracellular iron concentration, internalising the transferrin-
iron complex and is transported to the ERC where iron is released. The receptor-transferrin
complex is then recycled to the plasma membrane via endocytic recycling pathway depen-
dent on Rab11 (Grant & Donaldson, 2009).
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Figure 3.1 : Distribution of proteins that traffic in well-defined pathways in infected
cells. A) Confocal microscopy images showing the localisation of A) TrfR B) CD-
MPR and C) CI-MPR in infected and non-infected cells. Cells were infected with
wild-type Salmonella constitutively expressing GFP (blue), fixed after 14 h and im-
munolabelled for the protein of interest (red) and TGN46 (green). Images were false
coloured using Zeiss LSM software. All scale bars correspond to 10 μm.
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After 14 h of infection there were no obvious changes to overall TGN46 labelling in
infected cells when compared to non-infected cells, besides a moderate change to the TGN
ribbon morphology associated with the MTOC-associated Salmonella microcolony (Rams-
den et al., 2007) (Fig. 3.1 A, B, C). Thereafter, I used TGN46 to define the TGN in infected
and uninfected cells. After 14 h of infection there was also no obvious changes to TrfR
labelling in infected cells when compared with non-infected cells (Fig. 3.1 A). These results
indicate that the pathways through which TGN46 and TrfR traffic are likely unaffected by
Salmonella infection.
In contrast, there was a striking difference observed in the steady state labelling of both
CD-MPR and CI-MPR (Fig. 3.1 B, C). In uninfected cells a proportion CD and CI-MPR
labelling strongly co-localised with TGN46 at the TGN, however in infected cells there was
a substantial reduction in the intensity of labelling of both MPRs co-localising with the
TGN46 (Fig. 3.1 B, C), indicative of interference during transport.
3.3 Distribution of endocytic SNAREs in infected cells
Given that the SCV has characteristics of the LE compartment, I analysed the distribution
of SNARE proteins known to be involved in LE fusion events or in traffic from endosomes
to the TGN that could interact with the LE compartments. The Q-SNAREs, Syn7, Syn8
and Vti1b partner with either of the R-SNAREs VAMP7 or VAMP8 to mediate LE-LE ho-
motypic fusion and LE-lysosome heterotypic fusion events respectively (Pryor et al., 2004).
The Q-SNAREs Syn6, Syn16, Syn10 and the R-SNAREs Vamp3 and Vamp4 function in
two separate endosome-to-TGN pathways differentiated by the presence Syn10 and Syn6
(Ganley et al., 2008).
HeLa cells were infected for 14 h with GFP-expressing Salmonella and labelled with
antibodies to detect TGN46 and the SNARE of interest. Of the SNAREs analysed Syn6,
Syn10, Syn16, Vamp3 and Vamp4 had a labelling indistinguishable to that observed in
uninfected cells.
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Figure 3.2 : Distribution of endocytic SNAREs in infected cells. A) Confocal microscopy
images showing the localisation of a) Vti1b b) Syn6 c) Syn7 d) Syn8 e) Syn10 and
f) Syn16 in infected and non-infected cells. B) Confocal microscopy images showing
the localisation of a) Vamp3 b) Vamp4 c) Vamp7 and d) Vamp8 in infected and non-
infected cells. Cells were infected with wild-type Salmonella constitutively expressing
GFP (blue), fixed after 14 h and immunolabelled for the SNARE of interest (red) and
TGN46 (green). Arrows indicate where tubular structures were observed emanating
from the region of the microcolony. Images were false coloured using Zeiss LSM
software. All scale bars correspond to 10 μm.
74
Chapter 3: The interaction of Salmonella with host trafficking proteins
In contrast, the LE SNAREs Syn7, Syn8 and Vamp7 were all recruited to the region
of the Salmonella SCVs and appeared on tubular structures arising from this region rem-
iniscent of Sifs (Fig. 3.2 Ac, Ad, Bc). The related late endocytic SNAREs, VAMP8 and
Vti1b were not recruited to the SCVs and were not detectable on any Sif-like structures
(Fig. 3.2 Aa, Bd). In the case of Vti1b in uninfected cells a proportion of its labelling
strongly co-localised with TGN46 at the TGN similar to both CD-and CI-MPR. However
in infected cells there appeared to be a substantial reduction in Vti1b labelling co-localising
with the TGN46 (Fig. 3.2 Aa) similar to the effect seen for both CD-and CI-MPR.
3.4 Syn7, Syn8 and Vamp7 but not Vti1b and Vamp8
are recruited to SCVs and Sifs.
Syn7 has been reported to be recruited to the SCV and Sif membranes (Smith et al., 2007).
Given that it functions in combination with Syn8 and Vamp7 and that the SCV and Sif
membranes have characteristics of LE compartments it would not be surprising that Syn8
and Vamp7 are also recruited to SCV and Sif membranes. The tubular structures observed
during infection suggest that this may be the case (Fig. 3.2 Ac, Ad, Bc).
To further investigate this possibility I infected HeLa cells for 14 h with GFP-expressing
wild-type Salmonella and then labelled with an antibody to Lamp1, which is known to be
recruited to the SCV and Sif membranes and either Vti1b, Syn7, Syn8, Vamp7 or Vamp8.
I then analysed by confocal microscopy the co-localisation of these SNAREs with Lamp1
in infected cells. There was a strong co-localisation observed between Lamp1 and Syn7,
Syn8 or Vamp7 on tubular structures emanating from SCVs (Fig. 3.3 A, B, C), confirming
their recruitment to Sif membranes. This is strong evidence to indicate that the tubular
structures seen in infected cells labelled with either Syn7, Syn8 or Vamp7 and TGN46
(Fig. 3.2 Ac, Ad, Bc) were Sifs. In addition there was greatly enhanced labelling in the
region of SCVs for all three proteins that also co-localised strongly with Lamp1, indicating
recruitment to the SCV membrane.
75
Chapter 3: The interaction of Salmonella with host trafficking proteins
A
B
C
D
Lamp1 MergedSyn7Salmonella
Lamp1 MergedSyn8Salmonella
Lamp1 MergedVamp7Salmonella
Lamp1 MergedVamp8Salmonella
Lamp1 MergedVti1bSalmonellaE
Figure 3.3 : Syn7, Syn8 and Vamp7 but not Vti1b and Vamp8 are recruited to SCVs
and Sifs. Cells were infected with wild-type Salmonella constitutively expressing
GFP (blue), fixed after 14 h and immunolabelled for the SNARE of interest (red) and
Lamp1 (green). Arrows indicate where tubular structures are observed emanating
from the region of the microcolony. Images were false coloured using Zeiss LSM
software. All scale bars correspond to 10 μm.
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By contrast when cells were labelled for either Vti1b or Vamp8 and Lamp1 there was no
obvious co-localisation with the Lamp1 positive SCV or Sifs (Fig. 3.3 D, E), though this re-
sult is subject to the influence of antibody sensitivity and specificity. The absence of Vti1b
and Vamp8 from Sifs is conspicuous given that their partner SNAREs in LE/lysosomal
compartments (Syn7, Syn8 and Vamp7) are recruited. Depleting the cellular levels of
Vti1b and Vamp8 would be required to test the specificity of antibody labelling by im-
munofluorescence. If they were found to be specific, then it would greatly strengthen the
conclusion that they are not recruited to the SCV and Sif membranes.
3.5 Distribution of the retromer components in infected
cells
The retromer complex mediates the selection and packaging of endocytic cargo destined
for the TGN into vesicular carriers derived from EE/ERC, which then traffic to the TGN
(Bonifacino & Hurley, 2008). The multimer including VPS26-VPS35-VPS29 cargo selec-
tion complex and tubulating complex of SNX proteins has been shown to be essential for
the trafficking both CI-MPR (Arighi et al., 2004; Seaman, 2004; Bonifacino & Hurley,
2008), wntless, Shiga toxin, and polymeric immunoglobulin receptors (Vergés et al., 2004;
Bujny et al., 2007; Belenkaya et al., 2008). Furthermore, during early stages of vacuole
maturation Salmonella has been reported to recruit SNX1 to the SCV and it has been
shown to be important for replication (Bujny et al., 2008).
To address whether there was an alteration to the distribution of retromer components
during later stages of infection, I labelled HeLa cells infected for 14 h with GFP-expressing
Salmonella with antibodies to TGN46, SNX1, SNX2, VPS29 and VPS35. Though there
was moderate clustering of puncta juxtaposed to Salmonella microcolonies, there was no
gross change in the labelling of these proteins (Fig. 3.4). In addition they did not display
the characteristic labelling of a protein closely associated with the SCV and Sifs as seen
with Syn7, Syn8 and Vamp7 (Fig. 3.2 Ac, Ad, Bc; Fig. 3.3 A, B, C).
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Figure 3.4 : Distribution of the retromer components in infected cells. Confocal mi-
croscopy images showing the localisation of A) SNX1 B) SNX2 C) Vps29 and
D) Vps35 in infected and non-infected cells. Cells were infected with wild-type
Salmonella constitutively GFP (blue), fixed after 14 h and immunolabelled for
the retromer component of interest (red) and TGN46 (green). Images were false
coloured using Zeiss LSM software. All scale bars correspond to 10 μm.
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3.6 Distribution of Rab GTPases and the adapter pro-
tein EpsinR in infected cells
Rab GTPases function as regulators of trafficking events within the cell (Stenmark, 2009).
They are targets of manipulation by several intracellular pathogens, including Salmonella,
which uses Rab7 (Méresse et al., 1999a; Harrison et al., 2004; Brumell & Scidmore, 2007), to
modify its environment. I analysed a selected group of Rab GTPases involved in vesicular
trafficking. These included Rab6, a TGN-associated protein that regulates vesicular traffic
fusing with and exiting from the TGN (Starr et al., 2010); Rab7, a late endocytic protein
that regulates fusion between LEs and lysosomes (Starr et al., 2010); Rab9, a late endocytic
protein that regulates retrograde traffic from LE to the TGN (Ganley et al., 2004) and
Rab11, an endosomal protein involved in endocytic recycling to the plasma membrane
(Jones et al., 2006). In addition, I analysed the distribution of EpsinR, an adapter protein
involved in AP-1 and clatherin associated retrograde trafficking to the TGN from the
endocytic compartment (Mills et al., 2003).
In agreement with other work, Rab7 was heavily recruited to SCVs (Fig. 3.5 C) (Méresse
et al., 1999a). In addition there was moderate clustering of Rab9 puncta juxtaposed to
SCVs (Fig. 3.5 D). There was no obvious influence of Salmonella on the distributions of
Rab6, EpsinR or Rab11 compared to non-infected cells (Fig. 3.5 A, B, E).
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Figure 3.5 : Distribution of Rab GTPases and the adapter protein EpsinR in infected
cells. Confocal microscopy images showing the localisation of A) EpsinR B) Rab6
C) Rab7 D) Rab9 and E) Rab11 in infected and non-infected cells. Cells were
infected with wild-type Salmonella constitutively expressing GFP (blue), fixed after
14 h and immunolabelled for EpsinR or Rab protein of interest (red) and TGN46
(green). Arrows indicate where there is recruitment to the SCV (C) or where there
is clustering in close proximity to the SCV (D). Images were false coloured using
Zeiss LSM software. All scale bars correspond to 10 μm.
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3.7 Characterisation of TGN46-associated labelling of
Vti1b in HeLa cells
Given the association between SCVs and the Golgi (Salcedo & Holden, 2003), the difference
in Vti1b co-localisation with TGN46 could be relevant in terms of infection. Accordingly,
I decided to investigate the TGN46-associated labelling of Vti1b in greater detail.
In work of others, Vti1b was observed in the TGN region of NRK cells but its lo-
calisation was only moderately sensitive to brefelden A (BFA) treatment, suggesting a
localisation outside the TGN (Kreykenbohm et al., 2002). BFA inhibits nucleotide ex-
change on the GTPase Arf1 which is involved in the formation of COPI coated vesicles
(Chardin & McCormick, 1999). The inhibition of Arf1 results in the redistribution of many
Golgi components into the ER. Immunoelectron microscopy has been used to reveal that a
considerable amount of Vti1b is found in recycling endosomes of NRK cells (Kreykenbohm
et al., 2002).
To determine whether the distribution of Vti1b in HeLa cells is similar to that in
NRK cells I investigated its cellular distribution and sensitivity to BFA treatment by
immunofluorescence microscopy. Cells were co-labelled for a panel of markers associated
with the Golgi/TGN and late endocytic compartments. Immunolabelling of Golgi matrix
protein 130 (GM130), a cis-Golgi protein (Nakamura et al., 1995), and TGN46 or Rab6,
which are both predominately associated with the TGN (Prescott et al., 1997; Starr et al.,
2010), were used as positive controls for BFA-induced Golgi/TGN disruption. Lamp1,
which is localised to the late endocytic compartments and therefore should be insensitive
to BFA treatment, was used as a control for indirect effects of BFA on late endocytic
compartments.
Exposure of HeLa cells to BFA caused a fragmentation of the Golgi/TGN and loss of
Golgi/TGN-associated labelling of Vti1b, TGN46, GM130 and Rab6 (Fig. 3.6 A, B, C).
The distribution of Lamp1 was not affected (Fig. 3.6 B). These results indicate that the
majority of Vti1b observed in HeLa cells is localised to the TGN. Therefore, Salmonella
81
Chapter 3: The interaction of Salmonella with host trafficking proteins
infection appears to reduce TGN localisation of Vti1b.
3.8 Quantification of TGN-associated protein levels in
infected cells
To determine in an unbiased manner if there was a reduction of proteins co-localising
with the TGN, I employed an automated method for quantitative measurement of the
fluorescent signal localised to the TGN. This technique relies on the rendering of images of
cells in 3d, which have been acquired by confocal microscopy. The 3d shape of the TGN is
automatically differentiated using fluorescence intensity associated with Rab6 or TGN46
labelling (Fig. 3.7 A). The mean fluorescence intensities of the reference and test samples
are measured in the computer-defined TGN compartment in infected and non-infected cells
(see Materials and Methods for further details). All fluorescence signals are corrected for
background fluorescence using a primary isotype antibody controls to determine the signal
associated with non-specific labelling (Fig. 3.7 B).
I quantified the TGN associated labelling of CD-MPR, CI-MPR and Vti1b in infected
cells in addition to several proteins which did not display any obvious difference during
infection: TGN46, Rab6, EpsinR, Syn6 and Syn10. To verify that the juxta-nuclear la-
belling of TGN46 was indeed TGN-localised after infection with Salmonella, HeLa cells
were co-labelled with Rab6 (Starr et al., 2010). There was no detectable difference in the
levels of TGN46 or Rab6 labelling in TGN compartments of infected cells when compared
to non-infected cells (Fig. 3.7 C). This shows that the TGN46 labelling seen after wild-
type Salmonella infection is indeed localised to TGN compartments and that the extent
of this labelling is unaffected by wild-type Salmonella. In addition this result confirms the
suitability of using TGN46 as a reference protein to identify the TGN in infected cells.
Next I analysed the TGN associated levels of Vti1b, CD-MPR, CI-MPR, EpsinR, Syn6
and Syn10. There was no detectable difference in the levels of TGN-localised fluorescence
of EpsinR, Syn6 or Syn10 when comparing infected and non-infected cells (Fig. 3.7 C).
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Figure 3.6 : Golgi/TGN disruption by BFA in HeLa cells. All panels show either un-
treated or BFA treated cells labelled with Rab6 (red), TGN46 (blue) and either (A)
GM130 (green), (B) Lamp1 (green) or (C) Vti1b (green). Disruption of Golgi/TGN
associated labelling of Vti1b, RAB6, TGN46 and GM130 was observed in treated
cells whereas Lamp1 labelling was unaffected. All scale bars correspond to 10 μm.
Images were false coloured using Zeiss LSM software.
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Figure 3.7 : Quantification of TGN-associated protein levels in infected cells. (A)
Example of a 3 dimensional field of view of infected and non-infected HeLa cells
showing the computer-defined TGN regions (boxed) (B) Quantitative analysis of the
sum fluorescent signal associated with background labelling determined using rele-
vant isotype controls for TGN46, Rab6, Vti1b, CD-MPR and CI-MPR. Results are
expressed as a percentage of the fluorescence signal associated with specific anti-
body labelling (C) Quantitative analysis of the mean fluorescence of TGN46, Vti1b,
CD-MPR, CI-MPR, Rab6,EpsinR, Syn6 and Syn10 in infected cells. Results are
expressed as a percentage of the average mean fluorescence signal in TGN compart-
ments of non infected cells corrected for background labelling. Statistically significant
relationships in are denoted (* = P<0.05).
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However, there was significantly reduced labelling of Vti1b, CD-MPR and CI-MPR co-
localising with the TGN of cells infected with Salmonella when compared to non-infected
cells (Fig. 3.7 C).
These results indicate that intracellular Salmonella alters the trafficking to the TGN
of CD-MPR, CI-MPR and Vti1b. This was not as a result of a broad reduction of protein
levels in the TGN as TGN46, Rab6, EpsinR, Syn6 and Syn10 levels were all unaffected.
3.9 Dynamics of TGN-associated Vti1b in infected HeLa
cells
To investigate the dynamics of the effects of Salmonella infection on Vti1b protein lev-
els in the TGN, HeLa cells were infected for 8 h and 14 h with GFP-expressing wild-type
Salmonella. Cells labelled for Vti1b and TGN46 were analysed qualitatively by immunoflu-
orescence microscopy for effects on Vti1b labelling associated with the TGN. Perturbation
of Vti1b labelling associated with the TGN in infected cells, compared to non-infected
cells was evident for both timepoints after inoculation, but was more pronounced at 14 h
(Fig. 3.8 A). This suggests that there is an increasing effect on the TGN localisation of
Vti1b as infection proceeds.
To analyse the reduction of Vti1b localised to TGN compartments in a more detailed
and quantitative manner samples were analysed over a time-course of infection using quan-
titative immunofluorescence analysis. HeLa cells were infected with GFP-expressing wild-
type Salmonella. Cells were fixed every two hours between 2 h to 14 h of infection, then
labelled for TGN46 and Vti1b. The decrease in the fluorescent signal localised to the TGN
region in infected cells was first detectable 8 h after inoculation (Fig. 3.8 B). This decrease
continued beyond 8 h, with the greatest decrease observed at 14 h. There was no significant
change in the sum fluorescence signal of TGN46 when comparing infected to non-infected
cells for all time points. The average bacterial number per cell between 2 and 14 h was
also calculated within the same experiment by counting bacterial cells per infected HeLa
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Figure 3.8 : Dynamics of TGN-associated Vti1b in infected HeLa cells. HeLa cells
were infected with wild-type Salmonella expressing GFP and analysed at the speci-
fied times pi (A) Quantification of the frequency of TGN associated labelling Vti1b
in HeLa cells at 8 and 14 h pi. Scoring of infected and non-infected cells was done by
epi-fluorescence microscopy. Statistically significant relationships in are denoted (*
= P<0.05) (B) Quantitative analysis of the mean fluorescence of Vti1b and TGN46
in infected cells. Results are expressed as a percentage of the average mean fluores-
cence signal in TGN compartments of non infected cells corrected for background
labelling.
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cell by immunofluorescence microscopy (Fig. 3.8 B). The decrease in fluorescence of Vti1b
localised to the TGN coincided with increasing bacterial numbers. The greatest difference
of Vti1b labelling between infected and non-infected cells was at 14 h. Accordingly, I used
this timepoint for further investigation into how Salmonella affects proteins in the TGN.
3.10 Reduction in TGN-localised Vti1b in infected cells
is dependent on the SPI-2 T3SS
Phenotypes associated with the action of the SPI-2 T3SS effector proteins become apparent
6 h to 8 h after invasion of host cells (Ramsden et al., 2007). Therefore, it was possible
that the reduction in TGN associated levels of Vti1b, CD-MPR and CI-MPR was mediated
by the activities of the SPI-2 T3SS. To address this possibility HeLa cells were infected
with an ssaV mutant strain, which has an inactive SPI-2 T3SS (Deiwick et al., 1998) and
analysed with respect to TGN-associated Vti1b levels.
After 14 h pi, cells were fixed and analysed by quantitative immunofluorescence mi-
croscopy. In contrast to results obtained when cells were infected with wild-type Salmonella
(Fig. 3.9 B) the TGN-associated levels of Vti1b were unaltered in cells infected with the
ssaV mutant strain when compared to non-infected cells (Fig. 3.9 A, B).
The ssaV mutant strain has a replication defect in HeLa cells (Ochman et al., 1996;
Cirillo et al., 1998; Hensel et al., 1998). Therefore it was possible that the differences
observed between the wild-type and the ssaV mutant strain were a result of the differences
in replication rather than a loss of specific SPI-2 T3SS effector(s). To attempt to address
possible influences of the differences in the replication rates of wild-type Salmonella and
those of the ssaV mutant strain infected cells were analysed at 20 h and 24 h pi. This was
to allow time for greater growth of the ssaV mutant strain to occur. When samples were
analysed at these timepoints , the levels of Vti1b in the TGN of cells infected with the
ssaV mutant strain were again similar to those of non-infected cells (Fig. 3.9 B). These
data suggest that the reduction in TGN-localised Vti1b in cells infected with wild-type
87
Chapter 3: The interaction of Salmonella with host trafficking proteins
A TGN46 MergedVti1bssaV
B
wt
 - 1
4 h
ss
aV
 - 1
4 h
ss
aV
 - 2
0 h
ss
aV
 - 2
4 h
0
50
100
TGN46
Vti1b
%
TG
N
- a
ss
oc
ia
te
d 
flu
or
es
ce
nc
e
*
Figure 3.9 : Reduction in TGN-localised Vti1b in infected cells is SPI-2-dependent.
(A) Confocal microscopy images showing the localisation of Vti1b and TGN46 in
an infected HeLa cell. Cells were infected with an ssaV mutant strain constitu-
tively expressing GFP (blue), fixed after 14 h and immunolabelled for Vti1b (red)
and TGN46 (green). Images were false coloured using Zeiss LSM software. The
scale bar corresponds to 10 μm. (B) Quantitative analysis of the mean fluorescence
of Vti1b and TGN46 in wild-type and ssaV mutant strain infected cells for the
indicated timepoint. Results are expressed as a percentage of the average mean flu-
orescence signal in the TGN of non infected cells corrected for background labelling.
Statistically significant relationships in are denoted (* = P<0.05).
bacteria is due to the activities of specific SPI-2 T3SS effector(s).
3.11 Reduction in TGN-associated levels of Vti1b is not
due to bacterial replication
To further investigate the possibility of a non-specific effect of replication, I re-analysed,
TGN-associated Vti1b in cells containing between 15 to 30 bacteria for both the wild-
type and ssaV mutant strains and compared them to non-infected cells. Furthermore, I
88
Chapter 3: The interaction of Salmonella with host trafficking proteins
extended this analysis to include the two MPRs as well as Vti1b.
In cells infected with wild-type Salmonella there was a marked reduction in the TGN-
associated labelling of Vti1b, CD-MPR and CI-MPR when compared to non-infected cells
(Fig. 3.10 Aa, Ac, Ae, C). In contrast, in cells infected with the SPI-2 null mutant strain
there was no detectable difference in the levels of protein in the TGN when compared to
non-infected cells (Fig. 3.10 Ab, Ad, Ag, C). Therefore the differences observed in labelling
of these proteins were not due to indirect effects associated with differential replication.
I also infected cells with an aroCpurD mutant strain, which has a severe replication
defect (Beuzón et al., 2002) but has a functional SPI-2 T3SS (Fig. 3.10 B). After 14 h of
infection, I examined the levels of CD-MPR localised to the TGN. As a positive control
for effector translocation I labelled cells for epitope-tagged SseJ (an effector of the SPI-2
T3SS), and compared levels of CD-MPR in cells containing translocated effector with non-
infected cells. The levels of CD-MPR localised to the TGN in infected cells were reduced
to a similar extent to that observed in cells infected with wild-type Salmonella (Fig. 3.10
C), despite greatly reduced bacterial numbers.
Taken together these data indicate that SPI-2 T3SS effector(s), selectively interfere
with the TGN localisation of a subset of proteins known to be recycled from endocytic
compartments to the TGN.
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Figure 3.10 : Reduction in TGN-localised proteins is SPI-2-dependent and is not as-
sociated with replication. (A) HeLa cells were infected for 14 h with either
a GFP-expressing wild-type or ssaV mutant strains (blue), and were immunola-
belled for TGN46 (green) and either Vti1b, CD-MPR or CI-MPR (red). Images
were false coloured using Zeiss LSM software. Scale bars represent 10 μm. (B)
HeLa cells were infected for 14 h with an aroCpurD mutant strain expressing SseJ-
2HA and were immunolabelled, without permeabilising the bacterial membrane, for
HA (green), TGN46 (blue) and CD-MPR (red). Images were false coloured using
Zeiss LSM software. Scale bars represent 10 μm. (C) Quantitative 3d confocal mi-
croscopy of mean fluorescence signals of TGN46, Vti1b, CD-MPR and CI-MPR
localised to the TGN region in HeLa cells infected for 14 h with wild-type, ssaV
mutant or aroCpurD mutant strains. Only cells containing 15 to 30 bacteria for
wild-type and ssaV strains were analysed. Statistically significant relationships in
are denoted (* = P<0.05).
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Salmonella interferes with retrograde
trafficking
4.1 Introduction
In the previous chapter I demonstrated that Salmonella alters the cellular distribution of
the late-endocytic Qb-SNARE Vti1b, CD-MPR and CI-MPR by reducing their levels in the
TGN. All three proteins have a cellular distribution that, at steady state in non-dividing
cells, is largely TGN associated and is maintained through cycling between endocytic and
TGN compartments. These data led to the hypothesis that Salmonella could influence
endosome-to-TGN transport of Vti1b, CD-MPR and CI-MPR. Furthermore, the absence
of a detectable effect on the levels of TGN46 and Syn6 associated with the TGN suggests
that the interference is restricted to a subset of retrograde traffic.
Two retrograde trafficking routes from endosomes to the TGN have been described that
are distinguishable by the SNARE proteins that function within these pathways. The first
pathway, which transports TGN46, Shiga toxin and Cholera toxin, relies on the SNAREpin
complex of Syn6-Syn16-Vti1a and Vamp3 (Ganley et al., 2008). The second retrograde
trafficking pathway, which transports MPRs, relies on the SNAREpin complex of Syn10-
Syn16-Vti1a and Vamp3 or Vamp4 (Ganley et al., 2008) (Fig. 4.1) . It was shown through
the use of siRNA experiments that the distinguishing features between these pathways are
Syn6 and Syn10, each functioning in separate SNAREpin complexes with Syn16-Vti1a and
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Figure 4.1 : Endosome-to-TGN trafficking routes. Retrograde trafficking routes are de-
noted by red arrows and anterograde trafficking routes are denoted by black arrows.
The cargos that are transported by each of the two endosome-to-TGN trafficking
routes are shown in blue, adjacent to the route they follow. The SNAREpin com-
plex associated with each of the two transport routes are listed adjacent to relevant
route. EE, early endosome; RE, recycling endosome; MVB, multi-vesicular body;
ER, endoplasmic reticulum.
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Vamp3 (Ganley et al., 2008). Vti1b has been shown to recycle in a retrograde manner from
endosomes to the TGN (Hirst et al., 2004), but it is not known through which of the two
routes it travels.
I used siRNA-mediated depletion of Syn6 and Syn10 from host cells to evaluate if the
CD-MPR, CI-MPR and Vti1b share a similar endosome-to-TGN trafficking pathway. I also
investigated whether the phenotypes observed during infection could be recapitulated in
uninfected cells by directly targeting either of the retrograde trafficking pathways through
siRNA mediated depletion of Syn6 or Syn10. In addition, to assess the possible interfer-
ence of endosome-to-TGN transport by Salmonella more directly, I undertook assays of
molecules that undergo Syn6 or Syn10 dependent transport from the plasma membrane to
the TGN, in the context of Salmonella infection. Finally I investigated whether there were
any physiological ramifications of Salmonella infection on the pathways involving MPR
trafficking.
4.2 siRNA-mediated depletion of Syn10
To verify the protein level of Syn10 after siRNA treatment, SDS-PAGE and immunoblot-
ting of intracellular protein was undertaken in HeLa cells treated with indicated siRNA
oligos (Fig. 4.2 D). The pool of four oligos as well as single oligos 2 and 3 were found to be
the most effective and were selected for use in further experimentation. Using 3d confocal
microscopy to determine protein levels in TGN compartments, I observed that CD-MPR
was reduced after siRNA-mediated depletion of Syn10 using either a pool of 4 oligos or
single oligos 2 or 3 targeted against Syn10 (Fig. 4.2 A, C). This agrees with published data
showing a dependency on Syn10 for the retrograde traffic of MPR (Ganley et al., 2008).
Interestingly, the TGN localisation of Vti1b was similarly reduced indicating that it is also
dependent on Syn10 for retrograde recycling (Fig. 4.2 B, C) . Although it is thought to
be recycled to the TGN, the pathway through which Vti1b travels has not been described
previously. In addition, similar to cells infected with Salmonella, there was no detectable
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Figure 4.2 : siRNA depletion of Syn10. Confocal microscopy images showing the localisation
of (A) CD-MPR (red), TGN46 (green), Syn10 (blue), and (B) Vti1b (red), TGN46
(green), and Rab6 (blue) in HeLa cells treated with scramble siRNA or Syn10-3
siRNA targeted against Syn10. Images were false coloured using Zeiss LSM soft-
ware. The scale bar corresponds to 10 μm. (C) Quantitative analysis of the mean
fluorescence of Rab6, TGN46, CD-MPR, and Vti1b after siRNA treatment using
scrambled siRNA, a siRNA pool of 4 oligos and 2 single oligos against Syn10. Re-
sults are expressed as a percentage of the average mean fluorescence signal in mock
treated cells corrected for background. Quantitative fluorescence scoring was done
using at least 100 cells in each condition. Experiments were undertaken in triplicate.
Statistically significant differences are denoted using a * , as determined through a
two tailed student t-test resulting in a P<0.05. (D) SDS-PAGE and immunoblotting
of levels of Syn10 in HeLa cells treated with indicated siRNA oligos.
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effect of Syn10 depletion on the TGN localisation of TGN46 and Rab6. These observations
were confirmed using another non-overlapping, single siRNA oligo against Syn10 (Fig. 4.2
C).
When quantified, the reduction of Vti1b and CD-MPR at the TGN was similar in
magnitude to that observed during infection. The reduction of Vti1b and CD-MPR in
the TGN compartments, and the lack of an effect on TGN46 localisation (Fig. 4.2 C),
recapitulates the effects observed upon infection with S. Typhimurium (Fig. 3.7 C). This is
consistent with the hypothesis that Salmonella interferes with Syn10-dependent retrograde
traffic to the TGN.
4.3 siRNA-mediated depletion of Syn6
TGN46 and Syn6 were shown to be unaffected by Salmonella infection, suggesting that
the retrograde trafficking route defined by Syn6 is not perturbed by Salmonella. However,
the possibility exists that the technique I employed to assess TGN-localisation of the pro-
teins examined was not sensitive enough to detect disturbances in retrograde trafficking of
TGN46. To test this I disrupted the pathway by depleting Syn6 using siRNA. Depletion of
Syn6 has been shown previously to reduce the amount of TGN46 in TGN compartments
(Ganley et al., 2008).
In agreement with published data, knock-down of Syn6, using a pool of oligos (verified
by immunoblot and immunofluorescence analysis (Fig. 4.3 A, C)), resulted in a reduction
in the fluorescence of TGN46 in TGN compartments, defined by Rab6 (Fig. 4.3 A, B).
Syn6 knock-down did not affect the sum fluorescent signal of Rab6 in TGN compartments,
suggesting that the TGN remained intact (Fig. 4.3 A, B). These results indicate that the
technique I used is sensitive enough to detect perturbation in the retrograde trafficking
route defined by Syn6.
Interestingly, depletion of Syn6 enhanced the levels of CD-MPR in the TGN (Fig. 4.3
B). This is in broad agreement with the reported observation that Syn6 depletion from
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Figure 4.3 : siRNA depletion of Syn6. Confocal microscopy images showing the localisation
of (A) Rab6 (red) TGN46 (green) and Syn6 (blue) in HeLa cells treated with scram-
ble siRNA or Syn6-oligo pool siRNA consisting of 4 oligos targeted against Syn6.
Images were false coloured using Zeiss LSM software. The scale bar corresponds
to 10 μm. (B) Quantitative analysis of the mean fluorescence of Rab6, TGN46
and CD-MPR after siRNA treatment using scrambled siRNA and Syn6-pool siRNA
consisting of 4 oligos. Results are expressed as a percentage of the average mean
fluorescence signal of mock treated cells corrected for background. Quantitative flu-
orescence scoring was done using at least 100 cells in each condition. Experiments
were undertaken in triplicate. Statistically significant differences are denoted using
*, as determined through a two tailed student t-test resulting in a P<0.05. (C)
SDS-PAGE and immunoblotting of levels of Syn6 in HeLa cells treated with indi-
cated siRNA oligos.
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HeLa cells increases the cellular levels of CI-MPR (Ganley et al., 2008). These data also
support the hypothesis that Salmonella affects retrograde traffic defined by MPR trafficking
and does not interfere with retrograde traffic defined by Syn6.
4.4 Effect of Salmonella on Syn6 and Syn10 dependent
pathways: trafficking assays
Certain molecules undergo retrograde transport from the plasma membrane to the TGN
and can be used as probes to detect disruption of this type of transport. These assays
exploit the previously described specificity in the retrograde trafficking routes from the
plasma membrane through the endocytic compartment to the TGN of cholera toxin B
subunit (CTxB) (Ganley et al., 2008), and antibody-labelled CI-MPR (Robinson et al.,
2010). A small proportion of CI-MPR undergoes anterograde transport to the plasma
membrane, where it can be labelled with antibodies, and from there the labelled receptor
traffics to the TGN (Ghosh et al., 2003; Robinson et al., 2010). Transport of CI-MPR to
the TGN from endocytic compartments has been shown to be dependent on Syn10 whereas
transport of CTxB is dependent on the Syn6 retrograde pathway (Ganley et al., 2008).
HeLa cells were infected for 13 h with wild-type or ssaV mutant strains and then
incubated in the presence of culture medium containing either anti-CI-MPR antibody
or CTxB for 30 min followed by a chase of 30 min with media only. Cells were then
fixed and analysed by immunofluorescence microscopy. Strikingly, the trafficking to the
TGN of antibody-labelled CI-MPR was strongly perturbed in cells infected with wild-type
Salmonella (Fig. 4.4 A, B), while there was no apparent effect on CTxB transport (Fig. 4.4
A, C). Furthermore, this interference was dependent on a functional SPI-2 T3SS since there
was no effect on CI-MPR traffic to the TGN in HeLa cells infected with the ssaV mutant
strain (Fig. 4.4 B). To control for the sensitivity of the assay to detect a perturbation in
CTxB traffic, siRNA mediated depletion of Syn6 was undertaken. As expected there was
a significant reduction in the amount of CTxB associated with the TGN (Fig. 4.4 C).
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Figure 4.4 : Effect of Salmonella on CI-MPR and CTxB trafficking. HeLa cells were
infected for 14 h with wild-type or ssaV mutant Salmonella strains (blue) or depleted
of Syn6 (Syn6 KD). Cells were then allowed to internalise either fluorescent CTxB
(red) or an anti-CI-MPR antibody (red) for 30 min followed by a 30 min chase.
Cells were fixed and labelled to detect CI-MPR or TGN46 (green). (A) Confocal mi-
croscopy images showing the localisation of TGN46 and either internalised CI-MPR
or CTxB in cells infected with wild-type Salmonella and non-infected cells. Images
were false coloured using Zeiss LSM software. The scale bar corresponds to 10 μm.
(B) Quantification of the frequency of TGN associated CI-MPR in uninfected cells
or cells infected with wild-type or ssaV mutant Salmonella strains. Experiments
were conducted in triplicate. Statistically significant differences are denoted using
*, as determined through a two tailed student t-test resulting in a P<0.05. (C)
Quantification of the frequency of TGN associated CTxB in uninfected cells or in
cells infected with wild-type Salmonella or in cells depleted of Syn6. Experiments
were conducted in triplicate. Statistically significant differences are denoted using *,
as determined through a two tailed student t-test resulting in a P<0.05. (D) FACS
analysis of plasma membrane associated CI-MPR. Cells were infected for 14 h with
either GFP-expressing wild-type or ssaV mutant Salmonella then collected and la-
belled with an antibody against CI-MPR or an isotype (iso) control. Histograms
represent the levels of fluorescence labelling associated with CI-MPR or isotype con-
trol. Cells were gated for infection by GFP fluorescence. Over 10000 cells were
analysed per condition.
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Finally, I analysed the surface expression of CI-MPR by flow cytometry to verify that
the differences in antibody labelled CI-MPR transport from the plasma membrane to the
TGN in cells infected with wild-type bacteria was not due to differences in the levels of
CI-MPR on the plasma membrane. I infected cells with GFP-expressing wild-type or
ssaV mutant Salmonella for 14 h. Cells were collected and labelled for plasma membrane
associated CI-MPR. The specificity of the labelling was confirmed by the difference in fluo-
rescence between CI-MPR labelled cells and those labelled with an isotype control (Fig. 4.4
D). There was no detectable difference in the levels of plasma membrane associated CI-
MPR between uninfected cells or cells infected with wild-type or ssaV mutant Salmonella
(Fig. 4.4 D). Therefore, differences in CI-MPR transport to the TGN from the plasma
membrane seen during infection with wild-type bacteria are not a result of differences in
the surface levels of CI-MPR.
These results, together with those showing redistribution of Vti1b and the MPRs from
the TGN, provide strong evidence for selective inhibition of Syn10-dependent retrograde
trafficking by Salmonella SPI-2 T3SS effector(s).
4.5 Levels of Vti1b and CD-MPR in infected cells
As stated in section 1.3.4.5, trafficking of MPRs is very important for generation of func-
tional lysosomes. Mislocalisation of the MPRs away from the TGN would be expected to
result in insufficient receptor to bind newly synthesised lysosomal enzymes as they arrive in
TGN compartments. The enzymes would then be re-routed via the bulk secretory pathway
to the plasma membrane, and secreted outside the cell (Riederer et al., 1994a; Ikeda et al.,
2008). If MPR traffic was impaired in cells infected with Salmonella then it is possible
that there may also be re-routing of lysosomal enzymes in these cells.
Before addressing whether Salmonella infection results in rerouting of lysosomal en-
zymes, I investigated whether the reduced levels of Vti1b, CD-MPR, and CI-MPR at the
TGN after 14 h of infection was associated with depletion of these proteins from the cell or
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their dispersion into other compartments. Immunoblot analysis and fluorescence-activated
cell sorting (FACS) analysis were used to assess whether there was any change in the overall
levels of Vti1b and CD-MPR after 14 h of infection with either wild-type or ssaV mutant
strains of S. Typhimurium.
There was no noticeable reduction in the levels of Vti1b or CD-MPR in cells infected
with either wild-type or ssaV mutant strains when compared to non-infected cells when
analysed by immunoblotting (Fig. 4.5 A). However, in this experiment samples contained
both infected and uninfected cells. As an alternative approach I analysed protein levels at
the single cell level via FACS analysis. In these experiments cells were depleted of Vti1b or
CD-MPR by siRNA treatment to act as positive controls for a reduction in protein levels.
Prior to FACS analysis, infected cells were gated to ensure that only infected cells were
analysed. The results of these experiments showed that, while it was possible to detect
reduced protein levels after specific siRNA treatments, there was no detectable reduction
in the levels of either Vti1b or CD-MPR after 14 h of wild-type or ssaV mutant strain
infection (Fig. 4.5 B, C).
These results indicate that the effects on Vti1b, CD-MPR and CI-MPR observed during
infection with wild-type bacteria are not a consequence of reduction in overall levels but
rather a redistribution of these proteins away from TGN compartments. It is possible that
they could be trapped in an early endocytic compartment, as has been described for MPRs
localised to SNX1 positive compartments in cells depleted of Syn10 (Ganley et al., 2008).
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Figure 4.5 : Analysis of levels of Vti1b and CD-MPR. (A) HeLa cells were left uninfected
or infected for 14 h with either GFP-expressing wild-type or ssaV mutant strains.
Intracellular proteins were analysed by SDS-PAGE and immunoblotting. (B and C)
FACS analysis of levels of Vti1b and CD-MPR in HeLa cells. (Bi, Ci) Uninfected
HeLa cells (ni) were prepared according to the following conditions for analysis;
left unlabelled, labelled with secondary antibody only (secondary), labelled with IgG
isotype control (iso) or labelled with a specific primary antibody to Vti1b or CD-
MPR prior to secondary antibody (specific). (Bii, Cii) HeLa cells were treated with
mock or scramble controls or indicated siRNA oligos and labelled with antibody to
Vti1b or CD-MPR. (Biii, Ciii) HeLa cells left uninfected or infected for 14 h with
either GFP-expressing wild-type or ssaV mutant strains and labelled with antibody
to Vti1b or CD-MPR for analysis.
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4.6 Secreted lysosomal enzyme activity assay
To analyse misrouting of lysosomal enzymes in Salmonella-infected cells, the extracellular
activities of two lysosomal enzymes, β-hexosaminidase (β-hexo) and cathepsin D (CatD),
were measured. The assays involved fluorescent substrates for β-hexo (4-methylumbelliferyl-
2-acetamido-2-deoxy-β-d-glucopyranoside) and CatD (MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-
Phe-Arg-Leu-Lys(Dnp)-d-Arg-NH2); these substrates have been shown previously to be
suitable reagents to assess activities of these enzymes (Ikeda et al., 2008). Both substrates
fluoresce upon their cleavage and the sum fluorescent signal from a sample is proportional
to the amount of cleavage that occurs. For these assays, the intracellular and extracellular
activities of each enzyme were calculated to provide the total enzyme activity and the
extracellular activity is presented as a percentage of total enzyme activity (Fig. 4.6 B, C).
Exposure of cells to amiodarone causes an increase in secretion of lysosomal enzymes via
the secretory pathway due to a blockade of MPR trafficking (Ikeda et al., 2008). Ami-
odarone was used as a positive control to cause increased secretion of β-hexo and CatD
in HeLa cells. The enzymatic activity assays were undertaken in acidified buffer (pH 4.2
or pH 4.4), which allows for autoactivation of any immature inactive enzyme (Turk et al.,
2012).
To control for non-specific release of intracellular enzymes due to cytotoxicity, a lactate
dehydrogenase (LDH) cytotoxicity assay was used to test all extracellular samples. LDH is
a stable cytoplasmic enzyme but when the plasma membrane is damaged, LDH is released
into the culture supernatant. The amount of LDH in the supernatant corresponds to the
degree of cell lysis within the cell culture (Decker & Lohmann-Matthes, 1988). SPI-1 T3SS
mediated invasion by Salmonella has been shown to cause cytotoxicity in cells (Monack
et al., 1996; Hersh et al., 1999). To remove the effects of SPI-1-associated cytotoxicity
within the cell culture, all cells were washed thoroughly 8 h pi (at which time the SPI-1
T3SS is no longer active) and then the secreted lysosomal enzymes were collected at 14
h pi. There was very low cytoxicity detected for all samples and no detectable difference
observed between the samples (Fig. 4.6 A).
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Figure 4.6 : Secreted lysosomal enzyme activity assay Cells were either treated with DMSO
or amiodarone (ami) or infected with wild-type Salmonella or the ssaV mutant
strain or left non-infected (ni) for 14 h. Cells were washed 8 h pi and samples were
analysed 14 h pi. (A) Cytotoxicity was assessed using LDH levels and expressed as a
percentage of LDH levels of control samples (uninfected cells completely lysed in 1%
Triton X100-PBS). (B and C) Secreted levels of CatD and β-hexo were expressed
as a percentage of total CatD or β-hexo, which equals the sum of the intracellular
and extracellular levels of the enzyme. Statistically significant relationships in both
are denoted using *=P<0.05 or **=P<0.005 or ***=P<0.0005
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As was predicted from published data(Ikeda et al., 2008), a statistically significant
increase in the extracellular activity for both CatD and β-hexo was observed in cells treated
with amiodarone when compared to cells treated with dimethyl-sulfoxide (DMSO) alone. In
addition, a statistically significant increase in the extracellular enzymatic activity of CatD
and β-hexo was observed for wild-type Salmonella-infected cells compared to non-infected
cells (Fig. 4.6 B, C). There was also a significant increase in the extracellular enzymatic
activity of CatD and β-hexo in wild-type Salmonella infected cells when compared with
cells infected with the ssaV mutant strain, indicating that the SPI-2 T3SS accounted for a
major proportion of the Salmonella effect in the levels of extracellular activity of secreted
CatD and β-hexo (Fig. 4.6 B, C).
4.7 Levels of secreted lysosomal enzymes
The conditions under which the above assays were conducted were acidic (pH 4.2 or pH 4.4)
to ensure conversion of any immature CatD and β-hexo to their active mature forms. If the
increased activities of CatD in the extracellular fractions of cells infected with Salmonella
were due to a misrouted secretion of this enzyme directly from the TGN, then this enzyme
would be expected to be present in its inactive, immature form. To test this, intracellular
and extracellular fractions were subjected to SDS-PAGE and immunoblotting using an
antibody that recognises both immature and mature forms of CatD.
There was a marked increase in the secretion of CatD in cells treated with amiodarone
and cells infected with wild-type bacteria when compared with non-infected cells (Fig. 4.7).
Furthermore, the vast majority of increased secreted protein was in the immature state in-
dicating that the immature pro-CatD had not encountered an acidic environment (Fig. 4.7).
This suggests that it was likely to have been trafficked directly from the TGN to the plasma
membrane. In addition, the proportion of the intracellular levels of immature to mature
CatD appeared to be higher in cells infected with wild-type bacteria or amiodarone-treated
cells when compared to non-infected cells (Fig. 4.7). This is a further indication of an im-
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Figure 4.7 : Lysosomal enzyme secretion levels. Cells were either treated with amiodarone
(ami) or infected with wild-type Salmonella or the ssaV mutant strain or left non-
infected for 14 h. Cells were washed 8 h pi and intracellular and extracellular sam-
ples were analysed 14 h pi. In one case cells infected with wild-type bacteria were also
exposed to chloramphenicol (cm) 2 h pi to block bacterial protein synthesis. Intra-
cellular and extracellular proteins were analysed by SDS-PAGE and immunoblotting
using antibodies against CatD and actin (loading control).
paired maturation pathway characteristic of a blockade in MPR traffic.
The effect of Salmonella on CatD required bacterial protein synthesis as it was not
observed in cells infected with wild-type bacteria and then exposed to chloramphenicol 2 h
pi (Fig. 4.7). In cells infected with the ssaV mutant strain there was a very small increase
in the levels of secreted CatD when compared to non-infected cells (Fig. 4.7).
Together the data presented in this chapter indicate that Salmonella interferes with a
retrograde trafficking route defined by Syn10 in a SPI-2 T3SS-dependent manner, disrupt-
ing MPR trafficking. This is accompanied by a re-routing of lysosomal enzymes from the
TGN to the extracellular space.
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SifA impairs lysosome function
5.1 Introduction
In this chapter I examine the physiological impact of interference by Salmonella on ret-
rograde recycling and investigate the underlying mechanism. Trafficking of MPRs is very
important for cellular homeostasis of the lysosomal pathway. Mis-localisation of MPRs
from the TGN results in insufficient receptor to bind newly synthesised lysosomal enzymes
as they arrive in Golgi compartments from the ER. There is a resultant failure to retain
mannosylated lysosomal enzymes as they traffic through the Golgi cisternae, which are then
re-routed via the bulk secretory pathway to the plasma membrane, and secreted outside
the cell (Riederer et al., 1994b; Ikeda et al., 2008).
From a physiological point of view, it could be beneficial for a vacuolated pathogen
to interfere with lysosomal biogenesis, since lysosomes are a major component of the in-
nate immune system. Rerouting of hydrolytic enzymes could be an important mechanism
through which Salmonella detoxifies lysosomes.
5.2 Lysosome function in infected HeLa cells
If Salmonella causes the misrouting of newly synthesised lysosomal enzymes out of the cell,
the functionality of lysosomal compartments might be impaired. To test this I assayed
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lysosomal cathepsin B (CatB) in living cells infected with Salmonella using a fluorescent
substrate of cathepsin B (Magic Red cathepsin B (MRcatB)). I used this substrate in
combination with fluorescence recovery after photo-bleaching (FRAP) analysis and FACS
analysis. FRAP analysis, with this protease detection system, has previously been em-
ployed to study lysosome function in the context of MPR trafficking (Metcalf et al., 2008).
It has also been used in conjunction with FACS analysis to detect steady state levels of
CatB activity in living cells (Creasy et al., 2007) (used during transfection experiments in
section 5.9 and 5.10).
Both assays employ the use a membrane-permeant cathepsin B-specific substrate linked
to a di-substituted cresyl violet fluorophore with two dipeptide CatB targeting sequences.
In this conformation the peptide is non-fluorescent, but upon hydrolysis by CatB the
fluorophore is converted to a form that fluoresces strongly in the visible red spectrum. As
CatB activity progresses, more of the peptide is converted to the fluorescent state until
eventually an equilibrium of red fluorescence intensity is reached within the cell. This
steady state equilibrium of fluorescence intensity is the threshold of product formation
versus product decay and differences in these levels (which are reflective of overall CatB
activity in the cell) can be detected using either confocal microscopy or FACS analysis.
Using FRAP analysis I investigated whether there was any reduction in lysosome activ-
ity in infected and non-infected HeLa cells after 14 h of infection. Infected cells containing
between 10 and 30 bacteria per cell were selected for analysis together with non-infected
cells in the same field of view.
Prior to FRAP it was evident that cells infected with wild-type bacteria had lower
steady state levels of fluorescence compared with uninfected cells (Fig. 5.1 A, B). When
quantified using a large sample set over 3 separate experiments, these cells also exhibited
a marked reduction in rate of recovery after bleaching (Fig. 5.1 A, Movie S1, B ) (files for
Movies S1 and S2 are included in supplemental material). By contrast, prior to FRAP
there was no obvious reduction in levels of fluorescence in cells infected with the ssaV
mutant strain (Fig. 5.1 A, Movie S2, B), and these cells consistently recovered to higher
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Figure 5.1 : CatB activity in infected HeLa cells. HeLa cells were infected for 14 h with wt
or ssaV mutant Salmonella and exposed to a CatB substrate (MRcatB, red). (A)
Still frames at indicated time points from Movie S1 (wt, green) and Movie S2 ( ssaV,
green). Entire cells were selected for analysis using differential interference contrast
(DIC). Infected and uninfected cells in the same field of view were analysed using
fluorescence recovery after photobleaching (FRAP) and were imaged every 3 sec over
150 second (s). Arrows indicate fluorescence recovery in infected cells after 150 s.
(B) Infected and uninfected cells in the same fields of view were analysed by FRAP
assay over 300 s. Data were normalised to the mean fluorescence of uninfected cells.
Error bars represent +/- SEM.
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levels of fluorescence compared to cells infected with the wild-type strain (Fig. 5.1 A, Movie
S2, B).
These data suggest that lysosome function is compromised in wild-type infected HeLa
cells and that this is dependent on the SPI-2 T3SS. This is consistent with the effect
of Salmonella on MPR trafficking and the misrouting of lysosomal enzymes reported in
chapters 3 and 4.
5.3 Lysosomal function in infected macrophage cells
Much of the virulence of Salmonella in systemic disease is due to its ability to survive
and replicate in host macrophages. During systemic infection macrophages represent the
primary reservoir of bacterial replication (Watson & Holden, 2010). To determine if the
SPI-2 T3SS-dependent impairment of lysosome function observed in infected HeLa cells
was also evident in infected mouse macrophages, I infected macrophages with wild-type
or ssaV mutant strain S. Typhimurium and analysed them for CatB activity using the
FRAP assay.
Two macrophage cell types were used in these experiments. Initially, CatB activity was
analysed in RAW264.7 cells, a mouse macrophage-like cell line. In cells infected for 14 h
with wild-type Salmonella, there was a reduction in both steady state CatB activity, and
in recovery of CatB activity following fluorescence bleaching, compared to cells infected
with the ssaV mutant strain (Fig. 5.2 A).
I also conducted infections in primary C57BL/6 bone-marrow derived mouse macro-
phages. These cells are much more restrictive to bacterial growth (Helaine et al., 2010) and
it can be argued that they are a more physiologically relevant cell type than RAW264.7
mouse macrophages-like cells given that they are derived from an in vivo source. Bone-
marrow macrophages were infected for 48 h or 72 h with either wild-type or ssaV mutant
strains. Macrophages containing similar numbers of bacteria were selected for analysis.
There was a marked reduction in CatB activity when cells were infected with wild-type
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Figure 5.2 : CatB activity in infected macrophages. (A) RAW264.7 cells were infected for
14 h with wild-type (wt) or ssaV mutant Salmonella and were analysed by FRAP as-
say of CatB activity. (B and C) C57BL/6 mouse bone marrow-derived macrophages
were infected for 48 h (B) or 72 h (C) with wt or ssaV mutant Salmonella and were
analysed by FRAP assay of CatB activity. Data were normalised to the mean fluo-
rescence of uninfected cells.
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Salmonella, when compared with cells infected with the ssaV mutant strain at both 48 h
and 72 h post-uptake. This was evident both at steady state levels and by FRAP (Fig. 5.2
B, C).
These results show a reduction in lysosome function in a SPI-2 T3SS-dependent manner
in three separate cell types of human and mouse origin.
5.4 Lysosomal activity in cells depleted of Syn6 or Syn10
If impairment of lysosome function is due to the effect of Salmonella on MPR recycling to
the TGN, then blocking MPR traffic in uninfected cells should recapitulate the reduction in
CatB activity observed during infection. To investigate whether reduced lysosome function
occurs in cells with impaired endosome-to-TGN traffic I depleted HeLa cells of Syn10 or
Syn6 by siRNA and examined lysosome function using the MRcatB FRAP assay.
There was a marked reduction in steady state and FRAP levels of CatB activity in cells
depleted of Syn10 using either a pool of oligos or a single oligo, compared to cells treated
with a scrambled oligo (Fig. 5.3 A). In contrast, Syn6 depletion enhanced levels of CatB
activity, both at steady state and during FRAP (Fig. 5.3B). These results are consistent
with the data shown in (Fig. 4.2 B; Fig. 4.3 B), of reduced or increased TGN localisation of
CD-MPR in cells depleted of Syn10 or Syn6, respectively, and show that Syn10 is required
to maintain lysosome enzyme levels.
5.5 Growth of Salmonella in cells depleted of Syn10 or
Syn6
I next examined the effects of Syn6 and Syn10 depletion, or pharmacological inhibition
of cathepsins, on the intracellular growth of GFP-expressing Salmonella. Two methods
of analysis were employed. Initially the numbers of individual GFP-expressing wild-type
bacteria per cell were counted after 8 h of infection using fluorescence microscopy. HeLa
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Figure 5.3 : Lysosomal activity assay in siRNA treated cells. (A) HeLa cells depleted of
Syn10 using either a pool of 4 oligos (-p) or oligo 3 (-3) or exposed to scrambled
siRNA were analysed by FRAP assay of CatB activity. Error bars represent +/-
SEM. (B) HeLa cells depleted of Syn6 using a pool of 4 oligos (-p) or exposed
to scrambled siRNA were analysed by FRAP assay of CatB activity. Error bars
represent +/- SEM.
cells were either treated with the transfection reagent alone (mock), scramble siRNA or
siRNA against Syn10. Cells were then infected for 8 h with GFP-expressing Salmonella,
fixed and labelled for F-actin as a marker for HeLa cells. For each condition, growth of
Salmonella was assessed by counting individual bacteria per cell. Increased growth was
observed when cells were depleted of Syn10 (Fig. 5.4 A).
Bacterial growth in Syn6 or Syn10-depleted cells was also measured by flow cytometry,
which provides a sensitive measure of the amount intracellular bacterial growth (Kuijl
et al., 2007; Yu et al., 2011). HeLa cells were treated with transfection reagent, scramble
siRNA, siRNA against Syn10 or siRNA against Syn6 and were then infected with GFP-
expressing wild-type bacteria. At 2 h and 8 h pi cells were collected and analysed by flow
cytometry. Results were expressed as GFP fluorescence per HeLa cell and represent the
median of the ratio between 2 h and 8 h after inoculation, normalised to mock-treated cells.
Cells depleted of Syn6 contained significantly less fluorescence than control cells, while cells
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Figure 5.4 : Replication of Salmonella in HeLa cells depleted of Syn6 or Syn10 (A)
HeLa cells treated with mock-transfected, control siRNA or Syn10 siRNA were in-
fected with GFP-expressing wild-type Salmonella. The data represent the average
bacterial number per cell over 3 experiments with over 200 cells per condition per
experiment analysed. (B) HeLa cells treated with control, Syn6 siRNA or Syn10
siRNA, or with lysosome protease inhibitor (Lys) were infected with GFP-expressing
wild-type Salmonella. Bacterial load, expressed as GFP fluorescence per HeLa cell,
was measured by flow cytometry (n > 10,000). %GFP signal/cell represents the me-
dian of the ratio between 2 h and 8 h after infection normalised to mock-transfected
or DMSO treated cells.
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depleted of Syn10 contained significantly greater fluorescence, indicating increased bacterial
growth (Fig. 5.4 B).
Finally, to investigate more directly the sensitivity of Salmonella to lysosomal enzyme
activity, cells were exposed to either DMSO or a lysosome cathepsin inhibitor, Cathepsin
III. After 4 h of exposure to the inhibitor, cells were infected with GFP-expressing wild-
type bacteria, and the inhibitor was maintained in the culture medium for the duration of
the infection. After 2 h and 8 h pi cells were collected and analysed by flow cytometry as
above. Cells exposed to the inhibitor contained significantly more fluorescence than control
cells indicating increased bacterial growth (Fig. 5.4 B). Therefore, the intracellular growth
of Salmonella was reduced in cells with enhanced lysosomal enzyme activity and enhanced
in cells with reduced lysosomal enzyme activity.
5.6 sifAsseJ and sifAsopD2 mutant strains fail to re-
distribute CD-MPR
To identify a Salmonella effector protein(s) that could impair lysosome function, HeLa cells
were infected with various mutant strains for 14 h and examined for effects on CD-MPR
localisation. SifA is a SPI-2 T3SS effector that is prenylated by host cell geranyl geranyl
transferase, allowing it to insert into the SCV membrane (Reinicke et al., 2005). In this
environment it functions in co-operation with the SPI-2 T3SS effectors PipB2, SseJ and
SopD2 to mediate Sif formation and reorganisation of the late endosomal network (Stein
et al., 1996). SifA is also required to maintain the SCV membrane (Beuzón et al., 2000).
Loss of the vacuolar membrane around a sifA mutant is inhibited by absence of either SseJ
or SopD2 (Ruiz-Albert et al., 2002; Schroeder et al., 2010). Therefore the possible effect
of SifA was examined using sifAsseJ or sifAsopD2 double mutant strains along with sseJ
and aroCpurD mutants or wild-type strains. Infection of HeLa cells with the sifAsseJ or
sifAsopD2 strains did not induce redistribution of CD-MPR while infection with the sseJ
or aroCpurD mutants or wild-type strains caused its redistribution (Fig. 5.5 A, B).
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Figure 5.5 : sifAsseJ and sifAsopD2 fail to redistribute CD-MPR. (A) HeLa cells were
infected for 14 h with either a GFP-expressing S. Typhimurium sifAsseJ or sifA-
sopD2 mutant strains (blue) and were immunolabelled for TGN46 (green) and CD-
MPR (red). (B) Quantitative 3d confocal microscopy of mean fluorescence signals of
CD-MPR localised to the TGN region in HeLa cells infected for 14 h with wild-type,
sifAsseJ, sseJ, sifAsopD2 or an aroCpurD mutant strains. Scale bars represent 10
μm. Statistically significant relationships in are denoted (* = P<0.05).
These data show that SifA is required by Salmonella to interfere with MPR retrograde
traffic to the TGN.
115
Chapter 5: SifA impairs lysosome function
5.7 SifA but not SifA(L130D) complements CD-MPR re-
distribution in a sifAsseJ or sifAsopD2 mutant
strain
SifA activity is mediated at least in part through its interaction on the SCV membrane
with the host cell protein SKIP (Boucrot et al., 2005). Once bound on the membrane
the complex of SifA and SKIP are able to cross-link the SCV with the kinesin-associated
microtubule network to promote anterograde movement of membrane, generating Sifs (Du-
mont et al., 2010; Schroeder et al., 2011). The binding between SifA and SKIP has been
characterised at the atomic level and shown to be dependent on a SifA leucine residue at
position 130 (L130), which is intimately associated with the PH domain of SKIP (Boucrot
et al., 2005; Ohlson et al., 2008; Diacovich et al., 2009).
To test the requirement of a SifA-SKIP interaction in the alteration of MPR trafficking,
HeLa cells were infected with the sifAsseJ mutant strain harboring a plasmid encoding
either an epitope-tagged wild-type SifA (SifAwt-HA) or a point mutant (SifA(L130D)-HA).
Cells were also infected with sifAsopD2 mutant strain harboring SifAwt-HA as well as ssaV,
sifAsseJ mutant or wild-type strains. Complementation of sifAsseJ or sifAsopD2 mutant
strains with the wild-type SifA protein, caused redistribution of MPR similar to that caused
by wild-type Salmonella infection (Fig. 5.6 A, B). However cells infected with sifAsseJ
mutant bacteria producing the point mutant SifA(L130D)-HA, were indistinguishable from
cells infected with the ssaV or sifAsseJ mutants, in terms of accumulation of MPR at the
TGN (Fig. 5.6 A, B). This failure to complement was not due to a defect in translocation
of effector into the host cell (Fig. 5.6 A) Together these results show that SifA is required
to impair MPR trafficking during infection and requirement for L130 strongly implicates
SKIP in this process.
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Figure 5.6 : SifA but not SifA(L130D) complements CD-MPR redistribution in
sifAsseJ and sifAsopD2 mutant strains (A) HeLa cells were infected for 14
h with a S. Typhimurium sifAsseJ mutant strain expressing either SifA-HA or
pSifA(L130D)-HA and were immunolabelled for TGN46 (green) and CD-MPR (red)
and HA (blue). Scale bars represent 10 μm. (B) Quantitative 3d confocal mi-
croscopy of mean fluorescence signals of CD-MPR localised to the TGN region in
HeLa cells infected for 14 h with wild-type, ssaV, sifAsseJ, sifAsseJ pSifA-HA, sifA-
sopD2 pSifA-HA or sifAsseJ pSifA(L130D)-HA mutant strains. Statistically signifi-
cant relationships in are denoted (* = P<0.05). Results are the average of triplicate
experiments for all strains except for sifAsopD2 pSifA-HA strain which was under-
taken 2 times.
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5.8 Leucine 130 of SifA is required for inhibition of lyso-
some function
If Salmonella can alter MPR traffic through the actions of SifA then it is possible that SifA
is also responsible for the SPI-2 T3SS-dependent impairment of lysosome function observed
during infection. To investigate whether this was the case HeLa cells were infected for 14 h
with wild-type, sifAsseJ mutant and complemented strains and then subjected to FRAP
assay for CatB activity.
Both steady state levels of fluorescence and its rate of recovery during FRAP were
higher in HeLa cells infected with the sifAsseJ mutant strain, compared to cells infected
with wild-type bacteria (Fig. 5.7). Production of SifA in the double mutant strain lowered
the fluorescence to that obtained in cells infected with wild-type bacteria, but production
of SifA(L130D) in the double mutant strain failed to reduce CatB activity either at steady
state or during FRAP (Fig. 5.7). Therefore, SifA accounts for the inhibition of lysosomal
function by Salmonella and the requirement for leucine 130 implicates SKIP in this process.
5.9 SifA but not SifA(L130D)is sufficient to redistribute
CD-MPR and attenuate lysosome function
Next I addressed whether expression of SifA alone was sufficient to redistribute the MPR
from the TGN and impair lysosome function. SifA::EGFP or SifA(L130D)::EGFP was ex-
pressed ectopically in HeLa cells after transient transfection. Levels of MPR localised to
the TGN were examined by quantitative 3d immunofluorescence microscopy. Consistent
with results of experiments involving infected cells, expression of wild-type SifA was suf-
ficient to reduce CD-MPR localised to the TGN, and this was dependent on leucine 130
(Fig. 5.8 A). Furthermore, expression of SifA was sufficient to reduce both steady state and
FRAP-associated CatB activity and again this effect required leucine 130 of SifA (Fig. 5.8
B).
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Figure 5.7 : Role of SifA in lysosome functions. FRAP assay of CatB activity in HeLa
cells infected for 14 h with the indicated strains. Data were normalised to the mean
fluorescence of uninfected cells. Error bars represent +/- SEM.
To examine CatB activity in these cells by an independent method HeLa cells were
transiently transfected with a vector expressing SifA::EGFP or SifA(L130D)::EGFP. After
24 h of transfection cells were collected and incubated with MRcatB substrate. Cells
expressing similar levels of EGFP tagged SifA or SifA(L130D) were selected for analysis of
steady state levels of CatB activity using flow cytometry. This method enabled a much
larger number of cells to be analysed than the microscopy-based FRAP assay. In agreement
with the FRAP assay, we observed a significant reduction in CatB-dependent fluorescence
in cells expressing with SifA, compared to cells expressing equivalent levels of SifA(L130D)
(Fig. 5.8 B inset).
Together, these data show that SifA is sufficient to inhibit MPR traffic and lysosome
function. Since L130 is required for binding of SifA to SKIP, they also provide evidence
that SKIP might be involved in lysosome function. These experiments were done together
with Dr. Teresa Thurston of our laboratory.
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Figure 5.8 : SifA is sufficient to redistribute MPRs and attenuate lysosome func-
tion. Cells were transfected with pEGFP-N1 expression vectors expressing GFP
C-terminally fused to SifA or SifA(L130D) and then 24 h later were analysed. (A)
Quantitative 3d confocal microscopy of mean fluorescence signals of CD-MPR lo-
calised to the TGN region in HeLa cells expressing similar levels EGFP tagged in-
dicated proteins normalised to SifA(L130D)-transfected cells. (B) FRAP analysis of
CatB activity in HeLa cells expressing similar levels of the indicated proteins. (Inset
in B) Steady state levels of CatB activity analysed by FACS analysis. Cells were
incubated with Optimem medium for 1 h 30 min. MRcatB fluorescent substrate was
then added for 10 min and cells were analysed by FACS. Statistically significant
differences are denoted using *, as determined through a two tailed student t-test
resulting in a P<0.05.
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5.10 SKIP functions in MPR trafficking
SKIP is a protein of 1020 amino acids that possesses a kinesin-interacting RUN domain and
a PH domain. The N-terminal RUN domain interacts with kinesin-1 and the PH domain
interacts with SifA and Rab9 (Boucrot et al., 2005; Jackson et al., 2008a). To date there
has only been one function ascribed to SKIP in the absence of SifA. It has been shown that
SKIP interacts with the TPR domain of kinesin-1 (Dumont et al., 2010) and affects the
distribution of LE and lysosomes. In SKIP-depleted cells Lamp1-positive vesicles cluster
in the vicinity of the MTOC, whereas in cells overproducing SKIP, Lamp1-positive vesicles
are redistributed to the periphery of the cell (Jackson et al., 2008a; Dumont et al., 2010).
The data presented in this thesis indicate that SKIP might also have a function in
MPR trafficking and lysosomal biogenesis. To investigate this, I depleted endogenous
levels of SKIP in uninfected cells using an siRNA oligo previously shown to affect SKIP
levels (Boucrot et al., 2005) and monitored the impact on CD-MPR TGN localisation
and CatB activity. In cells that were depleted of SKIP (Fig. 5.9 A), there was increased
MPR localised to the TGN compared to scramble-siRNA treated control cells (Fig. 5.9
B). In addition, depletion of SKIP increased both steady state and FRAP-associated CatB
activity (Fig. 5.9 C, C inset).
These results indicate that SKIP acts to negatively regulate MPR trafficking and lysoso-
mal activity. Experiments to analyse the steady state of CatB activity by flow cytometry
and the levels of CD-MPR localised to the TGN were done together with Dr. Teresa
Thurston of our laboratory.
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Figure 5.9 : SKIP is a negative regulator of MPR trafficking and lysosomal biogen-
esis. (A) SDS-PAGE and immunoblotting of the intracellular levels of SKIP in
HeLa cells treated with siRNA oligo against SKIP or scramble control. (B) Quan-
titative 3d confocal microscopy of mean fluorescence signals of CD-MPR localised
to the TGN region in HeLa cells depleted of SKIP by siRNA or exposed to scram-
ble siRNA control normalised to mock-transfected cells (C) HeLa cells depleted of
SKIP by siRNA or exposed to scramble siRNA control were analysed by FRAP as-
say of CatB activity. Error bars represent +/- SEM. (Inset in C) Steady state levels
of CatB activity analysed by FACS analysis. Cells were incubated with Optimem
medium for 1 h 30 min. MRcatB fluorescent substrate was then added for 10 min
and cells were analysed by FACS. Statistically significant differences are denoted
using *, as determined through a two tailed student t-test resulting in a P<0.05.
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5.11 Summary
In this chapter I have shown that intracellular Salmonella reduces the functionality of
lysosomes through the action of SifA, a SPI-2 T3SS effector. Attenuation of lysosome
function was shown in human epithelial cells and mouse macrophages. These results are
consistent with the effect of Salmonella on Syn10-dependent trafficking of MPRs from
endosomes to the TGN. I also show that Syn10 is required for full lysosomal enzyme
activity. The finding that depletion of Syn6 actually stimulates lysosomal enzyme activity
is interesting in relation to the requirement of these two SNARES for shared partner
proteins (Ganley et al., 2008) and suggest that one or more of these proteins might be
rate-limiting, so that removal of Syn6 or Syn10 could stimulate an equilibrium shift to
favour binding to the other partner. Despite the ability of Salmonella to interfere with the
Syn10 pathway, the growth of wild-type bacteria appears to be inhibited to some extent
by the actions of Syn10 and lysosomes, since there was increased bacterial growth in cells
depleted of Syn10 or in which lysosome function was further compromised by exposure to
a lysosomal protease inhibitor. My experiments with bacterial mutants, SifA and SKIP
show clearly that this effect of Salmonella is mediated by SifA and is very likely to involve
SKIP. Perhaps surprisingly, SKIP appears to be a negative regulator of lysosome biogenesis.
Therefore the simplest hypothesis to explain my results is that SifA augments the negative
regulatory activity of SKIP (Fig. 5.10). A mechanistic framework for how this could occur
will be discussed further in the Discussion.
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Figure 5.10 : Salmonella interferes with MPR retrograde traffic through the action
of SifA and SKIP to attenuate lysosome function. Salmonella (turquoise)
in shown in a microcolony associated with the TGN. Retrograde trafficking routes
are denoted with the red arrows or the blocked red line to show interference. An-
terograde trafficking routes are denoted with black arrows. The cargos that define
the two endosome-to-TGN retrograde trafficking routes are shown in blue adjacent
to the route they follow or redistributed to LE/MVB. The SNARE defining the
route of each of the two endosome-to-TGN transport routes are listed adjacent to
relevant route. The physiological impact on the cell are shown in violet adjacent
to the region that they are present. SifA and SKIP complexes are shown on the
surface of the SCV and Sifs.
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Discussion
6.1 Introduction
After bacteria enter a cell they are normally enclosed in a vacuole that is rapidly transported
in a sequential process through endocytic compartments to lysosomes where hydrolytic en-
zymes and other bactericidal molecules mediate their killing (Vieira et al., 2002; Haas, 2007;
Flannagan et al., 2009). Successful intracellular parasitism by a pathogen is dependent on
its ability to manipulate this hostile environment, allowing the establishment of a niche
conducive to survival and replication. As discussed in Chapter 1, there are a variety of
mechanisms employed by bacterial pathogens to accomplish this, including vaculolar lysis,
inhibition of vacuole maturation and deviation of the maturation of the vacuole into one
that will not interact with lysosomes.
The intracellular biology of Salmonella has been the subject of investigation for over
20 years (Finiay & Falkow, 1989). During this time, the broad consensus of the research
community has been that Salmonella manipulates the maturation process of the SCV
to prevent interaction with lysosomes while maintaining an ability to recruit lgps to the
vacuolar membrane. This consensus is based on work from many groups, which has shown
the mature SCV to be relatively devoid of MPR-delivered hydrolytic enzymes yet enriched
in lgps and the vATPase (Garcia-del Portillo & Finlay, 1995; Rathman et al., 1997; Méresse
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et al., 1999b; Hang et al., 2006; Thompson et al., 2011). In spite of intense activity in this
area, the underlying mechanisms by which this is achieved are not understood.
Much of the ability of Salmonella to modify its environment from within the mature
SCV is associated with the SPI-2 T3SS. Acidification of the SCV lumen is used as a sig-
nal for Salmonella to assemble the SPI-2 T3SS (Yoon et al., 2009; Arpaia et al., 2011)
and recognition of the near-neutral cytosolic pH, following formation of the T3SS translo-
con pore in the vacuolar membrane, results in delivery of many effector proteins into the
host-cell cytoplasm, some of which modify endocytic compartments (Yu et al., 2010). To
investigate the characteristics of mature SCVs in more detail, I began by investigating the
influence that Salmonella has on selected proteins of the endomembrane trafficking system
in epithelial cells.
6.2 SCVs and Sifs contain a subset of late endocytic
SNAREs
SNARE proteins are essential components of the cellular machinery governing the speci-
ficity with which intracellular compartments interact. My findings that the late-endocytic
SNAREs Syn7, Syn8 and Vamp7 are enriched on SCVs and Sifs are consistent with previ-
ously reported findings that SCV and Sif membranes contain proteins normally localised
to LEs (Garcia-del Portillo et al., 1993; Garcia-del Portillo & Finlay, 1995; Méresse et al.,
1999a; Mota et al., 2009).
Given these observations it was surprising that I failed to detect appreciable levels
of Vti1b or Vamp8 on SCV or Sif membranes. Both these SNAREs normally function
in conjunction with Syn7 and Syn8 to form SNAREpin complexes (Pryor et al., 2004).
Therefore it might be expected that they would be recruited together with their binding
partner proteins. These data are preliminary and due to time constraints and the direction
that the project has taken these observations have not been investigated as thoroughly as
they might otherwise have been. Nonetheless, these results present the intriguing possibility
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that Salmonella could differentially recruit functionally linked SNARE proteins.
Interestingly, Vti1b and Vamp8 have been identified as critical components for lysoso-
mal fusion events bacterial containing compartments (Furuta et al., 2010). Syn11 has been
proposed as a regulator of Vti1b function in macrophages by controlling its incorporation
in SNAREpin complexes either with Syn7-Syn8 or with Syn6-Syn7 (Offenhäuser et al.,
2011). Binding of Vti1b by Syn11 controls its availability to participate in SNARE com-
plexes that mediate LE to lysosome fusion (Offenhäuser et al., 2011). In addition, Vamp8
and Vti1b have been shown to be essential components enabling lysosomal fusion with the
xenophagosome, a bacteria-containing autophagic compartment that normally fuses with
lysosomes (Furuta et al., 2010). Of LE SNARE proteins involved in lysosomal fusion only
Vamp8 and Vti1b were found to be essential (Furuta et al., 2010). If, as my data suggest,
Salmonella inhibits the recruitment or retention of Vamp8 and Vti1b on SCV and Sif mem-
branes, then this could indicate a novel mechanism through which fusion with lysosomal
compartments is impaired.
6.3 Interactions with post-TGN traffic
The ability of SCVs to localise to the TGN region correlates with the efficiency of intra-
cellular replication of Salmonella (Salcedo & Holden, 2003). From this region Salmonella
is positioned to exploit a site of concentrated transport to and from the TGN. Through
interaction with vesicular traffic at this position Salmonella could satisfy membrane or
nutritional requirements, alter lysosomal enzyme transport and promote the stability of
the SCV membrane. My study provides strong evidence to show that Salmonella interferes
with a subset of cellular traffic that travels from LE to the TGN. However, interactions with
vesicular traffic by Salmonella are not restricted to this pathway. The most striking exam-
ple is in the reorganisation of late endosomal vesicles into Sifs that extend from SCVs and
the collapse of peripherally distributed LEs towards the MTOC/Salmonella microcolony
(Garcia-del Portillo et al., 1993; Brumell et al., 2001; Schroeder et al., 2011). Furthermore,
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recent work has shown that Salmonella specifically recruits SCAMP3, a primarily TGN-
localised protein, to the SCV and its associated tubular network (Mota et al., 2009). These
data provide evidence that Salmonella intercepts and recruits membrane from post-TGN
traffic.
There are several intracellular pathogens that interact with the secretory pathway
through their association with the ER, including Legionella pneumophila, Brucella spp.,
Toxoplasma gondii and several viruses (Salcedo & Holden, 2005; Roy et al., 2006). Only
Salmonella, Chlamydia trachomatis and Chlamydia pneumoniae are known to interfere
with post-TGN exocytic traffic (Hackstadt et al., 1996; van Ooij et al., 2000; Kuhle et al.,
2006; Mota et al., 2009; Capmany & Damiani, 2010). For Chlamydia a subset of TGN-
derived exocytic vesicles rich in sphingomyelin and cholesterol are redirected to the chlamy-
dial inclusion and facilitate replication (Hackstadt et al., 1996; van Ooij et al., 2000; Cap-
many & Damiani, 2010). Similarly Salmonella redirects a subset of post-TGN traffic de-
rived from SCAMP3-containing vesicles to the SCV and tubular membranes (Mota et al.,
2009), though experiments using a VSVG secretion assay did not provide evidence of fusion
between TGN-derived exocytic vesicles and SCVs (Kuhle et al., 2006). It is plausible that
these interactions could help to satisfy membrane or nutrient requirements of replicating
bacteria. Similar to post-TGN traffic these data provide evidence that there is selected
interference with a subset of retrograde traffic by Salmonella. However, in contrast to
SCAMP3-associated traffic I obtained no evidence to suggest that Syn10-dependent traffic
is redirected to SCVs or Sifs membranes.
6.4 Counteracting lysosome function at different stages
after invasion
It has been reported that at early stages following uptake of Salmonella by host-cells,
SCVs selectively avoid fusion with lysosomes (Garcia-del Portillo & Finlay, 1995; Bakowski
et al., 2010; Thompson et al., 2011). Bacteria pretreated with an inhibitor of protein
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synthesis prior to internalisation were unable to prevent being trafficked to lysosomes within
the first 2 hours following internalisation, showing that newly synthesised proteins are
required for this process (Garvis et al., 2001). Recently it was reported that the SPI-1
T3SS effector, SopB, alters the membrane surface charge of the SCV by reducing the levels
of phosphatidylinositol-4,5-bisphosphate and phosphatidylserine on the SCV membrane
(Hernandez et al., 2004; Bakowski et al., 2010). This alters the normal recruitment of host-
cell proteins involved in endocytic trafficking, such as Rab35, and helps bacteria deviate
the maturation of the SCV from trafficking to lysosomes. One of these studies (Bakowski
et al., 2010) suggested that SptP also has a role in this function. Early stage avoidance of
lysosomes by the SPI-1 T3SS might protect the SCV until the SPI-2 T3SS is assembled
and its effectors are translocated into the host-cell, which occurs approximately 2-4 h after
bacterial uptake (Yu et al., 2010).
The main finding to come from my work is that Salmonella possesses a second mecha-
nism by which the antibacterial activities of lysosomes can be reduced through the activity
of the SPI-2 T3SS effector SifA, which somehow interferes with Syn10-dependent retro-
grade trafficking of MPRs to the TGN, thereby preventing normal delivery of hydrolytic
enzymes to endosomes.
6.5 Altered lysosome activity affects the intracellular
growth of Salmonella
The reduction in lysosome activity in cells infected with Salmonella at later stages of in-
fection was also observed when cells were depleted of Syn10 (Fig. 5.3 A). Interestingly,
Syn6 depletion had the opposite effect and enhanced lysosome function (Fig. 5.3 B). This
was correlated with reduced or increased TGN localisation of CD-MPR in Syn10 or Syn6-
depleted cells respectively (Fig. 4.2;Fig. 4.3). Exploiting the differences in MPR localisa-
tion and associated lysosomal activity observed as a result of Syn10 or Syn6 depletion I
was able to address whether lysosomal function has any bearing on Salmonella intracel-
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lular growth. I observed increased growth in Syn10-depleted cells and reduced growth in
Syn6-depleted cells (Fig. 5.4 A, B). Salmonella’s sensitivity to lysosomal activity was also
observed when lysosomal enzymes were exposed to a lysosome-specific protease inhibitor
(Fig. 5.4 B). Thus, enhanced growth observed during Syn10 depletion or pharmacological
treatment is likely to be due to reduced lysosome function and indicates that Salmonella
is sensitive to lysosomal enzymes. In turn, these results are consistent with the notion
that Salmonella does not have a robust mechanism for avoidance of SCV-lysosome fusion,
but rather depletes MPR-dependent hydrolytic enzymes from lysosomes. This conclusion
provides an explanation to resolve the long-standing paradox that SCVs are relatively de-
void of hydrolytic lysosomal enzymes (Hang et al., 2006) yet retain lysosomal membrane
glycoproteins in the vacuolar membrane (Garcia-del Portillo et al., 1993) and interact dy-
namically with the endo-lysosomal system (Drecktrah et al., 2007). The actions of SPI-2
T3SS effectors that regulate SCV membrane dynamics (Knodler & Steele-Mortimer, 2005;
Drecktrah et al., 2008; Dumont et al., 2010; Schroeder et al., 2010) could promote in-
teractions between SCVs and enzyme-depleted lysosomes to provide a source of vacuolar
membrane and possibly nutrients to enable bacterial growth. If such a process occurs,
it seems unlikely that it would involve the activity of Vti1b or Vamp8, which were not
recruited to the SCV or Sif membrane (Fig. 3.3 D, E).
6.6 MPR recycling to the TGN
MPR trafficking in the cell is one of the most extensively studied vesicular trafficking
pathways (Hille-Rehfeld, 1995; Ghosh et al., 2003; Pfeffer, 2009). One critical aspect of its
activity is how, after it delivers its cargo of lysosomal enzymes to endosomes, it is recycled
back to the TGN. Some reports have suggested that MPRs are not recycled in a retrograde
fashion from LE compartments (Meyer et al., 2000; Arighi et al., 2004). Depletion of AP1
or retromer component proteins (Meyer et al., 2000; Arighi et al., 2004) prevented MPRs
recycling to the TGN and resulted in their retention in EEs. These results led to the
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proposal that MPRs are trafficked directly from EEs to the TGN. However, MPRs bind
their ligands in a pH-dependent manner. At a pH <6.0 the ligands dissociate from the
MPRs (Tong & Kornfeld, 1989; Olson et al., 2008). The pH of EE is between pH 6.2-6.3,
while the pH of LEs is between pH 5.2-5.8 (Mukherjee et al., 1997; Mellman & Warren,
2000). Therefore, MPRs would need to traffic to LE to be exposed to an environment with
a pH less that 6.0 to enable the efficient dissociation of their enzyme cargo. Furthermore,
components of LEs that are involved in retrograde traffic to the TGN, such as Rab9, have
been shown to be essential for MPR retrieval (Riederer et al., 1994a; Seaman et al., 2009).
Similar to what was observed on interference of retromer function (Arighi et al., 2004;
Seaman, 2004), when dominant negative Rab7 was expressed in cells, MPRs were retained
in EEs (Rojas et al., 2008), implicating a role for Rab7 in MPR traffic. Interestingly Rab7
was reported to function in the correct localisation of the retromer complex (Rojas et al.,
2008; Seaman et al., 2009). Therefore MPRs probably pass through EEs on their way to
LEs. This EE to LE step is probably dependent on retromer, Rab7 and perhaps AP1.
Subsequently, upon arrival in acidic LEs ligands dissociate and the receptor is recycled to
the TGN in a Rab9-dependent fashion.
The data presented in this thesis support the view that MPR is recycled to the TGN
from LEs and that there are no effects on EE to TGN traffic. I show that Syn10-dependent
retrograde traffic to the TGN is impaired during infection by way of MPR and Vti1b
depletion in the TGN (Fig. 3.7) and impaired CI-MPR traffic from the plasma membrane
to the TGN (Fig. 4.4). In addition, results indicate that Syn6-dependent traffic is not
influenced by Salmonella infection as TGN46 levels in the TGN remained unchanged and
there was no detectable impairment in the retrograde traffic of CTxB (Fig. 3.7; Fig. 4.4).
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6.7 Rab9 and Rab9 effectors function in MPR traffic
and LE distribution
MPR trafficking from LEs to the TGN has been shown to be dependent on Rab9 and it ef-
fectors Tip47, P40, RhoBTB3 GTPase and GCC185 (Pfeffer, 2009). Though the evidence
is still somewhat contradictory (Bulankina et al., 2009) it is thought that a Rab9:Tip47
complex functions in the initial stages of MPR recycling from LE to the TGN (Díaz &
Pfeffer, 1998; Carroll et al., 2001; Aivazian et al., 2006). Tip47 is primarily a cytoso-
lic protein that is recruited by membrane-associated Rab9 on LEs (Díaz & Pfeffer, 1998;
Carroll et al., 2001; Ganley et al., 2004; Aivazian et al., 2006). Here the Rab9:Tip47 com-
plex recognises the cytoplasmic tails of the MPRs by complex-enhanced direct binding of
Tip47 (Carroll et al., 2001; Hanna et al., 2002; Burguete et al., 2004). MPRs are then
packaged into nascent vesicles for transport to the TGN (Barbero et al., 2002). At the
TGN interface, incoming MPR vesicles are guided towards fusion by their interaction with
the vesicle-associated Rab9 and TGN-associated GCC185, a coiled-coil tethering protein
localised to the TGN by Rab6 and Arl1 (Reddy et al., 2006; Burguete et al., 2008; Hayes
et al., 2009). Upon arrival at the TGN, RhoBTB3 GTPase interacts with Rab9 to me-
diate the uncoating of transport vesicles at which point Syn10-Syn16-Vti1a and Vamp3
enable membrane fusion (Espinosa et al., 2009) (Fig. 6.1). In addition to having a role
in MPR recycling, Rab9 has been shown to function in the maintenance of the peripheral
distribution of late endosomal compartments (Ganley et al., 2004). This function has been
ascribed to the interaction between Rab9 and its putative effector SKIP (Jackson et al.,
2008a). SKIP interaction with Rab9 has been localised to the PH domain of SKIP (Jack-
son et al., 2008a), which presumably allows for SKIP’s recruitment to the membrane of
LEs. This enables SKIP’s RUN domain to cross-link the membrane-associated complex
with the TPR domain of kinesin-1 to maintain peripheral distribution of LEs by movement
on microtubules (Dumont et al., 2010). In cells depleted of either Rab9 or SKIP there is
an abrogation of this function and LEs concentrate at the MTOC (Ganley et al., 2004;
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Figure 6.1 : Rab9-mediated retrograde transport from LE/MVBs to the TGN.
Schematic showing proteins known to function in Rab9-mediated transport from
LE/MVBs to the TGN. Retrograde trafficking routes are denoted with the red ar-
rows and anterograde trafficking routes are denoted with black arrows. Equilibrium
of Rab9 binding to its effectors, Tip47 and SKIP, is indicated by the double headed
blue arrow. Kinesin-mediated microtubule-associated anterograde force is indicated
with the green arrow.
Jackson et al., 2008a; Dumont et al., 2010).
Two lines of evidence implicate SKIP as having a second function in the lysosomal
biogenesis pathway. Firstly, the N-terminal region of SifA interacts with the PH domain
of SKIP and this is dependent on L130 of SifA (Diacovich et al., 2009). I showed that
the effect of bacterially-translocated SifA on lysosome function was dependent on L130
(Fig. 5.7), supporting the idea that SKIP is involved. However, it is also possible that SifA
interacts with other protein(s) in an L130-dependent manner. Secondly, and more directly,
in cells depleted of SKIP, there was an increase in the TGN localisation of MPRs and
an overall increase in CatB activity (Fig. 5.9). These data support the notion that SKIP
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acts as a negative regulator of lysosomal biogenesis and that SifA augments this activity.
Interestingly, PLEKHM1, a SKIP-related protein, has recently been reported to have a
negative regulatory role on Rab7-driven processes to lysosomes (Tabata et al., 2010). This
function requires its direct interaction with Rab7 (Tabata et al., 2010). Given that SKIP
binds GTP-bound Rab9 (and is likely to be a Rab9 effector) (Jackson et al., 2008a) and
Rab9’s role in MPR trafficking and lysosomal biogenesis, I hypothesise that SKIP functions
as a modulator of Rab9-driven processes in MPR traffic in an analogous manner to which
PLEKHM1 modulates Rab7.
The dramatic phenotype of collapse of LEs in infected cells also suggests that Rab9-
driven processes in the cell are antagonised (Stein et al., 1996). SifA binds SKIP with an
even greater affinity than Rab9 (Jackson et al., 2008a). These authors suggest that SifA
displaces Rab9 from SKIP and therefore antagonises Rab9:SKIP function, giving rise to
LE clustering at the MTOC. This higher affinity interaction might enhance the negative
regulatory activity of SKIP, thereby inhibiting MPR traffic and lysosome function.
6.8 Putative tri-molecular interaction of SifA, SKIP and
Rab9
As an alternative to the model of SifA competing with Rab9 for binding to SKIP (Jackson
et al., 2008a), I would like to propose a second model which agrees with my data and data
that have been published previously (Riederer et al., 1994a; Aivazian et al., 2006; Seaman
et al., 2009; Dumont et al., 2010). As mentioned there are two functions described for Rab9
and Rab9-binding proteins with respect to LE trafficking. The first is Rab9:Tip47-mediated
retrograde recycling of the MPRs and maintainance of lysosomal homeostasis (Díaz & Pf-
effer, 1998). Secondly, Rab9:SKIP interactions maintain the peripheral distribution of
LEs (Ganley et al., 2004; Jackson et al., 2008a). Results of my experiments suggest that
Rab9:SKIP can also influence MPR recycling and lysosomal homeostasis (Fig. 5.9). One
explanation that addresses the interrelatedness of these phenomena would be that mem-
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Figure 6.2 : Rab9 equilibrium model on LE/MVB membranes in the presence or ab-
sence of SifA. Schematic showing Rab9 on LE/MVBs interacting with SKIP or
Tip47 in the absence of SifA and the putative Rab9, SKIP and SifA tri-molecular
complex in the presence of SifA. Equilibrium of Rab9 binding to its effectors, Tip47
and SKIP, is indicated by the double headed blue arrow which is pushed towards
Rab9, SKIP interaction in the presence of SifA. Retrograde trafficking routes are
denoted by a red arrow or a blocked red line which indicates interference. Disso-
ciation of Tip47 from the membrane in the absence of Rab9 binding is denoted by
a dashed black arrow. Kinesin-mediated microtubule-associated anterograde force is
indicated with the green arrow.
brane associated Rab9 available for binding is limited. In this model (Fig. 6.2) GTP-bound
Rab9 on the LE membranes is in a state of equilibrium between binding its effectors, Tip47
and SKIP. If the availability of either of these partners increases then binding to the other
decreases. Thus, the ratio of Rab9:Tip47 and Rab9:SKIP binding regulates the steady
state level of MPR recycling and LE distribution in cells.
Under normal steady state conditions, Rab9 effector interactions would allow Tip47:Rab9
complex formation, leading to sufficient rates of MPR recycling to the TGN. It has been
shown that in the absence of Rab9 both MPR recycling to the TGN and LE positioning are
perturbed: MPR concentration at the TGN is reduced (Seaman et al., 2009) and Lamp1-
positive vesicles cluster at the MTOC (Ganley et al., 2004; Jackson et al., 2008a). In the
135
Chapter 6: Discussion
absence of SKIP there would be an increase in the amount of Rab9 available to recruit
and bind Tip47. This could give rise to an increased rate of MPR recycling to the TGN
(Fig. 5.9 B), increased lysosomal activity (Fig. 5.9 C) and, as a result of the inability to
engage kinesin, the clustering of LEs and lysosomes at the MTOC (Dumont et al., 2010).
Finally, it has been shown that Tip47 function is required for MPR recycling to the TGN
(Díaz & Pfeffer, 1998).
In the context of infection it is possible that membrane-associated SifA acts as a “sink”
for SKIP due to its higher affinity for SKIP and permanent membrane association (Reinicke
et al., 2005). If the membrane-recruited SKIP were free to interact with GTP-bound
Rab9 this might reduce the proportion of Rab9 available to interact with Tip47. The
Tip47:Rab9 complex co-stabilises the membrane association of each component (Díaz &
Pfeffer, 1998; Ganley et al., 2004; Aivazian et al., 2006). As a result of reduced Rab9
interaction Tip47 would be released from the membrane thereby impairing MPR recycling
to the TGN. However, for this hypothesis to be valid, during infection SifA would need
to be able to bind to SKIP without preventing the binding of Rab9 to SKIP, which is
not compatible with published results (Jackson et al., 2008a). Both SifA and Rab9 have
been reported to bind to SKIP through its PH domain (Jackson et al., 2008a) and this
binding was found to be competitive, though this was only shown in vitro using a truncated
recombinant form of SKIP composed solely of the PH domain. The structure of SifA in
complex with the PH domain of SKIP has been solved (Diacovich et al., 2009) revealing
that the binding interface between these two molecules is formed by the interaction of
two β-sheets from both proteins. Rab9 binding to human Tip47 has been shown to be
dependent on the residues 161GVDKTKSVVTGG172 of Tip47 (Hanna et al., 2002). The
greatest influence on binding was associated with the residues KTKSVV (Hanna et al.,
2002). Interestingly, the N-terminal region of the SKIP PH domain also contains a similar
sequence: 791HWKTCFVVL799. This sequence maps to a surface exposed β-sheet on an
opposing face of the PH domain to the SifA:SKIP interaction site (Fig. 6.3). If this motif
binds Rab9 then SKIP might be able to simultaneously bind SifA and Rab9. If it were
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Putative Rab9-binding site
(KTXXVV)
SKIP PHSifA
SifA, SKIP interface
SKIP R831
SifA, SKIP interface
SifA L130
Figure 6.3 : SifA:SKIP PH-domain crystal structure. SifA:SKIP PH-domain co-crystal
cartoon and surface topology model showing highlighted residues critical for binding
of SifA to SKIP and highlighted putative Rab9 binding site: SifA (L130, green),
SKIP (R831, pink) and the putative Rab9 binding site in SKIP (KTXXVV, yellow).
found to be the case, then it is conceivable that the increased proportion of membrane-
associated SKIP localised to the membrane could titrate the available Rab9 free to interact
with Tip47, thereby inhibiting its function in MPR traffic (Fig. 6.2).
Salmonella is not unique in its ability to interfere with Rab9 function. Rab9 and Rab9
effectors are important during the infection cycles of Marburg virus, Ebola virus, HIV
and measles for viral particle production (Pfeffer, 2009). Notably both HIV and Vaccinia
virus require Rab9 and Tip47 during their biogenesis (Murray et al., 2005; Chen et al.,
2009; Bauby et al., 2010). In addition the Pseudomonas exotoxin uses a Rab9-dependent
pathway to traffic through the cells, in contrast to cholera and Shiga toxins (Smith et al.,
2006; Deng et al., 2007), providing further evidence of a segregated retrograde trafficking
route dependent on Rab9.
6.9 Future areas of investigation
The observation that Salmonella attenuates lysosomal function has opened many avenues
of research to explore this phenomenon from both a mechanistic and physiological point of
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view. Here I describe in broad terms some of the areas that could be pursued in further
investigations.
6.9.1 Do SifA, SKIP and Rab9 form a tri-molecular complex?
To address this question immunoprecipitation experiments could be carried out with SKIP,
Rab9 and SifA. As proposed above, if SifA enhances SKIP recruitment to the membrane to
increase its activity then in the presence of SifA there should be increased SKIP and SKIP-
bound Rab9 associated with membrane fractions. By carrying out membrane fractionation
and co-immunoprecipitation experiments in presence or absence of SifA it would be possible
to assess SifA, SKIP and Rab9 do form a trimolecular complex and would provide an
explanation as to how SKIP could have enhanced negative regulation of lysosome function
during infection.
If evidence of a tri-molecular complex is attained, then the mechanism of interac-
tion could be investigated by mutation of the putative Rab9 binding motif in SKIP
(KTXXVV) to determine if SKIP binding to Rab9 is abrogated. In addition R831 of
SKIP, which has been reported to be essential for SifA binding, could be mutated to evalu-
ate if it still interacts either Rab9 and SifA. The protein-protein interactions could then be
further characterised through a range of biochemical techniques including chromatography,
surface plasmon resonance and structural x-ray crystallography.
6.9.2 What is SKIP’s function in the cell in presence and absence
of infection?
To continue to investigate the function of SKIP , SKIP knock-out mouse embryonic fibrob-
lasts cells could be used. SKIP knock-out mice have already been generated by the Sanger
Research Institute in Cambridge as part of a genome-wide mutation study in mice and are
available as a resource for the research community. Cells with this “clean” genetic back-
ground could be transfected to express wild-type SKIP and mutant versions to investigate
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their effects on lysosome function in the presence or absence of Salmonella.
SKIP has other reported binding partners including both Arl8, an Arf-like GTPase
involved in endocytic trafficking, and the kinesin-1 motor protein (Dumont et al., 2010;
Kaniuk et al., 2011). Both of these interactions have been localised to the RUN domain of
SKIP (Dumont et al., 2010; Kaniuk et al., 2011). Interestingly, depletion of Arl8 from C.
elegans has been reported to induce a pleolysosomal phenotype (Nakae et al., 2010). These
interactions and phenotypes in our systems could be examined to assess if they contribute
to the phenotypes I observed during infection.
6.9.3 What is the fate of MPRs and Vti1b?
An unanswered question raised by my results concerns the fate of both MPRs and Vti1b
in infected cells. In cells that are depleted of Syn10, MPRs are primarily re-localised to
compartments that are retromer (SNX1)-positive (Ganley et al., 2008). When I examined
SNX1 distribution in cells infected for 14 h with Salmonella I found that this protein, like
MPRs, was not recruited to the membranes of the SCV and Sifs. It would be interesting to
examine more closely by confocal microscopy the distribution of SNX1, MPRs, Vti1b and
other markers of EEs, LEs and REs in infected cells. This might help to define at which
point Salmonella blocks transport of MPRs and Vti1b.
6.9.4 What is the role of Rab9 in lysosome biogenesis?
Though interference in Rab9 function has been shown to impair MPR recycling and induce
increased secretion of lysosomal enzymes (Riederer et al., 1994b; Seaman et al., 2009), it
has not been established if its loss could impair lysosome activity. The MRcatB assays
could be used to assess if in cells depleted of Rab9 there is impaired CatB activity. If found
to be the case it would be interesting to assess if the phenotypes of disrupted MPR traffic
to the TGN and reduced lysosome function observed during infection could be reversed by
ectopically expressing Rab9 in infected cells. If SifA titrates available Rab9, preventing
it from functioning in MPR recycling, then the over-expression of Rab9 could rescue the
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phenotype and prevent the effects on lysosome function.
GCC185 tethering is reported to be dependent on the clathrin adaptor AP1 and Rab9
(Brown et al., 2011). GCC185 depletion gives rise to MPR localised to AP-1-positive
vesicles (Brown et al., 2011). GCC185 also binds Rab9 to guide fusion of incoming traffic
at the TGN (Hayes et al., 2009). My results show that SifA inhibits MPR trafficking
by specific interference with the Syn10-dependent endosome to TGN pathway. This is
accompanied by re-routing of lysosomal enzymes and impairment of lysosome function. It
is unlikely that SifA mediates its effect directly through Syn10, as SPI-2 T3SS-dependent
inhibition of lysosome function was also observed in mouse macrophages that lack Syn10
(Ganley et al., 2008) and Syn10 distribution was not altered at the TGN in infected HeLa
cells (Fig. 3.7; Fig. 5.2). Syn10 is a component of a SNARE complex that also interacts
with GCC185 (Ganley et al., 2008). It is possible that SifA inhibits Rab9 function by
preventing or limiting its interaction with GCC185. If so MPRs could re-localise to AP1-
positive compartments. It is also possible that Rab9 function is being interfered with at an
earlier stage where the Rab9:Tip47 complex packages MPRs into nascent recycling vesicles.
Defining the endocytic compartment that MPRs re-localise to during infection will help to
address where the block in MPR traffic is occurring.
6.9.5 Is lysosomal function compromised in infected mice?
An important question remaining is whether lysosomal function is attentuated in the con-
text of an in vivo infection. Isolation of macrophages containing bacteria from spleens
of infected mice has been undertaken in our laboratory previously (Helaine et al., 2010).
This procedure could be used in conjunction with the MRcatB assays to address whether
lysosome activity is reduced in these cells. If found to be the case further experiments to
explore the phenotype in vivo could involve doing infections with a combination of mutant
and wild-type bacteria in conjunction with wild-type or SKIP knock-out mice. These ex-
periments would involve examining lysosomal function in uninfected and infected cells and
would help to establish whether the phenotypes observed during infection of cells in vitro
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are also present in cells from infected tissues . They could also address whether lysosome
function affects bacterial growth in vivo as was observed in vitro (Fig. 5.4).
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